Gene_set,Term,Overlap,P-value,Adjusted P-value,Old P-value,Old Adjusted P-value,Odds Ratio,Combined Score,Genes
KEGG_2021_Human,mitotic cell cycle phase transition (GO:0044772),10/209,3.132131415477564e-13,2.9003536907322236e-10,0,0,49.675879396984925,1430.2625780852777,RB1;CCNB1;CCND1;UBE2C;CDKN2A;CDK4;MYC;E2F1;FOXM1;AURKA
KEGG_2021_Human,regulation of G1/S transition of mitotic cell cycle (GO:2000045),7/71,1.0001766912034066e-11,4.630818080271772e-09,0,0,94.6616847826087,2397.615702429981,RB1;CCND1;CDKN2A;CDK4;PTEN;E2F1;EGFR
KEGG_2021_Human,G1/S transition of mitotic cell cycle (GO:0000082),7/85,3.660160117433194e-11,1.1297694229143793e-08,0,0,77.6164994425864,1865.1965973105907,RB1;CCND1;CDKN2A;CDK4;MYC;E2F1;TYMS
KEGG_2021_Human,positive regulation of mitotic cell cycle phase transition (GO:1901992),6/58,2.5640631118544825e-10,4.856675995171381e-08,0,0,95.7596153846154,2114.780030739728,RB1;CCNB1;CCND1;UBE2C;CDK4;EGFR
KEGG_2021_Human,regulation of cell cycle (GO:0051726),9/296,3.286665115608851e-10,4.856675995171381e-08,0,0,29.39223494275759,641.8081815289999,RB1;CCNB1;CCND1;CDKN2A;CDK4;MYC;BIRC5;FOXM1;TP53
KEGG_2021_Human,"regulation of DNA-templated transcription, initiation (GO:2000142)",6/61,3.5066267204255374e-10,4.856675995171381e-08,0,0,90.52272727272728,1970.7880743786625,CCNB1;CCND1;CDKN2A;CDK4;PTEN;TP53
KEGG_2021_Human,regulation of cell population proliferation (GO:0042127),12/764,4.068874778237358e-10,4.856675995171381e-08,0,0,17.03723404255319,368.3873279171463,ALK;CDKN2A;CDK4;MYC;ERBB2;PTEN;BIRC5;KRAS;FOXM1;TP53;EGFR;VEGFA
KEGG_2021_Human,cell cycle G1/S phase transition (GO:0044843),6/63,4.2821851638974144e-10,4.856675995171381e-08,0,0,87.33771929824562,1883.9957862021104,RB1;CCND1;CDKN2A;CDK4;MYC;E2F1
KEGG_2021_Human,regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),6/64,4.720311442391191e-10,4.856675995171381e-08,0,0,85.82758620689656,1843.0595391299073,CCNB1;CCND1;CDKN2A;CDK4;PTEN;TP53
KEGG_2021_Human,positive regulation of cell population proliferation (GO:0008284),10/474,9.991526648145308e-10,9.252153676182557e-08,0,0,21.01939655172414,435.6083604978356,CDK4;MYC;ERBB2;PTEN;E2F1;BIRC5;KRAS;FOXM1;EGFR;VEGFA
KEGG_2021_Human,positive regulation of phosphorylation (GO:0042327),8/253,2.7010414824290188e-09,2.2737858297538833e-07,0,0,29.27643784786642,577.6132397335329,ALK;CCND1;ERBB2;KRAS;MMP9;MET;EGFR;VEGFA
KEGG_2021_Human,response to UV-A (GO:0070141),4/14,4.072753297544103e-09,3.142807961271533e-07,0,0,307.0769230769231,5932.4026729728075,CCND1;MMP1;MMP9;EGFR
KEGG_2021_Human,positive regulation of cellular process (GO:0048522),10/625,1.4119961653100971e-08,1.005775730059346e-06,0,0,15.735772357723578,284.4347277939742,CCND1;CDK4;MYC;ERBB2;PTEN;BIRC5;KRAS;FOXM1;EGFR;VEGFA
KEGG_2021_Human,negative regulation of apoptotic process (GO:0043066),9/485,2.4493078005720696e-08,1.6200421595212402e-06,0,0,17.551620648259302,307.58996299275725,RB1;PIK3CA;MYC;BIRC5;BRAF;MMP9;TP53;EGFR;VEGFA
KEGG_2021_Human,mitotic G1 DNA damage checkpoint signaling (GO:0031571),5/65,4.147827623661016e-08,2.560592253006734e-06,0,0,66.36666666666666,1128.1069719262523,CCNB1;CCND1;E2F1;TP53;AURKA
KEGG_2021_Human,positive regulation of protein phosphorylation (GO:0001934),8/371,5.326936402101244e-08,3.082964442716095e-06,0,0,19.64137240170298,328.9518283462831,CCND1;ERBB2;BRAF;KRAS;MMP9;TP53;EGFR;VEGFA
KEGG_2021_Human,negative regulation of programmed cell death (GO:0043069),8/381,6.538199880918128e-08,3.561395935135404e-06,0,0,19.105045088959297,316.05512130301787,MYC;BIRC5;BRAF;MMP9;MET;TP53;EGFR;VEGFA
KEGG_2021_Human,regulation of apoptotic process (GO:0042981),10/742,7.122287263378748e-08,3.6640211143826223e-06,0,0,13.140710382513662,216.2626080699125,ALK;TOP2A;MYC;E2F1;BIRC5;BRAF;MMP9;TP53;EGFR;VEGFA
KEGG_2021_Human,"DNA damage response, signal transduction by p53 class mediator (GO:0030330)",5/74,8.013740614758281e-08,3.905644110140089e-06,0,0,57.68405797101449,942.5299976485272,CCNB1;E2F1;FOXM1;TP53;AURKA
KEGG_2021_Human,transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),8/404,1.0257818243475557e-07,4.701387126224559e-06,0,0,17.9742883379247,289.25376178949733,COL1A1;ALK;PIK3CA;ERBB2;MMP9;MET;EGFR;VEGFA
KEGG_2021_Human,regulation of protein phosphorylation (GO:0001932),7/266,1.0661893050833235e-07,4.701387126224559e-06,0,0,23.16216216216216,371.8454615215965,CCND1;ERBB2;PTEN;KRAS;MMP9;EGFR;VEGFA
KEGG_2021_Human,regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),5/82,1.3461099408226645e-07,5.665899114553578e-06,0,0,51.67012987012987,817.466755991372,CCNB1;CCND1;CDKN2A;PTEN;EGFR
KEGG_2021_Human,anaphase-promoting complex-dependent catabolic process (GO:0031145),5/84,1.5198846538399078e-07,6.1191877802424114e-06,0,0,50.356962025316456,790.5771716985369,CDC20;RB1;CCNB1;UBE2C;AURKA
KEGG_2021_Human,negative regulation of cell cycle G1/S phase transition (GO:1902807),4/35,2.084444326282279e-07,8.04248102557246e-06,0,0,98.95285359801488,1522.2504597233535,RB1;CDKN2A;CDK4;PTEN
KEGG_2021_Human,negative regulation of mitotic cell cycle phase transition (GO:1901991),5/92,2.400965919274671e-07,8.844458803001882e-06,0,0,45.708045977011494,696.6922995272562,RB1;CDKN2A;CDK4;PTEN;AURKA
KEGG_2021_Human,MAPK cascade (GO:0000165),7/303,2.580535364327234e-07,8.844458803001882e-06,0,0,20.228848413631024,306.8736283976403,PIK3CA;MYC;ERBB2;BRAF;KRAS;MET;EGFR
KEGG_2021_Human,negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),4/37,2.623784252745423e-07,8.844458803001882e-06,0,0,92.94638694638697,1408.4610301442117,RB1;CDKN2A;CDK4;PTEN
KEGG_2021_Human,regulation of kinase activity (GO:0043549),5/94,2.67435039399625e-07,8.844458803001882e-06,0,0,44.67640449438202,676.1500911489362,ALK;RB1;ERBB2;MET;EGFR
KEGG_2021_Human,cellular response to cytokine stimulus (GO:0071345),8/482,3.941804873473308e-07,1.2167037709454278e-05,0,0,14.956655159186806,220.55767131363712,PIK3CA;CCND1;MMP1;MYC;BIRC5;MMP9;TP53;VEGFA
KEGG_2021_Human,positive regulation of gene expression (GO:0010628),8/482,3.941804873473308e-07,1.2167037709454278e-05,0,0,14.956655159186806,220.55767131363712,MYC;ERBB2;E2F1;BRAF;KRAS;TP53;EGFR;VEGFA
KEGG_2021_Human,regulation of fibroblast proliferation (GO:0048145),4/46,6.422530681585423e-07,1.881039894583026e-05,0,0,72.99633699633699,1040.8024617904323,CDK4;MYC;E2F1;TP53
KEGG_2021_Human,positive regulation of ubiquitin protein ligase activity (GO:1904668),3/12,6.638552689392329e-07,1.881039894583026e-05,0,0,246.4320987654321,3505.546305288435,CDC20;UBE2C;PTEN
KEGG_2021_Human,positive regulation of protein modification process (GO:0031401),6/214,6.703489905101496e-07,1.881039894583026e-05,0,0,23.752403846153847,337.6515220434298,CCND1;ERBB2;KRAS;MMP9;EGFR;VEGFA
KEGG_2021_Human,regulation of transcription by RNA polymerase II (GO:0006357),14/2206,9.890181703950437e-07,2.693620075840619e-05,0,0,7.096601277372263,98.12153462530333,RB1;CDKN2A;PTEN;FOXM1;EGFR;VEGFA;CCNB1;CCND1;CDK4;MYC;ERBB2;E2F1;MET;TP53
KEGG_2021_Human,microtubule cytoskeleton organization involved in mitosis (GO:1902850),5/128,1.2440768092745254e-06,3.291471786823459e-05,0,0,32.271544715447156,438.79996351470095,CDC20;CCNB1;BIRC5;BUB1;AURKA
KEGG_2021_Human,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",4/56,1.4306062572969215e-06,3.679837206269304e-05,0,0,58.928994082840234,793.0317666964794,CCNB1;E2F1;TP53;AURKA
KEGG_2021_Human,phosphorylation (GO:0016310),7/400,1.6618811208450946e-06,4.159194372709615e-05,0,0,15.160858502046686,201.75404010842968,ALK;PIK3CA;CDK4;ERBB2;BIRC5;BRAF;AURKA
KEGG_2021_Human,positive regulation of transferase activity (GO:0051347),5/148,2.5452345695736795e-06,6.202334766908493e-05,0,0,27.73006993006993,357.1990099143294,ALK;MYC;ERBB2;MET;EGFR
KEGG_2021_Human,cytokine-mediated signaling pathway (GO:0019221),8/621,2.6402287055231068e-06,6.268850721318967e-05,0,0,11.48272282366899,147.49149846049016,PIK3CA;CCND1;MMP1;MYC;BIRC5;MMP9;TP53;VEGFA
KEGG_2021_Human,ERBB signaling pathway (GO:0038127),4/66,2.7781889874226016e-06,6.274641469154461e-05,0,0,49.39950372208437,632.0029882878963,PIK3CA;ERBB2;BRAF;EGFR
KEGG_2021_Human,positive regulation of cell cycle (GO:0045787),4/66,2.7781889874226016e-06,6.274641469154461e-05,0,0,49.39950372208437,632.0029882878963,CCNB1;CCND1;CDK4;EGFR
KEGG_2021_Human,mitotic spindle organization (GO:0007052),5/157,3.4005796521994466e-06,7.34832320163586e-05,0,0,26.07631578947369,328.3416162255878,CDC20;CCNB1;BIRC5;BUB1;AURKA
KEGG_2021_Human,positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),3/20,3.412288311774752e-06,7.34832320163586e-05,0,0,130.41176470588235,1641.6399128222724,CCNB1;CCND1;CDK4
KEGG_2021_Human,myeloid leukocyte differentiation (GO:0002573),4/71,3.72597760282196e-06,7.841489227757126e-05,0,0,45.701492537313435,571.2769422532601,CDK4;E2F1;MMP9;VEGFA
KEGG_2021_Human,regulation of ubiquitin protein ligase activity (GO:1904666),3/21,3.976980759391483e-06,8.183742629325586e-05,0,0,123.1604938271605,1531.499217211056,CDC20;UBE2C;PTEN
KEGG_2021_Human,regulation of chromosome organization (GO:0033044),3/22,4.600272051318671e-06,9.260547651132802e-05,0,0,116.67251461988305,1433.8346311808384,RB1;MYC;BUB1
KEGG_2021_Human,"positive regulation of transcription, DNA-templated (GO:0045893)",10/1183,5.100540338322769e-06,9.949081988894036e-05,0,0,8.012361466325661,97.6399514580974,COL1A1;MYC;ERBB2;E2F1;SPP1;FOXM1;MET;TP53;EGFR;VEGFA
KEGG_2021_Human,cellular response to UV (GO:0034644),4/77,5.15719152772045e-06,9.949081988894036e-05,0,0,41.93256059009484,510.533890176415,MMP1;MYC;MMP9;TP53
KEGG_2021_Human,positive regulation of cell cycle G2/M phase transition (GO:1902751),3/23,5.284966899503806e-06,9.987508875388825e-05,0,0,110.83333333333331,1346.696399028853,CCNB1;CCND1;CDK4
KEGG_2021_Human,"negative regulation of transcription, DNA-templated (GO:0045892)",9/948,6.753447820719468e-06,0.0001246100577727779,0,0,8.685988133272478,103.41066165617502,RB1;CCND1;CDKN2A;MYC;E2F1;BIRC5;FOXM1;TP53;VEGFA
KEGG_2021_Human,protein phosphorylation (GO:0006468),7/496,6.862972944289064e-06,0.0001246100577727779,0,0,12.124744376278118,144.15557006020202,ALK;CDK4;ERBB2;BIRC5;BRAF;EGFR;AURKA
KEGG_2021_Human,regulation of mitotic metaphase/anaphase transition (GO:0030071),3/26,7.735344501697224e-06,0.00013774863478022362,0,0,96.3623188405797,1134.1565994177497,RB1;CCNB1;UBE2C
KEGG_2021_Human,"regulation of transcription, DNA-templated (GO:0006355)",13/2244,8.145229835275475e-06,0.00014035552839680482,0,0,6.080285812218209,71.24926400785914,RB1;CDKN2A;TYMS;FOXM1;EGFR;VEGFA;COL1A1;MYC;ERBB2;E2F1;SPP1;BIRC5;TP53
KEGG_2021_Human,regulation of mitotic cell cycle phase transition (GO:1901990),5/188,8.192707705149034e-06,0.00014035552839680482,0,0,21.62513661202186,253.279354526915,CDC20;CCNB1;UBE2C;E2F1;AURKA
KEGG_2021_Human,positive regulation of nucleic acid-templated transcription (GO:1903508),7/511,8.336451470652554e-06,0.00014035552839680482,0,0,11.754830917874395,137.4712537250563,COL1A1;MYC;E2F1;SPP1;FOXM1;TP53;EGFR
KEGG_2021_Human,positive regulation of fibroblast proliferation (GO:0048146),3/28,9.726841758002346e-06,0.00016084027621268164,0,0,88.64444444444445,1023.0119639068774,CDK4;MYC;E2F1
KEGG_2021_Human,regulation of epithelial cell proliferation (GO:0050678),4/93,1.0943185324258111e-05,0.00017777876509233355,0,0,34.36646499567848,392.5610377906923,MYC;ERBB2;EGFR;VEGFA
KEGG_2021_Human,regulation of cell cycle phase transition (GO:1901987),4/95,1.1907152458916844e-05,0.0001901038478785689,0,0,33.607776838546066,381.05745207513735,CDC20;CCNB1;UBE2C;TP53
KEGG_2021_Human,negative regulation of cellular macromolecule biosynthetic process (GO:2000113),7/547,1.2976555697628123e-05,0.0002011604133078584,0,0,10.950885668276973,123.22337615321985,RB1;CDKN2A;E2F1;BIRC5;TYMS;FOXM1;TP53
KEGG_2021_Human,regulation of protein kinase B signaling (GO:0051896),5/207,1.3062406452714093e-05,0.0002011604133078584,0,0,19.572277227722772,220.1053709381813,PIK3CA;ERBB2;PTEN;MET;EGFR
KEGG_2021_Human,positive regulation of ubiquitin-protein transferase activity (GO:0051443),3/31,1.330577067114537e-05,0.0002011604133078584,0,0,79.13492063492063,888.4725019735519,CDC20;UBE2C;PTEN
KEGG_2021_Human,regulation of peptidyl-serine phosphorylation (GO:0033135),4/98,1.3468623785191383e-05,0.0002011604133078584,0,0,32.53027823240589,364.8318764531277,PTEN;BRAF;EGFR;VEGFA
KEGG_2021_Human,response to UV (GO:0009411),4/99,1.4021132937600505e-05,0.0002060883984161598,0,0,32.18623481781376,359.6793996924981,CCND1;MYC;TP53;EGFR
KEGG_2021_Human,ERBB2 signaling pathway (GO:0038128),3/32,1.466738837337456e-05,0.00020895387128838216,0,0,76.40229885057471,850.3487240482457,PIK3CA;ERBB2;EGFR
KEGG_2021_Human,regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),3/32,1.466738837337456e-05,0.00020895387128838216,0,0,76.40229885057471,850.3487240482457,RB1;E2F1;TYMS
KEGG_2021_Human,positive regulation of protein localization to membrane (GO:1905477),4/101,1.5176027371704345e-05,0.0002129242628211852,0,0,31.519429024583665,349.7330763791421,ERBB2;E2F1;TP53;EGFR
KEGG_2021_Human,regulation of cell growth (GO:0001558),5/217,1.6402619832629297e-05,0.00022669889500021983,0,0,18.639622641509433,205.37265753153028,RB1;CDKN2A;ERBB2;TP53;EGFR
KEGG_2021_Human,phosphatidylinositol 3-kinase signaling (GO:0014065),3/34,1.765973730172786e-05,0.00024048406972647057,0,0,71.46594982078852,782.1393087705632,PIK3CA;ERBB2;PTEN
KEGG_2021_Human,small GTPase mediated signal transduction (GO:0007264),4/106,1.83688783630966e-05,0.00024299401948896357,0,0,29.96681749622926,326.7837312439411,RB1;CDKN2A;KRAS;TP53
KEGG_2021_Human,positive regulation of protein serine/threonine kinase activity (GO:0071902),4/106,1.83688783630966e-05,0.00024299401948896357,0,0,29.96681749622926,326.7837312439411,CCND1;ERBB2;EGFR;VEGFA
KEGG_2021_Human,regulation of gene expression (GO:0010468),9/1079,1.912954842712098e-05,0.000249047169781128,0,0,7.570093457943925,82.24358755160058,RB1;CDK4;MYC;E2F1;BRAF;KRAS;TP53;VEGFA;AURKA
KEGG_2021_Human,positive regulation of macromolecule metabolic process (GO:0010604),6/384,1.936435877347863e-05,0.000249047169781128,0,0,12.957671957671955,140.6176455091447,MYC;E2F1;BRAF;KRAS;TP53;VEGFA
KEGG_2021_Human,positive regulation of cellular component organization (GO:0051130),4/114,2.4469635298620526e-05,0.00030620111198003525,0,0,27.776223776223777,294.9300990642989,CDC20;RB1;MMP1;VEGFA
KEGG_2021_Human,positive regulation of kinase activity (GO:0033674),4/114,2.4469635298620526e-05,0.00030620111198003525,0,0,27.776223776223777,294.9300990642989,ALK;ERBB2;MET;EGFR
KEGG_2021_Human,regulation of nitric oxide mediated signal transduction (GO:0010749),2/6,3.250333722969562e-05,0.00040130787032930857,0,0,356.5357142857143,3684.499894523836,EGFR;VEGFA
KEGG_2021_Human,positive regulation of epithelial cell proliferation (GO:0050679),4/123,3.298141714694363e-05,0.00040185252997460263,0,0,25.66386554621849,264.83996129648244,MYC;ERBB2;EGFR;VEGFA
KEGG_2021_Human,branching morphogenesis of an epithelial tube (GO:0048754),3/44,3.869184698386548e-05,0.00046530714684492775,0,0,54.00813008130081,548.7162098920684,MYC;MET;VEGFA
KEGG_2021_Human,chromosome condensation (GO:0030261),3/45,4.14136453788013e-05,0.0004916543028303847,0,0,52.71957671957672,532.0407033036188,RB1;TOP2A;CCNB1
KEGG_2021_Human,negative regulation of stress-activated protein kinase signaling cascade (GO:0070303),2/7,4.546235690936047e-05,0.0005328878797223772,0,0,285.2142857142857,2851.750942795132,MYC;FOXM1
KEGG_2021_Human,epidermal growth factor receptor signaling pathway (GO:0007173),3/47,4.722800299708779e-05,0.0005466641346912911,0,0,50.31818181818182,501.19543536852706,PIK3CA;BRAF;EGFR
KEGG_2021_Human,regulation of stress-activated MAPK cascade (GO:0032872),3/49,5.355353443650065e-05,0.0006104273639690427,0,0,48.1256038647343,473.30707301492265,MYC;FOXM1;EGFR
KEGG_2021_Human,negative regulation of transcription by RNA polymerase II (GO:0000122),7/684,5.43357571485425e-05,0.0006104273639690427,0,0,8.6732387129921,85.17404930240279,RB1;CCND1;MYC;E2F1;FOXM1;TP53;VEGFA
KEGG_2021_Human,enzyme linked receptor protein signaling pathway (GO:0007167),4/140,5.4714331759644216e-05,0.0006104273639690427,0,0,22.436651583710407,220.1794973259299,ALK;ERBB2;MET;EGFR
KEGG_2021_Human,negative regulation of nucleic acid-templated transcription (GO:1903507),6/464,5.584676011933568e-05,0.0006156440460774386,0,0,10.65065502183406,104.30078938692238,RB1;CDKN2A;E2F1;BIRC5;FOXM1;TP53
KEGG_2021_Human,regulation of cellular component movement (GO:0051270),3/50,5.691425903052129e-05,0.000620030633673679,0,0,47.09929078014184,460.3468031322656,ERBB2;EGFR;VEGFA
KEGG_2021_Human,Ras protein signal transduction (GO:0007265),4/142,5.78236474103305e-05,0.0006226127616507679,0,0,22.109253065774805,215.7445840397391,RB1;CDKN2A;KRAS;TP53
KEGG_2021_Human,regulation of G2/M transition of mitotic cell cycle (GO:0010389),4/149,6.972867537884472e-05,0.0007421695793196577,0,0,21.03448275862069,201.31890817721697,CCNB1;CCND1;CDK4;AURKA
KEGG_2021_Human,positive regulation of mitochondrion organization (GO:0010822),3/58,8.887739009987521e-05,0.000933416951589509,0,0,40.23232323232323,375.2972809322434,MMP9;TP53;AURKA
KEGG_2021_Human,protein autophosphorylation (GO:0046777),4/159,8.971286035795496e-05,0.000933416951589509,0,0,19.667493796526056,183.27933769617135,ALK;ERBB2;EGFR;AURKA
KEGG_2021_Human,positive regulation of protein kinase B signaling (GO:0051897),4/161,9.416140358294387e-05,0.0009688162190867336,0,0,19.41499265066144,179.98669303277816,PIK3CA;ERBB2;MET;EGFR
KEGG_2021_Human,"DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)",2/10,9.7147588503534e-05,0.00098855677971728,0,0,178.23214285714286,1646.7365311362207,FOXM1;TP53
KEGG_2021_Human,proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),5/321,0.00010579775635637448,0.0010648774172391,0,0,12.439240506329114,113.86857429979756,CDC20;RB1;CCNB1;UBE2C;AURKA
KEGG_2021_Human,cellular response to UV-A (GO:0071492),2/11,0.00011862538453320848,0.0011562853271342,0,0,158.4206349206349,1432.0496756090347,MMP1;MMP9
KEGG_2021_Human,"DNA damage response, signal transduction resulting in transcription (GO:0042772)",2/11,0.00011862538453320848,0.0011562853271342,0,0,158.4206349206349,1432.0496756090347,FOXM1;TP53
KEGG_2021_Human,positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),2/11,0.00011862538453320848,0.0011562853271342,0,0,158.4206349206349,1432.0496756090347,TP53;EGFR
KEGG_2021_Human,neuron differentiation (GO:0030182),4/174,0.00012709277160129578,0.0012259156927374,0,0,17.918552036199095,160.74004200179456,ALK;ERBB2;MET;VEGFA
KEGG_2021_Human,positive regulation of developmental process (GO:0051094),4/177,0.0001357435324457757,0.0012785803429037,0,0,17.605157847932414,156.7694103955469,CDC20;ALK;VEGFA;AURKA
KEGG_2021_Human,positive regulation of intracellular signal transduction (GO:1902533),6/546,0.00013681459856486894,0.0012785803429037,0,0,8.99537037037037,80.03076531727088,PIK3CA;ERBB2;MET;TP53;EGFR;VEGFA
KEGG_2021_Human,regulation of mitotic cell cycle (GO:0007346),4/178,0.00013871972775252736,0.0012785803429037,0,0,17.50309460654288,155.48095219143642,CDC20;RB1;CCNB1;UBE2C
KEGG_2021_Human,regulation of keratinocyte migration (GO:0051547),2/12,0.00014221789991262262,0.0012785803429037,0,0,142.57142857142858,1262.919124249693,PTEN;MMP9
KEGG_2021_Human,regulation of sister chromatid cohesion (GO:0007063),2/12,0.00014221789991262262,0.0012785803429037,0,0,142.57142857142858,1262.919124249693,RB1;BUB1
KEGG_2021_Human,replicative senescence (GO:0090399),2/12,0.00014221789991262262,0.0012785803429037,0,0,142.57142857142858,1262.919124249693,CDKN2A;TP53
KEGG_2021_Human,mitotic G1/S transition checkpoint signaling (GO:0044819),2/12,0.00014221789991262262,0.0012785803429037,0,0,142.57142857142858,1262.919124249693,CCND1;TP53
KEGG_2021_Human,cellular response to decreased oxygen levels (GO:0036294),3/69,0.0001492461826251745,0.0013162091915324,0,0,33.50841750841751,295.206255852885,MYC;TP53;VEGFA
KEGG_2021_Human,positive regulation of MAP kinase activity (GO:0043406),3/69,0.0001492461826251745,0.0013162091915324,0,0,33.50841750841751,295.206255852885,ERBB2;EGFR;VEGFA
KEGG_2021_Human,cellular response to DNA damage stimulus (GO:0006974),5/350,0.00015857875499494133,0.0013853200672199,0,0,11.376811594202898,99.53867363363952,TOP2A;CCND1;MYC;E2F1;TP53
KEGG_2021_Human,phosphatidylinositol-mediated signaling (GO:0048015),3/71,0.00016247922795874684,0.001406128645699,0,0,32.51960784313726,283.7322904048699,PIK3CA;ERBB2;PTEN
KEGG_2021_Human,negative regulation of cellular process (GO:0048523),6/566,0.00016643978547304622,0.0014270670495188,0,0,8.665178571428571,75.39465261038788,RB1;CDKN2A;MYC;PTEN;FOXM1;TP53
KEGG_2021_Human,negative regulation of cell differentiation (GO:0045596),4/191,0.00018185667570382255,0.001544947538548,0,0,16.27560674619498,140.17027252258384,RB1;PTEN;E2F1;EGFR
KEGG_2021_Human,vascular endothelial growth factor signaling pathway (GO:0038084),2/14,0.00019572323532665868,0.0016476337810225,0,0,118.79761904761904,1014.3901741044946,PIK3CA;VEGFA
KEGG_2021_Human,negative regulation of protein serine/threonine kinase activity (GO:0071901),3/78,0.0002147426973093748,0.0017914570964728,0,0,29.474074074074075,248.9400929097906,RB1;CDKN2A;PTEN
KEGG_2021_Human,positive regulation of endothelial cell chemotaxis (GO:2001028),2/15,0.0002256241583974691,0.0018489200944783,0,0,109.65384615384616,920.7238662710552,MET;VEGFA
KEGG_2021_Human,macrophage differentiation (GO:0030225),2/15,0.0002256241583974691,0.0018489200944783,0,0,109.65384615384616,920.7238662710552,MMP9;VEGFA
KEGG_2021_Human,negative regulation of cell population proliferation (GO:0008285),5/379,0.00022954966827580075,0.0018636589475213,0,0,10.479144385026736,87.80884953478704,CDKN2A;MYC;PTEN;E2F1;TP53
KEGG_2021_Human,negative regulation of cell cycle (GO:0045786),3/80,0.00023144792544811684,0.0018636589475213,0,0,28.705627705627705,240.29927766413917,RB1;CDKN2A;PTEN
KEGG_2021_Human,regulation of ERBB signaling pathway (GO:1901184),2/16,0.00025761600687002403,0.0020564863996693,0,0,101.81632653061224,841.4142385973647,ERBB2;EGFR
KEGG_2021_Human,extracellular structure organization (GO:0043062),4/216,0.00029088238061144585,0.002289047375094,0,0,14.338171262699564,116.74987235018932,COL1A1;MMP1;SPP1;MMP9
KEGG_2021_Human,positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),2/17,0.00029169286205301905,0.002289047375094,0,0,95.02380952380952,773.4756743774749,CCND1;EGFR
KEGG_2021_Human,external encapsulating structure organization (GO:0045229),4/217,0.00029603696132733307,0.0023036153461269,0,0,14.270133622246298,115.94521015883412,COL1A1;MMP1;SPP1;MMP9
KEGG_2021_Human,positive regulation of transcription by RNA polymerase II (GO:0045944),7/908,0.0003158879680919844,0.0024283706982097,0,0,6.4412971094918685,51.91764658650781,MYC;E2F1;FOXM1;MET;TP53;EGFR;VEGFA
KEGG_2021_Human,positive regulation of cell motility (GO:2000147),4/221,0.0003173140977142343,0.0024283706982097,0,0,14.004253810705425,112.81292509766702,COL1A1;MMP9;EGFR;VEGFA
KEGG_2021_Human,regulation of cell migration (GO:0030334),5/408,0.0003225648010460889,0.0024287040375895,0,0,9.710669975186104,78.06608126579629,COL1A1;PTEN;MMP9;EGFR;VEGFA
KEGG_2021_Human,negative regulation of fibroblast proliferation (GO:0048147),2/18,0.00032784881716921787,0.0024287040375895,0,0,89.08035714285714,714.6879621205851,MYC;TP53
KEGG_2021_Human,regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),2/18,0.00032784881716921787,0.0024287040375895,0,0,89.08035714285714,714.6879621205851,TP53;EGFR
KEGG_2021_Human,positive chemotaxis (GO:0050918),2/18,0.00032784881716921787,0.0024287040375895,0,0,89.08035714285714,714.6879621205851,MET;VEGFA
KEGG_2021_Human,regulation of peptidyl-tyrosine phosphorylation (GO:0050730),3/92,0.00034949988210486357,0.0025685467526119,0,0,24.820224719101123,197.5443505613132,TP53;EGFR;VEGFA
KEGG_2021_Human,positive regulation of peptidyl-serine phosphorylation (GO:0033138),3/93,0.0003607851781524913,0.0026306068895213,0,0,24.54320987654321,194.55961688941923,BRAF;EGFR;VEGFA
KEGG_2021_Human,negative regulation of MAPK cascade (GO:0043409),3/94,0.0003723028623192989,0.0026933785195911,0,0,24.27228327228327,191.6491643817023,MYC;PTEN;FOXM1
KEGG_2021_Human,negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),2/20,0.00040637445946356223,0.0028640798576606,0,0,79.17460317460318,618.2139479571657,CDKN2A;PTEN
KEGG_2021_Human,positive regulation of cyclin-dependent protein kinase activity (GO:1904031),2/20,0.00040637445946356223,0.0028640798576606,0,0,79.17460317460318,618.2139479571657,CCND1;EGFR
KEGG_2021_Human,granulocyte differentiation (GO:0030851),2/20,0.00040637445946356223,0.0028640798576606,0,0,79.17460317460318,618.2139479571657,CDK4;E2F1
KEGG_2021_Human,regulation of MAP kinase activity (GO:0043405),3/97,0.000408270562863074,0.0028640798576606,0,0,23.494089834515368,183.33802033627984,ERBB2;EGFR;VEGFA
KEGG_2021_Human,regulation of ERK1 and ERK2 cascade (GO:0070372),4/238,0.000420147775095021,0.0029252393965262,0,0,12.975673898750822,100.88461971693135,ERBB2;PTEN;BRAF;EGFR
KEGG_2021_Human,regulation of intracellular signal transduction (GO:1902531),5/437,0.0004418206619695047,0.0030330379236916,0,0,9.045370370370373,69.87192676124101,PTEN;TP53;EGFR;VEGFA;AURKA
KEGG_2021_Human,spindle assembly checkpoint signaling (GO:0071173),2/21,0.0004487323925980029,0.0030330379236916,0,0,75.00375939849624,578.2102706794014,CDC20;BUB1
KEGG_2021_Human,mitotic spindle assembly checkpoint signaling (GO:0007094),2/21,0.0004487323925980029,0.0030330379236916,0,0,75.00375939849624,578.2102706794014,CDC20;BUB1
KEGG_2021_Human,mitotic spindle checkpoint signaling (GO:0071174),2/21,0.0004487323925980029,0.0030330379236916,0,0,75.00375939849624,578.2102706794014,CDC20;BUB1
KEGG_2021_Human,negative regulation of cyclin-dependent protein kinase activity (GO:1904030),2/22,0.0004931459174352375,0.0032618079967502,0,0,71.25,542.5477632515199,CDKN2A;PTEN
KEGG_2021_Human,negative regulation of mitotic metaphase/anaphase transition (GO:0045841),2/22,0.0004931459174352375,0.0032618079967502,0,0,71.25,542.5477632515199,CDC20;BUB1
KEGG_2021_Human,negative regulation of phosphate metabolic process (GO:0045936),2/22,0.0004931459174352375,0.0032618079967502,0,0,71.25,542.5477632515199,CDKN2A;TP53
KEGG_2021_Human,positive regulation of cellular metabolic process (GO:0031325),3/105,0.0005149106542529526,0.0033816118144555,0,0,21.642701525054463,163.8680859692293,CCNB1;TP53;VEGFA
KEGG_2021_Human,regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),3/106,0.0005293731230241498,0.0034521092388757,0,0,21.431499460625673,161.67531078544127,PIK3CA;PTEN;EGFR
KEGG_2021_Human,response to gamma radiation (GO:0010332),2/24,0.0005881163648560729,0.0037819149573383,0,0,64.76623376623377,481.769182294251,MYC;TP53
KEGG_2021_Human,positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),2/24,0.0005881163648560729,0.0037819149573383,0,0,64.76623376623377,481.769182294251,TP53;VEGFA
KEGG_2021_Human,regulation of protein serine/threonine kinase activity (GO:0071900),3/111,0.0006055954099760554,0.0038674575837091,0,0,20.43415637860082,151.40276287997665,RB1;CCNB1;CCND1
KEGG_2021_Human,positive regulation of release of cytochrome c from mitochondria (GO:0090200),2/25,0.0006386616282018391,0.0040506895048965,0,0,61.9472049689441,455.6920507677008,MMP9;TP53
KEGG_2021_Human,negative regulation of signal transduction (GO:0009968),4/267,0.0006475080417156471,0.0040513003150587,0,0,11.527932143901726,84.6424508619817,RB1;ERBB2;PTEN;EGFR
KEGG_2021_Human,protein deubiquitination (GO:0016579),4/267,0.0006475080417156471,0.0040513003150587,0,0,11.527932143901726,84.6424508619817,CDC20;MYC;PTEN;TP53
KEGG_2021_Human,cellular protein modification process (GO:0006464),7/1025,0.0006556331132667947,0.0040746057911748,0,0,5.6660117878192535,41.53135195368726,CDK4;ERBB2;PTEN;SPP1;BIRC5;BRAF;AURKA
KEGG_2021_Human,positive regulation of cell migration (GO:0030335),4/269,0.0006658546679345158,0.0041105428167157,0,0,11.43976777939042,83.67548505567132,COL1A1;MMP9;EGFR;VEGFA
KEGG_2021_Human,regulation of protein-containing complex assembly (GO:0043254),3/116,0.0006885071123852637,0.0041295965605198,0,0,19.525073746312685,142.16176730547792,RB1;MMP1;VEGFA
KEGG_2021_Human,cellular response to drug (GO:0035690),2/26,0.0006912391650978139,0.0041295965605198,0,0,59.36309523809524,431.9867091057638,MYC;TP53
KEGG_2021_Human,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),2/26,0.0006912391650978139,0.0041295965605198,0,0,59.36309523809524,431.9867091057638,E2F1;TP53
KEGG_2021_Human,positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),2/26,0.0006912391650978139,0.0041295965605198,0,0,59.36309523809524,431.9867091057638,CCND1;EGFR
KEGG_2021_Human,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),2/26,0.0006912391650978139,0.0041295965605198,0,0,59.36309523809524,431.9867091057638,E2F1;TP53
KEGG_2021_Human,positive regulation of MAPK cascade (GO:0043410),4/274,0.0007133348589822405,0.0042342825603689,0,0,11.225071225071224,81.33192257391161,ERBB2;BRAF;EGFR;VEGFA
KEGG_2021_Human,positive regulation of protein-containing complex assembly (GO:0031334),3/118,0.000723596787971595,0.0042678383800108,0,0,19.183574879227052,138.72172928780785,MMP1;TP53;VEGFA
KEGG_2021_Human,protein modification by small protein removal (GO:0070646),4/276,0.0007329832874236017,0.0042897564000659,0,0,11.141402714932129,80.42296383443296,CDC20;MYC;PTEN;TP53
KEGG_2021_Human,cellular response to cadmium ion (GO:0071276),2/27,0.0007458431753894333,0.0042897564000659,0,0,56.98571428571429,410.3538550694941,MMP9;EGFR
KEGG_2021_Human,positive regulation of gene silencing by miRNA (GO:2000637),2/27,0.0007458431753894333,0.0042897564000659,0,0,56.98571428571429,410.3538550694941,TP53;EGFR
KEGG_2021_Human,mitotic chromosome condensation (GO:0007076),2/27,0.0007458431753894333,0.0042897564000659,0,0,56.98571428571429,410.3538550694941,RB1;CCNB1
KEGG_2021_Human,cellular response to epidermal growth factor stimulus (GO:0071364),2/28,0.0008024678708939625,0.0045869459780728,0,0,54.79120879120879,390.5418048109173,ERBB2;EGFR
KEGG_2021_Human,cellular response to oxidative stress (GO:0034599),3/125,0.0008553395536436244,0.0048591682618036,0,0,18.07650273224044,127.69263274463742,MMP9;TP53;EGFR
KEGG_2021_Human,response to cadmium ion (GO:0046686),2/29,0.0008611074752315914,0.0048621068418564,0,0,52.75925925925926,372.337457949904,MMP9;EGFR
KEGG_2021_Human,negative regulation of cell growth (GO:0030308),3/126,0.0008753174929478949,0.0048827951715045,0,0,17.9286359530262,126.23416116696262,RB1;CDKN2A;TP53
KEGG_2021_Human,negative regulation of growth (GO:0045926),3/126,0.0008753174929478949,0.0048827951715045,0,0,17.9286359530262,126.23416116696262,RB1;CDKN2A;TP53
KEGG_2021_Human,positive regulation of macromolecule biosynthetic process (GO:0010557),3/129,0.000937026120780873,0.0051957256757071,0,0,17.499118165784832,122.01784063082128,MYC;ERBB2;EGFR
KEGG_2021_Human,G2/M transition of mitotic cell cycle (GO:0000086),3/130,0.000958193010549833,0.0052814686176734,0,0,17.36045494313211,120.66317071692114,CCNB1;FOXM1;AURKA
KEGG_2021_Human,cell cycle G2/M phase transition (GO:0044839),3/131,0.00097966142379343,0.0053050671253375,0,0,17.223958333333332,119.33281135445452,CCNB1;FOXM1;AURKA
KEGG_2021_Human,cellular response to hypoxia (GO:0071456),3/131,0.00097966142379343,0.0053050671253375,0,0,17.223958333333332,119.33281135445452,MYC;TP53;VEGFA
KEGG_2021_Human,cellular response to metal ion (GO:0071248),3/131,0.00097966142379343,0.0053050671253375,0,0,17.223958333333332,119.33281135445452,BRAF;MMP9;EGFR
KEGG_2021_Human,extracellular matrix organization (GO:0030198),4/300,0.000999699759624912,0.005382104519841,0,0,10.225571725571726,70.63881765839963,COL1A1;MMP1;SPP1;MMP9
KEGG_2021_Human,negative regulation of cell-matrix adhesion (GO:0001953),2/32,0.0010490581524956,0.005582918673626,0,0,47.476190476190474,325.6801394016241,CDKN2A;PTEN
KEGG_2021_Human,liver development (GO:0001889),2/32,0.0010490581524956,0.005582918673626,0,0,47.476190476190474,325.6801394016241,MET;AURKA
KEGG_2021_Human,cellular response to vascular endothelial growth factor stimulus (GO:0035924),2/34,0.0011843277749014,0.0061611658402177,0,0,44.504464285714285,299.8968904507324,PIK3CA;VEGFA
KEGG_2021_Human,positive regulation of DNA binding (GO:0043388),2/34,0.0011843277749014,0.0061611658402177,0,0,44.504464285714285,299.8968904507324,RB1;MMP9
KEGG_2021_Human,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),2/34,0.0011843277749014,0.0061611658402177,0,0,44.504464285714285,299.8968904507324,E2F1;TP53
KEGG_2021_Human,sister chromatid segregation (GO:0000819),2/34,0.0011843277749014,0.0061611658402177,0,0,44.504464285714285,299.8968904507324,RB1;TOP2A
KEGG_2021_Human,positive regulation of cell cycle G1/S phase transition (GO:1902808),2/35,0.0012549361838792,0.0064920162361573,0,0,43.15367965367965,288.29551709674206,CCND1;EGFR
KEGG_2021_Human,negative regulation of gene expression (GO:0010629),4/322,0.0012986006909451,0.0066805791100846,0,0,9.507498790517658,63.19128633640498,RB1;TYMS;VEGFA;AURKA
KEGG_2021_Human,regulation of cell cycle G1/S phase transition (GO:1902806),2/36,0.00132751939454,0.0067173932204594,0,0,41.88235294117647,277.4472679372888,PTEN;E2F1
KEGG_2021_Human,regulation of microtubule-based process (GO:0032886),2/36,0.00132751939454,0.0067173932204594,0,0,41.88235294117647,277.4472679372888,ERBB2;AURKA
KEGG_2021_Human,positive regulation of mitotic nuclear division (GO:0045840),2/36,0.00132751939454,0.0067173932204594,0,0,41.88235294117647,277.4472679372888,RB1;AURKA
KEGG_2021_Human,positive regulation of intracellular protein transport (GO:0090316),3/148,0.0013923683734629,0.0069802065411135,0,0,15.191570881226054,99.91115036332026,ERBB2;E2F1;TP53
KEGG_2021_Human,negative regulation of stress-activated MAPK cascade (GO:0032873),2/37,0.0014020717242409,0.0069802065411135,0,0,40.68367346938776,267.2837742480994,MYC;FOXM1
KEGG_2021_Human,regulation of vascular associated smooth muscle cell proliferation (GO:1904705),2/37,0.0014020717242409,0.0069802065411135,0,0,40.68367346938776,267.2837742480994,PTEN;MMP9
KEGG_2021_Human,regulation of exit from mitosis (GO:0007096),2/39,0.0015570610672793,0.0076693539803227,0,0,38.48069498069498,248.77596779833652,CDC20;UBE2C
KEGG_2021_Human,endothelial cell migration (GO:0043542),2/39,0.0015570610672793,0.0076693539803227,0,0,38.48069498069498,248.77596779833652,PIK3CA;VEGFA
KEGG_2021_Human,negative regulation of ERBB signaling pathway (GO:1901185),2/40,0.0016374867723787,0.0080228187895382,0,0,37.46616541353384,240.3301899756201,ERBB2;EGFR
KEGG_2021_Human,cellular response to growth factor stimulus (GO:0071363),3/158,0.0016792809576817,0.0081842850884912,0,0,14.204301075268818,90.75681326113056,ERBB2;EGFR;VEGFA
KEGG_2021_Human,regulation of release of cytochrome c from mitochondria (GO:0090199),2/41,0.0017198589811284,0.0082947365444005,0,0,36.50366300366301,232.36454063940053,MMP9;TP53
KEGG_2021_Human,response to growth factor (GO:0070848),2/41,0.0017198589811284,0.0082947365444005,0,0,36.50366300366301,232.36454063940053,MYC;ERBB2
KEGG_2021_Human,positive regulation of chemotaxis (GO:0050921),2/45,0.0020687005204849,0.0098743127936548,0,0,33.10132890365448,204.59384020901297,MET;VEGFA
KEGG_2021_Human,positive regulation of RNA metabolic process (GO:0051254),2/45,0.0020687005204849,0.0098743127936548,0,0,33.10132890365448,204.59384020901297,TP53;EGFR
KEGG_2021_Human,regulation of telomerase activity (GO:0051972),2/46,0.0021607211003146,0.0102083047902622,0,0,32.3474025974026,198.5261432195098,MYC;TP53
KEGG_2021_Human,positive regulation of response to stimulus (GO:0048584),2/46,0.0021607211003146,0.0102083047902622,0,0,32.3474025974026,198.5261432195098,CDKN2A;MYC
KEGG_2021_Human,regulation of DNA binding (GO:0051101),2/47,0.0022546546050504,0.0105980211384603,0,0,31.626984126984127,192.75882990246353,E2F1;MMP9
KEGG_2021_Human,positive regulation of DNA repair (GO:0045739),2/48,0.0023504954789734,0.0109927212804517,0,0,30.937888198757765,187.27103230547277,FOXM1;EGFR
KEGG_2021_Human,positive regulation of cellular biosynthetic process (GO:0031328),3/180,0.0024341976842087,0.0113269701285289,0,0,12.42498430634024,74.77527107165375,MYC;ERBB2;EGFR
KEGG_2021_Human,negative regulation of catabolic process (GO:0009895),2/49,0.002448238177796,0.0113353427631958,0,0,30.278115501519757,182.0437366477304,ALK;EGFR
KEGG_2021_Human,intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),2/51,0.0026494069247459,0.0122057254344015,0,0,29.03935860058309,172.30269560126317,E2F1;TP53
KEGG_2021_Human,regulation of intrinsic apoptotic signaling pathway (GO:2001242),2/52,0.0027528219402575,0.0125572074713227,0,0,28.457142857142856,167.75852052625558,MMP9;TP53
KEGG_2021_Human,signal transduction in response to DNA damage (GO:0042770),2/52,0.0027528219402575,0.0125572074713227,0,0,28.457142857142856,167.75852052625558,E2F1;TP53
KEGG_2021_Human,regulation of cyclin-dependent protein kinase activity (GO:1904029),2/54,0.0029652857587718,0.0133944127445013,0,0,27.35989010989011,159.25595242218557,CCNB1;CCND1
KEGG_2021_Human,regulation of focal adhesion assembly (GO:0051893),2/54,0.0029652857587718,0.0133944127445013,0,0,27.35989010989011,159.25595242218557,PTEN;VEGFA
KEGG_2021_Human,negative regulation of macromolecule metabolic process (GO:0010605),3/194,0.0030084636852775,0.0134581515582947,0,0,11.50610820244328,66.80821215499986,RB1;VEGFA;AURKA
KEGG_2021_Human,regulation of programmed cell death (GO:0043067),3/194,0.0030084636852775,0.0134581515582947,0,0,11.50610820244328,66.80821215499986,ALK;BIRC5;TP53
KEGG_2021_Human,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),2/55,0.0030743235966317,0.0136211657917751,0,0,26.842318059299192,155.2739619530397,MMP9;VEGFA
KEGG_2021_Human,positive regulation of response to DNA damage stimulus (GO:2001022),2/55,0.0030743235966317,0.0136211657917751,0,0,26.842318059299192,155.2739619530397,MYC;EGFR
KEGG_2021_Human,peptidyl-tyrosine modification (GO:0018212),2/56,0.0031852247621403,0.0139787589087297,0,0,26.343915343915345,151.45729225683525,ERBB2;EGFR
KEGG_2021_Human,positive regulation of establishment of protein localization to mitochondrion (GO:1903749),2/56,0.0031852247621403,0.0139787589087297,0,0,26.343915343915345,151.45729225683525,E2F1;TP53
KEGG_2021_Human,regulation of mitotic nuclear division (GO:0007088),2/57,0.003297983801264,0.0143377136148851,0,0,25.863636363636363,147.79630077100325,CCNB1;AURKA
KEGG_2021_Human,regulation of reactive oxygen species metabolic process (GO:2000377),2/57,0.003297983801264,0.0143377136148851,0,0,25.863636363636363,147.79630077100325,FOXM1;TP53
KEGG_2021_Human,modification-dependent protein catabolic process (GO:0019941),3/201,0.0033243119085999,0.0143846393802033,0,0,11.095398428731762,63.315808706645385,CDC20;UBE2C;AURKA
KEGG_2021_Human,chordate embryonic development (GO:0043009),2/58,0.0034125952701803,0.014697968465986,0,0,25.40051020408163,144.28206600498726,COL1A1;VEGFA
KEGG_2021_Human,negative regulation of autophagy (GO:0010507),2/59,0.0035290537376922,0.0149903842252433,0,0,24.953634085213032,140.90632208004251,PIK3CA;MET
KEGG_2021_Human,response to reactive oxygen species (GO:0000302),2/59,0.0035290537376922,0.0149903842252433,0,0,24.953634085213032,140.90632208004251,MMP9;EGFR
KEGG_2021_Human,mitotic DNA damage checkpoint signaling (GO:0044773),2/59,0.0035290537376922,0.0149903842252433,0,0,24.953634085213032,140.90632208004251,CCND1;TP53
KEGG_2021_Human,phosphate-containing compound metabolic process (GO:0006796),3/212,0.0038605585243045,0.0163236401529955,0,0,10.505582137161085,58.37892543116343,ALK;PIK3CA;PTEN
KEGG_2021_Human,negative regulation of multicellular organismal process (GO:0051241),3/214,0.0039633952822407,0.0166822910516133,0,0,10.404949973670352,57.54618054905871,RB1;PTEN;EGFR
KEGG_2021_Human,cellular response to reactive oxygen species (GO:0034614),2/63,0.0040132493415981,0.0167399499563959,0,0,23.31264637002342,128.64277412661008,MMP9;EGFR
KEGG_2021_Human,positive regulation of DNA metabolic process (GO:0051054),2/63,0.0040132493415981,0.0167399499563959,0,0,23.31264637002342,128.64277412661008,MYC;EGFR
KEGG_2021_Human,cellular component disassembly (GO:0022411),2/66,0.004395525019554,0.0181707864647637,0,0,22.216517857142858,120.57278137525562,MMP1;MMP9
KEGG_2021_Human,extracellular matrix disassembly (GO:0022617),2/66,0.004395525019554,0.0181707864647637,0,0,22.216517857142858,120.57278137525562,MMP1;MMP9
KEGG_2021_Human,regulation of epidermal growth factor receptor signaling pathway (GO:0042058),2/67,0.0045265652607379,0.0185469001391297,0,0,21.873626373626372,118.06928211852814,MMP9;EGFR
KEGG_2021_Human,vascular endothelial growth factor receptor signaling pathway (GO:0048010),2/67,0.0045265652607379,0.0185469001391297,0,0,21.873626373626372,118.06928211852814,PIK3CA;VEGFA
KEGG_2021_Human,peptidyl-tyrosine phosphorylation (GO:0018108),2/69,0.0047940362554891,0.0195562888660042,0,0,21.218550106609808,113.31517536894962,ERBB2;EGFR
KEGG_2021_Human,apoptotic process (GO:0006915),3/231,0.0049055030960435,0.0198504461177663,0,0,9.620857699805068,51.15792586631809,PIK3CA;MYC;MCM2
KEGG_2021_Human,cellular response to light stimulus (GO:0071482),2/70,0.0049304563791428,0.0198504461177663,0,0,20.90546218487395,111.05658271288344,MYC;TP53
KEGG_2021_Human,establishment of protein localization to membrane (GO:0090150),2/70,0.0049304563791428,0.0198504461177663,0,0,20.90546218487395,111.05658271288344,BRAF;EGFR
KEGG_2021_Human,response to ionizing radiation (GO:0010212),2/72,0.0052086393816279,0.0208796539713742,0,0,20.306122448979593,106.75815162079977,MYC;TP53
KEGG_2021_Human,regulation of cell division (GO:0051302),2/76,0.0057862287304151,0.0228976401895915,0,0,19.204633204633204,98.94754273926414,MYC;AURKA
KEGG_2021_Human,regulation of epithelial to mesenchymal transition (GO:0010717),2/76,0.0057862287304151,0.0228976401895915,0,0,19.204633204633204,98.94754273926414,COL1A1;PTEN
KEGG_2021_Human,positive regulation of growth (GO:0045927),2/76,0.0057862287304151,0.0228976401895915,0,0,19.204633204633204,98.94754273926414,ERBB2;EGFR
KEGG_2021_Human,positive regulation of DNA-binding transcription factor activity (GO:0051091),3/246,0.0058404590478201,0.0230138939501338,0,0,9.020118884316416,46.389983263599625,ALK;PTEN;VEGFA
KEGG_2021_Human,negative regulation of apoptotic signaling pathway (GO:2001234),2/78,0.0060855510763654,0.023878052104722,0,0,18.69736842105263,95.3909445901031,RB1;MMP9
KEGG_2021_Human,positive regulation of cell adhesion (GO:0045785),2/80,0.0063918361606561,0.0248690768267544,0,0,18.216117216117215,92.04118939174062,ERBB2;VEGFA
KEGG_2021_Human,skin development (GO:0043588),2/80,0.0063918361606561,0.0248690768267544,0,0,18.216117216117215,92.04118939174062,COL1A1;MET
KEGG_2021_Human,regulation of cell cycle G2/M phase transition (GO:1902749),2/85,0.0071877384972766,0.0266338713816507,0,0,17.1144578313253,84.46633049181104,TP53;AURKA
KEGG_2021_Human,negative regulation of phosphorylation (GO:0042326),2/86,0.007352053041878,0.0266338713816507,0,0,16.90986394557823,83.07436833271562,CDKN2A;PTEN
KEGG_2021_Human,positive regulation of endothelial cell migration (GO:0010595),2/86,0.007352053041878,0.0266338713816507,0,0,16.90986394557823,83.07436833271562,MET;VEGFA
KEGG_2021_Human,pyrimidine deoxyribonucleotide biosynthetic process (GO:0009221),1/5,0.0074781928285412,0.0266338713816507,0,0,172.1206896551724,842.6622961465415,TYMS
KEGG_2021_Human,negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001268),1/5,0.0074781928285412,0.0266338713816507,0,0,172.1206896551724,842.6622961465415,MMP9
KEGG_2021_Human,apoptotic chromosome condensation (GO:0030263),1/5,0.0074781928285412,0.0266338713816507,0,0,172.1206896551724,842.6622961465415,TOP2A
KEGG_2021_Human,regulation of adherens junction organization (GO:1903391),1/5,0.0074781928285412,0.0266338713816507,0,0,172.1206896551724,842.6622961465415,VEGFA
KEGG_2021_Human,bone marrow development (GO:0048539),1/5,0.0074781928285412,0.0266338713816507,0,0,172.1206896551724,842.6622961465415,TP53
KEGG_2021_Human,negative regulation of organ growth (GO:0046621),1/5,0.0074781928285412,0.0266338713816507,0,0,172.1206896551724,842.6622961465415,PTEN
KEGG_2021_Human,cellular response to antibiotic (GO:0071236),1/5,0.0074781928285412,0.0266338713816507,0,0,172.1206896551724,842.6622961465415,TP53
KEGG_2021_Human,regulation of guanyl-nucleotide exchange factor activity (GO:1905097),1/5,0.0074781928285412,0.0266338713816507,0,0,172.1206896551724,842.6622961465415,MET
KEGG_2021_Human,cellular response to testosterone stimulus (GO:0071394),1/5,0.0074781928285412,0.0266338713816507,0,0,172.1206896551724,842.6622961465415,SPP1
KEGG_2021_Human,coronary artery morphogenesis (GO:0060982),1/5,0.0074781928285412,0.0266338713816507,0,0,172.1206896551724,842.6622961465415,VEGFA
KEGG_2021_Human,regulation of protein kinase C activity (GO:1900019),1/5,0.0074781928285412,0.0266338713816507,0,0,172.1206896551724,842.6622961465415,EGFR
KEGG_2021_Human,positive regulation of attachment of spindle microtubules to kinetochore (GO:0051987),1/5,0.0074781928285412,0.0266338713816507,0,0,172.1206896551724,842.6622961465415,CCNB1
KEGG_2021_Human,positive regulation of axon extension involved in axon guidance (GO:0048842),1/5,0.0074781928285412,0.0266338713816507,0,0,172.1206896551724,842.6622961465415,VEGFA
KEGG_2021_Human,regulation of retinal ganglion cell axon guidance (GO:0090259),1/5,0.0074781928285412,0.0266338713816507,0,0,172.1206896551724,842.6622961465415,VEGFA
KEGG_2021_Human,positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway (GO:0038033),1/5,0.0074781928285412,0.0266338713816507,0,0,172.1206896551724,842.6622961465415,VEGFA
KEGG_2021_Human,positive regulation of mast cell chemotaxis (GO:0060754),1/5,0.0074781928285412,0.0266338713816507,0,0,172.1206896551724,842.6622961465415,VEGFA
KEGG_2021_Human,positive regulation of protein kinase C activity (GO:1900020),1/5,0.0074781928285412,0.0266338713816507,0,0,172.1206896551724,842.6622961465415,EGFR
KEGG_2021_Human,positive regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061419),1/5,0.0074781928285412,0.0266338713816507,0,0,172.1206896551724,842.6622961465415,VEGFA
KEGG_2021_Human,vascular endothelial growth factor receptor-2 signaling pathway (GO:0036324),1/5,0.0074781928285412,0.0266338713816507,0,0,172.1206896551724,842.6622961465415,VEGFA
KEGG_2021_Human,regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),2/87,0.007518066960634,0.0266732950404105,0,0,16.710084033613445,81.71976741790144,TP53;VEGFA
KEGG_2021_Human,negative regulation of binding (GO:0051100),2/88,0.0076857751375322,0.0270609421192199,0,0,16.514950166112957,80.40111986589167,E2F1;AURKA
KEGG_2021_Human,sensory perception of mechanical stimulus (GO:0050954),2/88,0.0076857751375322,0.0270609421192199,0,0,16.514950166112957,80.40111986589167,COL1A1;BIRC5
KEGG_2021_Human,regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),2/89,0.0078551724663544,0.0275526125145614,0,0,16.324302134646963,79.11708604949641,MYC;VEGFA
KEGG_2021_Human,positive regulation of binding (GO:0051099),2/90,0.0080262538558438,0.0280464568698542,0,0,16.13798701298701,77.86639055063492,MMP9;MET
KEGG_2021_Human,DNA metabolic process (GO:0006259),3/277,0.0080936926136961,0.0281757870687316,0,0,7.9870235198702355,38.47085825718167,TOP2A;TYMS;MCM2
KEGG_2021_Human,sensory perception of sound (GO:0007605),2/91,0.0081990142194101,0.0282440637268212,0,0,15.95585874799358,76.64781842787546,COL1A1;BIRC5
KEGG_2021_Human,positive regulation of supramolecular fiber organization (GO:1902905),2/91,0.0081990142194101,0.0282440637268212,0,0,15.95585874799358,76.64781842787546,RB1;MET
KEGG_2021_Human,positive regulation of cellular component biogenesis (GO:0044089),2/92,0.0083734484870981,0.0282440637268212,0,0,15.77777777777778,75.46021169623046,MMP1;VEGFA
KEGG_2021_Human,positive regulation of epithelial cell migration (GO:0010634),2/94,0.0087273184884668,0.0282440637268212,0,0,15.433229813664596,73.17352801930804,MMP9;VEGFA
KEGG_2021_Human,positive regulation of programmed cell death (GO:0043068),3/286,0.0088313849578002,0.0282440637268212,0,0,7.729485669414998,36.55616521496702,TOP2A;E2F1;TP53
KEGG_2021_Human,protein-DNA complex subunit organization (GO:0071824),1/6,0.008967337727522,0.0282440637268212,0,0,137.68965517241378,649.0919521468393,MYC
KEGG_2021_Human,negative regulation of cell size (GO:0045792),1/6,0.008967337727522,0.0282440637268212,0,0,137.68965517241378,649.0919521468393,PTEN
KEGG_2021_Human,negative regulation of excitatory postsynaptic potential (GO:0090394),1/6,0.008967337727522,0.0282440637268212,0,0,137.68965517241378,649.0919521468393,PTEN
KEGG_2021_Human,negative regulation of fat cell proliferation (GO:0070345),1/6,0.008967337727522,0.0282440637268212,0,0,137.68965517241378,649.0919521468393,E2F1
KEGG_2021_Human,regulation of collagen fibril organization (GO:1904026),1/6,0.008967337727522,0.0282440637268212,0,0,137.68965517241378,649.0919521468393,RB1
KEGG_2021_Human,centromeric sister chromatid cohesion (GO:0070601),1/6,0.008967337727522,0.0282440637268212,0,0,137.68965517241378,649.0919521468393,BUB1
KEGG_2021_Human,nuclear cell cycle DNA replication initiation (GO:1902315),1/6,0.008967337727522,0.0282440637268212,0,0,137.68965517241378,649.0919521468393,MCM2
KEGG_2021_Human,regulation of macrophage apoptotic process (GO:2000109),1/6,0.008967337727522,0.0282440637268212,0,0,137.68965517241378,649.0919521468393,CDKN2A
KEGG_2021_Human,regulation of mast cell chemotaxis (GO:0060753),1/6,0.008967337727522,0.0282440637268212,0,0,137.68965517241378,649.0919521468393,VEGFA
KEGG_2021_Human,regulation of mitotic sister chromatid segregation (GO:0033047),1/6,0.008967337727522,0.0282440637268212,0,0,137.68965517241378,649.0919521468393,CCNB1
KEGG_2021_Human,regulation of mitotic spindle checkpoint (GO:1903504),1/6,0.008967337727522,0.0282440637268212,0,0,137.68965517241378,649.0919521468393,CCNB1
KEGG_2021_Human,free ubiquitin chain polymerization (GO:0010994),1/6,0.008967337727522,0.0282440637268212,0,0,137.68965517241378,649.0919521468393,UBE2C
KEGG_2021_Human,regulation of thymocyte apoptotic process (GO:0070243),1/6,0.008967337727522,0.0282440637268212,0,0,137.68965517241378,649.0919521468393,TP53
KEGG_2021_Human,positive regulation of deacetylase activity (GO:0090045),1/6,0.008967337727522,0.0282440637268212,0,0,137.68965517241378,649.0919521468393,VEGFA
KEGG_2021_Human,positive regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902043),1/6,0.008967337727522,0.0282440637268212,0,0,137.68965517241378,649.0919521468393,PTEN
KEGG_2021_Human,response to testosterone (GO:0033574),1/6,0.008967337727522,0.0282440637268212,0,0,137.68965517241378,649.0919521468393,SPP1
KEGG_2021_Human,positive regulation of kidney development (GO:0090184),1/6,0.008967337727522,0.0282440637268212,0,0,137.68965517241378,649.0919521468393,MYC
KEGG_2021_Human,positive regulation of receptor binding (GO:1900122),1/6,0.008967337727522,0.0282440637268212,0,0,137.68965517241378,649.0919521468393,MMP9
KEGG_2021_Human,mitotic DNA replication initiation (GO:1902975),1/6,0.008967337727522,0.0282440637268212,0,0,137.68965517241378,649.0919521468393,MCM2
KEGG_2021_Human,venous blood vessel morphogenesis (GO:0048845),1/6,0.008967337727522,0.0282440637268212,0,0,137.68965517241378,649.0919521468393,VEGFA
KEGG_2021_Human,postsynaptic density assembly (GO:0097107),1/6,0.008967337727522,0.0282440637268212,0,0,137.68965517241378,649.0919521468393,PTEN
KEGG_2021_Human,prepulse inhibition (GO:0060134),1/6,0.008967337727522,0.0282440637268212,0,0,137.68965517241378,649.0919521468393,PTEN
KEGG_2021_Human,negative regulation of actin filament depolymerization (GO:0030835),1/6,0.008967337727522,0.0282440637268212,0,0,137.68965517241378,649.0919521468393,PIK3CA
KEGG_2021_Human,positive regulation of cell cycle process (GO:0090068),2/101,0.0100178506582505,0.0305384971857523,0,0,14.336940836940837,65.99848293232873,CCNB1;AURKA
KEGG_2021_Human,positive regulation of cell growth (GO:0030307),2/102,0.0102087472469366,0.0305384971857523,0,0,14.192857142857145,65.06730050963371,ERBB2;EGFR
KEGG_2021_Human,intrinsic apoptotic signaling pathway (GO:0097193),2/102,0.0102087472469366,0.0305384971857523,0,0,14.192857142857145,65.06730050963371,E2F1;TP53
KEGG_2021_Human,mitotic sister chromatid segregation (GO:0000070),2/102,0.0102087472469366,0.0305384971857523,0,0,14.192857142857145,65.06730050963371,RB1;CCNB1
KEGG_2021_Human,chromatin remodeling (GO:0006338),2/103,0.0104012626265877,0.0305384971857523,0,0,14.051626591230551,64.15731117281341,RB1;MYC
KEGG_2021_Human,negative regulation of cardiocyte differentiation (GO:1905208),1/7,0.0104543235506301,0.0305384971857523,0,0,114.73563218390804,523.2793468811269,EGFR
KEGG_2021_Human,negative regulation of cell cycle phase transition (GO:1901988),1/7,0.0104543235506301,0.0305384971857523,0,0,114.73563218390804,523.2793468811269,PTEN
KEGG_2021_Human,negative regulation of dendritic spine development (GO:0061000),1/7,0.0104543235506301,0.0305384971857523,0,0,114.73563218390804,523.2793468811269,PTEN
KEGG_2021_Human,regulation of blood-brain barrier permeability (GO:1905603),1/7,0.0104543235506301,0.0305384971857523,0,0,114.73563218390804,523.2793468811269,VEGFA
KEGG_2021_Human,regulation of fat cell proliferation (GO:0070344),1/7,0.0104543235506301,0.0305384971857523,0,0,114.73563218390804,523.2793468811269,E2F1
KEGG_2021_Human,regulation of histone deacetylase activity (GO:1901725),1/7,0.0104543235506301,0.0305384971857523,0,0,114.73563218390804,523.2793468811269,VEGFA
KEGG_2021_Human,chemical homeostasis within a tissue (GO:0048875),1/7,0.0104543235506301,0.0305384971857523,0,0,114.73563218390804,523.2793468811269,VEGFA
KEGG_2021_Human,collagen-activated tyrosine kinase receptor signaling pathway (GO:0038063),1/7,0.0104543235506301,0.0305384971857523,0,0,114.73563218390804,523.2793468811269,COL1A1
KEGG_2021_Human,oxygen transport (GO:0015671),1/7,0.0104543235506301,0.0305384971857523,0,0,114.73563218390804,523.2793468811269,MYC
KEGG_2021_Human,DNA ligation (GO:0006266),1/7,0.0104543235506301,0.0305384971857523,0,0,114.73563218390804,523.2793468811269,TOP2A
KEGG_2021_Human,endothelial cell morphogenesis (GO:0001886),1/7,0.0104543235506301,0.0305384971857523,0,0,114.73563218390804,523.2793468811269,MET
KEGG_2021_Human,skin morphogenesis (GO:0043589),1/7,0.0104543235506301,0.0305384971857523,0,0,114.73563218390804,523.2793468811269,COL1A1
KEGG_2021_Human,surfactant homeostasis (GO:0043129),1/7,0.0104543235506301,0.0305384971857523,0,0,114.73563218390804,523.2793468811269,VEGFA
KEGG_2021_Human,positive regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045899),1/7,0.0104543235506301,0.0305384971857523,0,0,114.73563218390804,523.2793468811269,TP53
KEGG_2021_Human,positive regulation of synaptic plasticity (GO:0031915),1/7,0.0104543235506301,0.0305384971857523,0,0,114.73563218390804,523.2793468811269,CDC20
KEGG_2021_Human,positive regulation of trophoblast cell migration (GO:1901165),1/7,0.0104543235506301,0.0305384971857523,0,0,114.73563218390804,523.2793468811269,VEGFA
KEGG_2021_Human,vascular associated smooth muscle cell development (GO:0097084),1/7,0.0104543235506301,0.0305384971857523,0,0,114.73563218390804,523.2793468811269,VEGFA
KEGG_2021_Human,vascular wound healing (GO:0061042),1/7,0.0104543235506301,0.0305384971857523,0,0,114.73563218390804,523.2793468811269,VEGFA
KEGG_2021_Human,positive regulation of apoptotic process (GO:0043065),3/310,0.0109877395054109,0.0317978911262865,0,0,7.116539992761491,32.10253554681002,TOP2A;E2F1;TP53
KEGG_2021_Human,regulation of cell cycle process (GO:0010564),2/106,0.0109884720954769,0.0317978911262865,0,0,13.64423076923077,61.54787719458521,BUB1;AURKA
KEGG_2021_Human,chromosome organization (GO:0051276),2/106,0.0109884720954769,0.0317978911262865,0,0,13.64423076923077,61.54787719458521,TOP2A;MYC
KEGG_2021_Human,cellular macromolecule biosynthetic process (GO:0034645),3/314,0.0113742620265401,0.0325166348011874,0,0,7.023579849946409,31.44036824327332,E2F1;TYMS;MCM2
KEGG_2021_Human,negative regulation of chromosome organization (GO:2001251),1/8,0.0119391531667426,0.0325166348011874,0,0,98.33990147783253,435.442406227662,TOP2A
KEGG_2021_Human,commissural neuron axon guidance (GO:0071679),1/8,0.0119391531667426,0.0325166348011874,0,0,98.33990147783253,435.442406227662,VEGFA
KEGG_2021_Human,coronary vasculature morphogenesis (GO:0060977),1/8,0.0119391531667426,0.0325166348011874,0,0,98.33990147783253,435.442406227662,VEGFA
KEGG_2021_Human,regulation of metaphase/anaphase transition of cell cycle (GO:1902099),1/8,0.0119391531667426,0.0325166348011874,0,0,98.33990147783253,435.442406227662,UBE2C
KEGG_2021_Human,phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092),1/8,0.0119391531667426,0.0325166348011874,0,0,98.33990147783253,435.442406227662,PIK3CA
KEGG_2021_Human,regulation of positive chemotaxis (GO:0050926),1/8,0.0119391531667426,0.0325166348011874,0,0,98.33990147783253,435.442406227662,VEGFA
KEGG_2021_Human,regulation of protein localization to chromatin (GO:1905634),1/8,0.0119391531667426,0.0325166348011874,0,0,98.33990147783253,435.442406227662,RB1
KEGG_2021_Human,entry of bacterium into host cell (GO:0035635),1/8,0.0119391531667426,0.0325166348011874,0,0,98.33990147783253,435.442406227662,MET
KEGG_2021_Human,ER overload response (GO:0006983),1/8,0.0119391531667426,0.0325166348011874,0,0,98.33990147783253,435.442406227662,TP53
KEGG_2021_Human,excitatory synapse assembly (GO:1904861),1/8,0.0119391531667426,0.0325166348011874,0,0,98.33990147783253,435.442406227662,PTEN
KEGG_2021_Human,positive regulation of cell migration by vascular endothelial growth factor signaling pathway (GO:0038089),1/8,0.0119391531667426,0.0325166348011874,0,0,98.33990147783253,435.442406227662,VEGFA
KEGG_2021_Human,positive regulation of chromosome segregation (GO:0051984),1/8,0.0119391531667426,0.0325166348011874,0,0,98.33990147783253,435.442406227662,CCNB1
KEGG_2021_Human,"regulation of wound healing, spreading of epidermal cells (GO:1903689)",1/8,0.0119391531667426,0.0325166348011874,0,0,98.33990147783253,435.442406227662,PTEN
KEGG_2021_Human,positive regulation of execution phase of apoptosis (GO:1900119),1/8,0.0119391531667426,0.0325166348011874,0,0,98.33990147783253,435.442406227662,TP53
KEGG_2021_Human,positive regulation of myeloid cell apoptotic process (GO:0033034),1/8,0.0119391531667426,0.0325166348011874,0,0,98.33990147783253,435.442406227662,CDKN2A
KEGG_2021_Human,stress-induced premature senescence (GO:0090400),1/8,0.0119391531667426,0.0325166348011874,0,0,98.33990147783253,435.442406227662,TP53
KEGG_2021_Human,meiotic sister chromatid cohesion (GO:0051177),1/8,0.0119391531667426,0.0325166348011874,0,0,98.33990147783253,435.442406227662,BUB1
KEGG_2021_Human,postsynaptic density organization (GO:0097106),1/8,0.0119391531667426,0.0325166348011874,0,0,98.33990147783253,435.442406227662,PTEN
KEGG_2021_Human,pre-replicative complex assembly involved in nuclear cell cycle DNA replication (GO:0006267),1/8,0.0119391531667426,0.0325166348011874,0,0,98.33990147783253,435.442406227662,MCM2
KEGG_2021_Human,phosphatidylinositol metabolic process (GO:0046488),2/112,0.0122059337373962,0.0331457320845422,0,0,12.896103896103895,56.818081065593866,PIK3CA;PTEN
KEGG_2021_Human,actin-mediated cell contraction (GO:0070252),1/9,0.0134218294793273,0.0348140450920367,0,0,86.04310344827586,370.92087702683546,PIK3CA
KEGG_2021_Human,anoikis (GO:0043276),1/9,0.0134218294793273,0.0348140450920367,0,0,86.04310344827586,370.92087702683546,PIK3CA
KEGG_2021_Human,regulation of actin filament organization (GO:0110053),1/9,0.0134218294793273,0.0348140450920367,0,0,86.04310344827586,370.92087702683546,PIK3CA
KEGG_2021_Human,regulation of helicase activity (GO:0051095),1/9,0.0134218294793273,0.0348140450920367,0,0,86.04310344827586,370.92087702683546,TP53
KEGG_2021_Human,collagen-activated signaling pathway (GO:0038065),1/9,0.0134218294793273,0.0348140450920367,0,0,86.04310344827586,370.92087702683546,COL1A1
KEGG_2021_Human,DNA topological change (GO:0006265),1/9,0.0134218294793273,0.0348140450920367,0,0,86.04310344827586,370.92087702683546,TOP2A
KEGG_2021_Human,endothelial cell chemotaxis (GO:0035767),1/9,0.0134218294793273,0.0348140450920367,0,0,86.04310344827586,370.92087702683546,VEGFA
KEGG_2021_Human,positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903589),1/9,0.0134218294793273,0.0348140450920367,0,0,86.04310344827586,370.92087702683546,VEGFA
KEGG_2021_Human,regulation of smooth muscle cell apoptotic process (GO:0034391),1/9,0.0134218294793273,0.0348140450920367,0,0,86.04310344827586,370.92087702683546,CDKN2A
KEGG_2021_Human,response to leptin (GO:0044321),1/9,0.0134218294793273,0.0348140450920367,0,0,86.04310344827586,370.92087702683546,CCND1
KEGG_2021_Human,response to vitamin (GO:0033273),1/9,0.0134218294793273,0.0348140450920367,0,0,86.04310344827586,370.92087702683546,SPP1
KEGG_2021_Human,response to vitamin D (GO:0033280),1/9,0.0134218294793273,0.0348140450920367,0,0,86.04310344827586,370.92087702683546,SPP1
KEGG_2021_Human,positive regulation of protein kinase C signaling (GO:0090037),1/9,0.0134218294793273,0.0348140450920367,0,0,86.04310344827586,370.92087702683546,VEGFA
KEGG_2021_Human,tetrahydrofolate interconversion (GO:0035999),1/9,0.0134218294793273,0.0348140450920367,0,0,86.04310344827586,370.92087702683546,TYMS
KEGG_2021_Human,positive regulation of smooth muscle cell apoptotic process (GO:0034393),1/9,0.0134218294793273,0.0348140450920367,0,0,86.04310344827586,370.92087702683546,CDKN2A
KEGG_2021_Human,positive regulation of synapse maturation (GO:0090129),1/9,0.0134218294793273,0.0348140450920367,0,0,86.04310344827586,370.92087702683546,CDC20
KEGG_2021_Human,negative regulation of response to external stimulus (GO:0032102),2/118,0.0134799084994332,0.0348670258951821,0,0,12.225369458128078,52.649225494811425,RB1;PTEN
KEGG_2021_Human,negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048),1/10,0.0149023554252653,0.0367010136271163,0,0,76.47892720306514,321.6884165593148,VEGFA
KEGG_2021_Human,regulation of attachment of spindle microtubules to kinetochore (GO:0051988),1/10,0.0149023554252653,0.0367010136271163,0,0,76.47892720306514,321.6884165593148,CCNB1
KEGG_2021_Human,regulation of axon guidance (GO:1902667),1/10,0.0149023554252653,0.0367010136271163,0,0,76.47892720306514,321.6884165593148,VEGFA
KEGG_2021_Human,negative regulation of phosphatidylinositol 3-kinase signaling (GO:0014067),1/10,0.0149023554252653,0.0367010136271163,0,0,76.47892720306514,321.6884165593148,PTEN
KEGG_2021_Human,regulation of DNA methylation (GO:0044030),1/10,0.0149023554252653,0.0367010136271163,0,0,76.47892720306514,321.6884165593148,MYC
KEGG_2021_Human,negative regulation of telomerase activity (GO:0051974),1/10,0.0149023554252653,0.0367010136271163,0,0,76.47892720306514,321.6884165593148,TP53
KEGG_2021_Human,regulation of organ growth (GO:0046620),1/10,0.0149023554252653,0.0367010136271163,0,0,76.47892720306514,321.6884165593148,PTEN
KEGG_2021_Human,regulation of receptor binding (GO:1900120),1/10,0.0149023554252653,0.0367010136271163,0,0,76.47892720306514,321.6884165593148,MMP9
KEGG_2021_Human,regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045898),1/10,0.0149023554252653,0.0367010136271163,0,0,76.47892720306514,321.6884165593148,TP53
KEGG_2021_Human,regulation of tau-protein kinase activity (GO:1902947),1/10,0.0149023554252653,0.0367010136271163,0,0,76.47892720306514,321.6884165593148,RB1
KEGG_2021_Human,hematopoietic stem cell differentiation (GO:0060218),1/10,0.0149023554252653,0.0367010136271163,0,0,76.47892720306514,321.6884165593148,TP53
KEGG_2021_Human,positive regulation of keratinocyte migration (GO:0051549),1/10,0.0149023554252653,0.0367010136271163,0,0,76.47892720306514,321.6884165593148,MMP9
KEGG_2021_Human,positive regulation of mesenchymal cell proliferation (GO:0002053),1/10,0.0149023554252653,0.0367010136271163,0,0,76.47892720306514,321.6884165593148,MYC
KEGG_2021_Human,lactation (GO:0007595),1/10,0.0149023554252653,0.0367010136271163,0,0,76.47892720306514,321.6884165593148,VEGFA
KEGG_2021_Human,positive regulation of T cell apoptotic process (GO:0070234),1/10,0.0149023554252653,0.0367010136271163,0,0,76.47892720306514,321.6884165593148,TP53
KEGG_2021_Human,mitotic DNA replication (GO:1902969),1/10,0.0149023554252653,0.0367010136271163,0,0,76.47892720306514,321.6884165593148,MCM2
KEGG_2021_Human,presynaptic membrane assembly (GO:0097105),1/10,0.0149023554252653,0.0367010136271163,0,0,76.47892720306514,321.6884165593148,PTEN
KEGG_2021_Human,myelin maintenance (GO:0043217),1/10,0.0149023554252653,0.0367010136271163,0,0,76.47892720306514,321.6884165593148,PTEN
KEGG_2021_Human,regulation of phosphorylation (GO:0042325),2/125,0.0150362505284807,0.0369325410858704,0,0,11.525551684088269,48.37609771345922,CDKN2A;EGFR
KEGG_2021_Human,circulatory system development (GO:0072359),2/126,0.0152646533217662,0.037295696506479,0,0,11.432027649769584,47.811201675266936,PIK3CA;PTEN
KEGG_2021_Human,phosphatidylinositol biosynthetic process (GO:0006661),2/126,0.0152646533217662,0.037295696506479,0,0,11.432027649769584,47.811201675266936,PIK3CA;PTEN
KEGG_2021_Human,ubiquitin-dependent protein catabolic process (GO:0006511),3/354,0.0156747656315464,0.0379213990955021,0,0,6.210509654954099,25.80903450086288,CDC20;UBE2C;AURKA
KEGG_2021_Human,positive regulation of canonical Wnt signaling pathway (GO:0090263),2/130,0.0161932461679938,0.0379213990955021,0,0,11.072544642857142,45.653884539843645,COL1A1;EGFR
KEGG_2021_Human,angiogenesis involved in wound healing (GO:0060055),1/11,0.0163807339505408,0.0379213990955021,0,0,68.82758620689656,282.994903106762,VEGFA
KEGG_2021_Human,camera-type eye morphogenesis (GO:0048593),1/11,0.0163807339505408,0.0379213990955021,0,0,68.82758620689656,282.994903106762,VEGFA
KEGG_2021_Human,regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267),1/11,0.0163807339505408,0.0379213990955021,0,0,68.82758620689656,282.994903106762,MMP9
KEGG_2021_Human,central nervous system myelination (GO:0022010),1/11,0.0163807339505408,0.0379213990955021,0,0,68.82758620689656,282.994903106762,PTEN
KEGG_2021_Human,regulation of lipid kinase activity (GO:0043550),1/11,0.0163807339505408,0.0379213990955021,0,0,68.82758620689656,282.994903106762,RB1
KEGG_2021_Human,nuclear DNA replication (GO:0033260),1/11,0.0163807339505408,0.0379213990955021,0,0,68.82758620689656,282.994903106762,MCM2
KEGG_2021_Human,regulation of mesenchymal cell proliferation (GO:0010464),1/11,0.0163807339505408,0.0379213990955021,0,0,68.82758620689656,282.994903106762,MYC
KEGG_2021_Human,phosphorylated carbohydrate dephosphorylation (GO:0046838),1/11,0.0163807339505408,0.0379213990955021,0,0,68.82758620689656,282.994903106762,PTEN
KEGG_2021_Human,positive regulation of bone resorption (GO:0045780),1/11,0.0163807339505408,0.0379213990955021,0,0,68.82758620689656,282.994903106762,SPP1
KEGG_2021_Human,regulation of synapse maturation (GO:0090128),1/11,0.0163807339505408,0.0379213990955021,0,0,68.82758620689656,282.994903106762,CDC20
KEGG_2021_Human,positive regulation of dendrite development (GO:1900006),1/11,0.0163807339505408,0.0379213990955021,0,0,68.82758620689656,282.994903106762,ALK
KEGG_2021_Human,positive regulation of leukocyte apoptotic process (GO:2000108),1/11,0.0163807339505408,0.0379213990955021,0,0,68.82758620689656,282.994903106762,CDKN2A
KEGG_2021_Human,induction of positive chemotaxis (GO:0050930),1/11,0.0163807339505408,0.0379213990955021,0,0,68.82758620689656,282.994903106762,VEGFA
KEGG_2021_Human,inositol phosphate dephosphorylation (GO:0046855),1/11,0.0163807339505408,0.0379213990955021,0,0,68.82758620689656,282.994903106762,PTEN
KEGG_2021_Human,positive regulation of neuroblast proliferation (GO:0002052),1/11,0.0163807339505408,0.0379213990955021,0,0,68.82758620689656,282.994903106762,VEGFA
KEGG_2021_Human,tetrahydrofolate metabolic process (GO:0046653),1/11,0.0163807339505408,0.0379213990955021,0,0,68.82758620689656,282.994903106762,TYMS
KEGG_2021_Human,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),1/11,0.0163807339505408,0.0379213990955021,0,0,68.82758620689656,282.994903106762,TP53
KEGG_2021_Human,presynaptic membrane organization (GO:0097090),1/11,0.0163807339505408,0.0379213990955021,0,0,68.82758620689656,282.994903106762,PTEN
KEGG_2021_Human,monocyte differentiation (GO:0030224),1/11,0.0163807339505408,0.0379213990955021,0,0,68.82758620689656,282.994903106762,VEGFA
KEGG_2021_Human,regulation of cell adhesion (GO:0030155),2/133,0.0169052903850118,0.0389410420311466,0,0,10.81733914940022,44.136135547977105,ERBB2;VEGFA
KEGG_2021_Human,regulation of cell motility (GO:2000145),2/133,0.0169052903850118,0.0389410420311466,0,0,10.81733914940022,44.136135547977105,ERBB2;EGFR
KEGG_2021_Human,positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),2/134,0.0171455849404774,0.0391837734035003,0,0,10.734848484848484,43.64805041468954,TP53;VEGFA
KEGG_2021_Human,negative regulation of cell division (GO:0051782),1/12,0.0178569680089386,0.0391837734035003,0,0,62.56739811912226,251.8563944353508,MYC
KEGG_2021_Human,regulation of actin filament depolymerization (GO:0030834),1/12,0.0178569680089386,0.0391837734035003,0,0,62.56739811912226,251.8563944353508,PIK3CA
KEGG_2021_Human,brain morphogenesis (GO:0048854),1/12,0.0178569680089386,0.0391837734035003,0,0,62.56739811912226,251.8563944353508,PTEN
KEGG_2021_Human,cell cycle checkpoint signaling (GO:0000075),1/12,0.0178569680089386,0.0391837734035003,0,0,62.56739811912226,251.8563944353508,BUB1
KEGG_2021_Human,negative regulation of vascular permeability (GO:0043116),1/12,0.0178569680089386,0.0391837734035003,0,0,62.56739811912226,251.8563944353508,VEGFA
KEGG_2021_Human,chromatin assembly or disassembly (GO:0006333),1/12,0.0178569680089386,0.0391837734035003,0,0,62.56739811912226,251.8563944353508,TP53
KEGG_2021_Human,double-strand break repair via break-induced replication (GO:0000727),1/12,0.0178569680089386,0.0391837734035003,0,0,62.56739811912226,251.8563944353508,MCM2
KEGG_2021_Human,positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190),1/12,0.0178569680089386,0.0391837734035003,0,0,62.56739811912226,251.8563944353508,VEGFA
KEGG_2021_Human,exit from mitosis (GO:0010458),1/12,0.0178569680089386,0.0391837734035003,0,0,62.56739811912226,251.8563944353508,UBE2C
KEGG_2021_Human,eye photoreceptor cell differentiation (GO:0001754),1/12,0.0178569680089386,0.0391837734035003,0,0,62.56739811912226,251.8563944353508,VEGFA
KEGG_2021_Human,positive regulation of cellular senescence (GO:2000774),1/12,0.0178569680089386,0.0391837734035003,0,0,62.56739811912226,251.8563944353508,CDKN2A
KEGG_2021_Human,gas transport (GO:0015669),1/12,0.0178569680089386,0.0391837734035003,0,0,62.56739811912226,251.8563944353508,MYC
KEGG_2021_Human,inositol phosphate catabolic process (GO:0071545),1/12,0.0178569680089386,0.0391837734035003,0,0,62.56739811912226,251.8563944353508,PTEN
KEGG_2021_Human,positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),1/12,0.0178569680089386,0.0391837734035003,0,0,62.56739811912226,251.8563944353508,RB1
KEGG_2021_Human,positive regulation of mitotic metaphase/anaphase transition (GO:0045842),1/12,0.0178569680089386,0.0391837734035003,0,0,62.56739811912226,251.8563944353508,RB1
KEGG_2021_Human,positive regulation of mitotic sister chromatid separation (GO:1901970),1/12,0.0178569680089386,0.0391837734035003,0,0,62.56739811912226,251.8563944353508,RB1
KEGG_2021_Human,positive regulation of vascular permeability (GO:0043117),1/12,0.0178569680089386,0.0391837734035003,0,0,62.56739811912226,251.8563944353508,VEGFA
KEGG_2021_Human,mitotic nuclear membrane disassembly (GO:0007077),1/12,0.0178569680089386,0.0391837734035003,0,0,62.56739811912226,251.8563944353508,CCNB1
KEGG_2021_Human,mRNA transcription (GO:0009299),1/12,0.0178569680089386,0.0391837734035003,0,0,62.56739811912226,251.8563944353508,TP53
KEGG_2021_Human,chromatin organization (GO:0006325),2/142,0.0191203122992009,0.0412413380192704,0,0,10.11734693877551,40.03438268908486,RB1;MYC
KEGG_2021_Human,negative regulation of hydrogen peroxide-induced cell death (GO:1903206),1/13,0.0193310605643026,0.0412413380192704,0,0,57.35057471264368,226.30778348154325,MET
KEGG_2021_Human,regulation of cell aging (GO:0090342),1/13,0.0193310605643026,0.0412413380192704,0,0,57.35057471264368,226.30778348154325,FOXM1
KEGG_2021_Human,cardiac cell development (GO:0055006),1/13,0.0193310605643026,0.0412413380192704,0,0,57.35057471264368,226.30778348154325,VEGFA
KEGG_2021_Human,central nervous system neuron axonogenesis (GO:0021955),1/13,0.0193310605643026,0.0412413380192704,0,0,57.35057471264368,226.30778348154325,PTEN
KEGG_2021_Human,regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),1/13,0.0193310605643026,0.0412413380192704,0,0,57.35057471264368,226.30778348154325,CCNB1
KEGG_2021_Human,entry into host (GO:0044409),1/13,0.0193310605643026,0.0412413380192704,0,0,57.35057471264368,226.30778348154325,MET
KEGG_2021_Human,positive regulation of cell aging (GO:0090343),1/13,0.0193310605643026,0.0412413380192704,0,0,57.35057471264368,226.30778348154325,CDKN2A
KEGG_2021_Human,relaxation of cardiac muscle (GO:0055119),1/13,0.0193310605643026,0.0412413380192704,0,0,57.35057471264368,226.30778348154325,PIK3CA
KEGG_2021_Human,positive regulation of histone deacetylation (GO:0031065),1/13,0.0193310605643026,0.0412413380192704,0,0,57.35057471264368,226.30778348154325,VEGFA
KEGG_2021_Human,positive regulation of lipid transport (GO:0032370),1/13,0.0193310605643026,0.0412413380192704,0,0,57.35057471264368,226.30778348154325,SPP1
KEGG_2021_Human,negative regulation of DNA-binding transcription factor activity (GO:0043433),2/143,0.0193736307109963,0.0412413380192704,0,0,10.045086119554204,39.61623634122261,RB1;CDKN2A
KEGG_2021_Human,neuron development (GO:0048666),2/143,0.0193736307109963,0.0412413380192704,0,0,10.045086119554204,39.61623634122261,ALK;RB1
KEGG_2021_Human,branching involved in blood vessel morphogenesis (GO:0001569),1/14,0.02080301457834,0.0433864673413127,0,0,52.93633952254642,205.00430545239047,VEGFA
KEGG_2021_Human,nuclear membrane disassembly (GO:0051081),1/14,0.02080301457834,0.0433864673413127,0,0,52.93633952254642,205.00430545239047,CCNB1
KEGG_2021_Human,ovarian follicle development (GO:0001541),1/14,0.02080301457834,0.0433864673413127,0,0,52.93633952254642,205.00430545239047,VEGFA
KEGG_2021_Human,pancreas development (GO:0031016),1/14,0.02080301457834,0.0433864673413127,0,0,52.93633952254642,205.00430545239047,MET
KEGG_2021_Human,regulation of protein kinase C signaling (GO:0090036),1/14,0.02080301457834,0.0433864673413127,0,0,52.93633952254642,205.00430545239047,VEGFA
KEGG_2021_Human,regulation of trophoblast cell migration (GO:1901163),1/14,0.02080301457834,0.0433864673413127,0,0,52.93633952254642,205.00430545239047,VEGFA
KEGG_2021_Human,relaxation of muscle (GO:0090075),1/14,0.02080301457834,0.0433864673413127,0,0,52.93633952254642,205.00430545239047,PIK3CA
KEGG_2021_Human,steroid catabolic process (GO:0006706),1/14,0.02080301457834,0.0433864673413127,0,0,52.93633952254642,205.00430545239047,SPP1
KEGG_2021_Human,positive regulation of transmembrane transport (GO:0034764),1/14,0.02080301457834,0.0433864673413127,0,0,52.93633952254642,205.00430545239047,BRAF
KEGG_2021_Human,cellular response to organic cyclic compound (GO:0071407),2/150,0.0211864844342244,0.0440869316541389,0,0,9.566602316602316,36.87343378412446,SPP1;EGFR
KEGG_2021_Human,negative regulation of protein phosphorylation (GO:0001933),2/152,0.0217170439806354,0.0450319724468148,0,0,9.438095238095238,36.14467589357818,RB1;PTEN
KEGG_2021_Human,positive regulation of Wnt signaling pathway (GO:0030177),2/153,0.0219844015706981,0.0450319724468148,0,0,9.37511825922422,35.78878360110144,COL1A1;EGFR
KEGG_2021_Human,regulation of branching involved in ureteric bud morphogenesis (GO:0090189),1/15,0.0222728330244505,0.0450319724468148,0,0,49.152709359605915,186.9959576603662,VEGFA
KEGG_2021_Human,regulation of endothelial cell chemotaxis (GO:2001026),1/15,0.0222728330244505,0.0450319724468148,0,0,49.152709359605915,186.9959576603662,MET
KEGG_2021_Human,regulation of extracellular matrix organization (GO:1903053),1/15,0.0222728330244505,0.0450319724468148,0,0,49.152709359605915,186.9959576603662,RB1
KEGG_2021_Human,central nervous system neuron development (GO:0021954),1/15,0.0222728330244505,0.0450319724468148,0,0,49.152709359605915,186.9959576603662,PTEN
KEGG_2021_Human,peptidyl-tyrosine autophosphorylation (GO:0038083),1/15,0.0222728330244505,0.0450319724468148,0,0,49.152709359605915,186.9959576603662,EGFR
KEGG_2021_Human,photoreceptor cell development (GO:0042461),1/15,0.0222728330244505,0.0450319724468148,0,0,49.152709359605915,186.9959576603662,VEGFA
KEGG_2021_Human,eye photoreceptor cell development (GO:0042462),1/15,0.0222728330244505,0.0450319724468148,0,0,49.152709359605915,186.9959576603662,VEGFA
KEGG_2021_Human,response to muscle stretch (GO:0035994),1/15,0.0222728330244505,0.0450319724468148,0,0,49.152709359605915,186.9959576603662,PIK3CA
KEGG_2021_Human,positive regulation of protein export from nucleus (GO:0046827),1/15,0.0222728330244505,0.0450319724468148,0,0,49.152709359605915,186.9959576603662,TP53
KEGG_2021_Human,positive regulation of sprouting angiogenesis (GO:1903672),1/15,0.0222728330244505,0.0450319724468148,0,0,49.152709359605915,186.9959576603662,VEGFA
KEGG_2021_Human,myoblast differentiation (GO:0045445),1/15,0.0222728330244505,0.0450319724468148,0,0,49.152709359605915,186.9959576603662,RB1
KEGG_2021_Human,regulation of signal transduction by p53 class mediator (GO:1901796),2/156,0.0227947322131804,0.0459867582339979,0,0,9.191094619666048,34.7536042255875,TP53;AURKA
KEGG_2021_Human,negative regulation of anoikis (GO:2000811),1/16,0.0237405188646141,0.0465756789589676,0,0,45.87356321839081,171.5933676703201,PIK3CA
KEGG_2021_Human,negative regulation of cell-substrate junction organization (GO:0150118),1/16,0.0237405188646141,0.0465756789589676,0,0,45.87356321839081,171.5933676703201,PTEN
KEGG_2021_Human,negative regulation of epithelial cell differentiation (GO:0030857),1/16,0.0237405188646141,0.0465756789589676,0,0,45.87356321839081,171.5933676703201,MMP9
KEGG_2021_Human,negative regulation of focal adhesion assembly (GO:0051895),1/16,0.0237405188646141,0.0465756789589676,0,0,45.87356321839081,171.5933676703201,PTEN
KEGG_2021_Human,regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),1/16,0.0237405188646141,0.0465756789589676,0,0,45.87356321839081,171.5933676703201,VEGFA
KEGG_2021_Human,body fluid secretion (GO:0007589),1/16,0.0237405188646141,0.0465756789589676,0,0,45.87356321839081,171.5933676703201,VEGFA
KEGG_2021_Human,dendritic spine morphogenesis (GO:0060997),1/16,0.0237405188646141,0.0465756789589676,0,0,45.87356321839081,171.5933676703201,PTEN
KEGG_2021_Human,regulation of mitotic sister chromatid separation (GO:0010965),1/16,0.0237405188646141,0.0465756789589676,0,0,45.87356321839081,171.5933676703201,UBE2C
KEGG_2021_Human,regulation of monocyte differentiation (GO:0045655),1/16,0.0237405188646141,0.0465756789589676,0,0,45.87356321839081,171.5933676703201,MYC
KEGG_2021_Human,DNA unwinding involved in DNA replication (GO:0006268),1/16,0.0237405188646141,0.0465756789589676,0,0,45.87356321839081,171.5933676703201,MCM2
KEGG_2021_Human,resolution of meiotic recombination intermediates (GO:0000712),1/16,0.0237405188646141,0.0465756789589676,0,0,45.87356321839081,171.5933676703201,TOP2A
KEGG_2021_Human,response to organophosphorus (GO:0046683),1/16,0.0237405188646141,0.0465756789589676,0,0,45.87356321839081,171.5933676703201,TYMS
KEGG_2021_Human,mitotic sister chromatid cohesion (GO:0007064),1/16,0.0237405188646141,0.0465756789589676,0,0,45.87356321839081,171.5933676703201,RB1
KEGG_2021_Human,heart development (GO:0007507),2/164,0.0250153942087175,0.048026389942241,0,0,8.7336860670194,32.21213881896081,PTEN;VEGFA
KEGG_2021_Human,negative regulation of ATPase activity (GO:0032780),1/17,0.0252060750668781,0.048026389942241,0,0,43.00431034482759,158.28468525367578,TP53
KEGG_2021_Human,negative regulation of cell aging (GO:0090344),1/17,0.0252060750668781,0.048026389942241,0,0,43.00431034482759,158.28468525367578,FOXM1
KEGG_2021_Human,regulation of establishment of endothelial barrier (GO:1903140),1/17,0.0252060750668781,0.048026389942241,0,0,43.00431034482759,158.28468525367578,VEGFA
KEGG_2021_Human,cellular response to gamma radiation (GO:0071480),1/17,0.0252060750668781,0.048026389942241,0,0,43.00431034482759,158.28468525367578,TP53
KEGG_2021_Human,negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),1/17,0.0252060750668781,0.048026389942241,0,0,43.00431034482759,158.28468525367578,PTEN
KEGG_2021_Human,regulation of leukocyte migration (GO:0002685),1/17,0.0252060750668781,0.048026389942241,0,0,43.00431034482759,158.28468525367578,VEGFA
KEGG_2021_Human,regulation of neuroblast proliferation (GO:1902692),1/17,0.0252060750668781,0.048026389942241,0,0,43.00431034482759,158.28468525367578,VEGFA
KEGG_2021_Human,DNA biosynthetic process (GO:0071897),1/17,0.0252060750668781,0.048026389942241,0,0,43.00431034482759,158.28468525367578,TYMS
KEGG_2021_Human,epithelial cell morphogenesis (GO:0003382),1/17,0.0252060750668781,0.048026389942241,0,0,43.00431034482759,158.28468525367578,MET
KEGG_2021_Human,positive regulation of DNA replication (GO:0045740),1/17,0.0252060750668781,0.048026389942241,0,0,43.00431034482759,158.28468525367578,EGFR
KEGG_2021_Human,positive regulation of positive chemotaxis (GO:0050927),1/17,0.0252060750668781,0.048026389942241,0,0,43.00431034482759,158.28468525367578,VEGFA
KEGG_2021_Human,vasculature development (GO:0001944),1/17,0.0252060750668781,0.048026389942241,0,0,43.00431034482759,158.28468525367578,PIK3CA
KEGG_2021_Human,"protein localization to chromosome, centromeric region (GO:0071459)",1/17,0.0252060750668781,0.048026389942241,0,0,43.00431034482759,158.28468525367578,RB1
KEGG_2021_Human,regulation of MAPK cascade (GO:0043408),2/166,0.0255839561452235,0.0486462903295215,0,0,8.626306620209059,31.62222713955805,ERBB2;EGFR
KEGG_2021_Human,regulation of nucleic acid-templated transcription (GO:1903506),3/430,0.0260756390245396,0.0492933358486471,0,0,5.085349986989331,18.5450192430394,RB1;E2F1;TP53
KEGG_2021_Human,negative regulation of cation transmembrane transport (GO:1904063),1/18,0.0266695046006179,0.0492933358486471,0,0,40.47261663286004,146.68225415832842,MMP9
KEGG_2021_Human,negative regulation of lipid catabolic process (GO:0050995),1/18,0.0266695046006179,0.0492933358486471,0,0,40.47261663286004,146.68225415832842,ALK
KEGG_2021_Human,regulation of chromosome segregation (GO:0051983),1/18,0.0266695046006179,0.0492933358486471,0,0,40.47261663286004,146.68225415832842,BUB1
KEGG_2021_Human,cell migration involved in sprouting angiogenesis (GO:0002042),1/18,0.0266695046006179,0.0492933358486471,0,0,40.47261663286004,146.68225415832842,VEGFA
KEGG_2021_Human,negative regulation of Rho protein signal transduction (GO:0035024),1/18,0.0266695046006179,0.0492933358486471,0,0,40.47261663286004,146.68225415832842,MET
KEGG_2021_Human,DNA conformation change (GO:0071103),1/18,0.0266695046006179,0.0492933358486471,0,0,40.47261663286004,146.68225415832842,TOP2A
KEGG_2021_Human,regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091),1/18,0.0266695046006179,0.0492933358486471,0,0,40.47261663286004,146.68225415832842,TOP2A
KEGG_2021_Human,positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),1/18,0.0266695046006179,0.0492933358486471,0,0,40.47261663286004,146.68225415832842,VEGFA
KEGG_2021_Human,positive regulation of CREB transcription factor activity (GO:0032793),1/18,0.0266695046006179,0.0492933358486471,0,0,40.47261663286004,146.68225415832842,VEGFA
KEGG_2021_Human,regulation of transcription by RNA polymerase I (GO:0006356),1/18,0.0266695046006179,0.0492933358486471,0,0,40.47261663286004,146.68225415832842,ERBB2
KEGG_2021_Human,positive regulation of excitatory postsynaptic potential (GO:2000463),1/18,0.0266695046006179,0.0492933358486471,0,0,40.47261663286004,146.68225415832842,PTEN
KEGG_2021_Human,positive regulation of extracellular matrix organization (GO:1903055),1/18,0.0266695046006179,0.0492933358486471,0,0,40.47261663286004,146.68225415832842,RB1
KEGG_2021_Human,presynapse assembly (GO:0099054),1/18,0.0266695046006179,0.0492933358486471,0,0,40.47261663286004,146.68225415832842,PTEN
KEGG_2021_Human,neuron projection development (GO:0031175),2/171,0.0270284247863527,0.0498572138489295,0,0,8.368977176669484,30.219256789750094,RB1;PTEN
GO_Biological_Process_2021,mitotic cell cycle phase transition (GO:0044772),10/209,3.132131415477564e-13,2.9003536907322236e-10,0,0,49.675879396984925,1430.2625780852777,RB1;CCNB1;CCND1;UBE2C;CDKN2A;CDK4;MYC;E2F1;FOXM1;AURKA
GO_Biological_Process_2021,regulation of G1/S transition of mitotic cell cycle (GO:2000045),7/71,1.0001766912034066e-11,4.630818080271772e-09,0,0,94.6616847826087,2397.615702429981,RB1;CCND1;CDKN2A;CDK4;PTEN;E2F1;EGFR
GO_Biological_Process_2021,G1/S transition of mitotic cell cycle (GO:0000082),7/85,3.660160117433194e-11,1.1297694229143793e-08,0,0,77.6164994425864,1865.1965973105907,RB1;CCND1;CDKN2A;CDK4;MYC;E2F1;TYMS
GO_Biological_Process_2021,positive regulation of mitotic cell cycle phase transition (GO:1901992),6/58,2.5640631118544825e-10,4.856675995171381e-08,0,0,95.7596153846154,2114.780030739728,RB1;CCNB1;CCND1;UBE2C;CDK4;EGFR
GO_Biological_Process_2021,regulation of cell cycle (GO:0051726),9/296,3.286665115608851e-10,4.856675995171381e-08,0,0,29.39223494275759,641.8081815289999,RB1;CCNB1;CCND1;CDKN2A;CDK4;MYC;BIRC5;FOXM1;TP53
GO_Biological_Process_2021,"regulation of DNA-templated transcription, initiation (GO:2000142)",6/61,3.5066267204255374e-10,4.856675995171381e-08,0,0,90.52272727272728,1970.7880743786625,CCNB1;CCND1;CDKN2A;CDK4;PTEN;TP53
GO_Biological_Process_2021,regulation of cell population proliferation (GO:0042127),12/764,4.068874778237358e-10,4.856675995171381e-08,0,0,17.03723404255319,368.3873279171463,ALK;CDKN2A;CDK4;MYC;ERBB2;PTEN;BIRC5;KRAS;FOXM1;TP53;EGFR;VEGFA
GO_Biological_Process_2021,cell cycle G1/S phase transition (GO:0044843),6/63,4.2821851638974144e-10,4.856675995171381e-08,0,0,87.33771929824562,1883.9957862021104,RB1;CCND1;CDKN2A;CDK4;MYC;E2F1
GO_Biological_Process_2021,regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),6/64,4.720311442391191e-10,4.856675995171381e-08,0,0,85.82758620689656,1843.0595391299073,CCNB1;CCND1;CDKN2A;CDK4;PTEN;TP53
GO_Biological_Process_2021,positive regulation of cell population proliferation (GO:0008284),10/474,9.991526648145308e-10,9.252153676182557e-08,0,0,21.01939655172414,435.6083604978356,CDK4;MYC;ERBB2;PTEN;E2F1;BIRC5;KRAS;FOXM1;EGFR;VEGFA
GO_Biological_Process_2021,positive regulation of phosphorylation (GO:0042327),8/253,2.7010414824290188e-09,2.2737858297538833e-07,0,0,29.27643784786642,577.6132397335329,ALK;CCND1;ERBB2;KRAS;MMP9;MET;EGFR;VEGFA
GO_Biological_Process_2021,response to UV-A (GO:0070141),4/14,4.072753297544103e-09,3.142807961271533e-07,0,0,307.0769230769231,5932.4026729728075,CCND1;MMP1;MMP9;EGFR
GO_Biological_Process_2021,positive regulation of cellular process (GO:0048522),10/625,1.4119961653100971e-08,1.005775730059346e-06,0,0,15.735772357723578,284.4347277939742,CCND1;CDK4;MYC;ERBB2;PTEN;BIRC5;KRAS;FOXM1;EGFR;VEGFA
GO_Biological_Process_2021,negative regulation of apoptotic process (GO:0043066),9/485,2.4493078005720696e-08,1.6200421595212402e-06,0,0,17.551620648259302,307.58996299275725,RB1;PIK3CA;MYC;BIRC5;BRAF;MMP9;TP53;EGFR;VEGFA
GO_Biological_Process_2021,mitotic G1 DNA damage checkpoint signaling (GO:0031571),5/65,4.147827623661016e-08,2.560592253006734e-06,0,0,66.36666666666666,1128.1069719262523,CCNB1;CCND1;E2F1;TP53;AURKA
GO_Biological_Process_2021,positive regulation of protein phosphorylation (GO:0001934),8/371,5.326936402101244e-08,3.082964442716095e-06,0,0,19.64137240170298,328.9518283462831,CCND1;ERBB2;BRAF;KRAS;MMP9;TP53;EGFR;VEGFA
GO_Biological_Process_2021,negative regulation of programmed cell death (GO:0043069),8/381,6.538199880918128e-08,3.561395935135404e-06,0,0,19.105045088959297,316.05512130301787,MYC;BIRC5;BRAF;MMP9;MET;TP53;EGFR;VEGFA
GO_Biological_Process_2021,regulation of apoptotic process (GO:0042981),10/742,7.122287263378748e-08,3.6640211143826223e-06,0,0,13.140710382513662,216.2626080699125,ALK;TOP2A;MYC;E2F1;BIRC5;BRAF;MMP9;TP53;EGFR;VEGFA
GO_Biological_Process_2021,"DNA damage response, signal transduction by p53 class mediator (GO:0030330)",5/74,8.013740614758281e-08,3.905644110140089e-06,0,0,57.68405797101449,942.5299976485272,CCNB1;E2F1;FOXM1;TP53;AURKA
GO_Biological_Process_2021,transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),8/404,1.0257818243475557e-07,4.701387126224559e-06,0,0,17.9742883379247,289.25376178949733,COL1A1;ALK;PIK3CA;ERBB2;MMP9;MET;EGFR;VEGFA
GO_Biological_Process_2021,regulation of protein phosphorylation (GO:0001932),7/266,1.0661893050833235e-07,4.701387126224559e-06,0,0,23.16216216216216,371.8454615215965,CCND1;ERBB2;PTEN;KRAS;MMP9;EGFR;VEGFA
GO_Biological_Process_2021,regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),5/82,1.3461099408226645e-07,5.665899114553578e-06,0,0,51.67012987012987,817.466755991372,CCNB1;CCND1;CDKN2A;PTEN;EGFR
GO_Biological_Process_2021,anaphase-promoting complex-dependent catabolic process (GO:0031145),5/84,1.5198846538399078e-07,6.1191877802424114e-06,0,0,50.356962025316456,790.5771716985369,CDC20;RB1;CCNB1;UBE2C;AURKA
GO_Biological_Process_2021,negative regulation of cell cycle G1/S phase transition (GO:1902807),4/35,2.084444326282279e-07,8.04248102557246e-06,0,0,98.95285359801488,1522.2504597233535,RB1;CDKN2A;CDK4;PTEN
GO_Biological_Process_2021,negative regulation of mitotic cell cycle phase transition (GO:1901991),5/92,2.400965919274671e-07,8.844458803001882e-06,0,0,45.708045977011494,696.6922995272562,RB1;CDKN2A;CDK4;PTEN;AURKA
GO_Biological_Process_2021,MAPK cascade (GO:0000165),7/303,2.580535364327234e-07,8.844458803001882e-06,0,0,20.228848413631024,306.8736283976403,PIK3CA;MYC;ERBB2;BRAF;KRAS;MET;EGFR
GO_Biological_Process_2021,negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),4/37,2.623784252745423e-07,8.844458803001882e-06,0,0,92.94638694638697,1408.4610301442117,RB1;CDKN2A;CDK4;PTEN
GO_Biological_Process_2021,regulation of kinase activity (GO:0043549),5/94,2.67435039399625e-07,8.844458803001882e-06,0,0,44.67640449438202,676.1500911489362,ALK;RB1;ERBB2;MET;EGFR
GO_Biological_Process_2021,cellular response to cytokine stimulus (GO:0071345),8/482,3.941804873473308e-07,1.2167037709454278e-05,0,0,14.956655159186806,220.55767131363712,PIK3CA;CCND1;MMP1;MYC;BIRC5;MMP9;TP53;VEGFA
GO_Biological_Process_2021,positive regulation of gene expression (GO:0010628),8/482,3.941804873473308e-07,1.2167037709454278e-05,0,0,14.956655159186806,220.55767131363712,MYC;ERBB2;E2F1;BRAF;KRAS;TP53;EGFR;VEGFA
GO_Biological_Process_2021,regulation of fibroblast proliferation (GO:0048145),4/46,6.422530681585423e-07,1.881039894583026e-05,0,0,72.99633699633699,1040.8024617904323,CDK4;MYC;E2F1;TP53
GO_Biological_Process_2021,positive regulation of ubiquitin protein ligase activity (GO:1904668),3/12,6.638552689392329e-07,1.881039894583026e-05,0,0,246.4320987654321,3505.546305288435,CDC20;UBE2C;PTEN
GO_Biological_Process_2021,positive regulation of protein modification process (GO:0031401),6/214,6.703489905101496e-07,1.881039894583026e-05,0,0,23.752403846153847,337.6515220434298,CCND1;ERBB2;KRAS;MMP9;EGFR;VEGFA
GO_Biological_Process_2021,regulation of transcription by RNA polymerase II (GO:0006357),14/2206,9.890181703950437e-07,2.693620075840619e-05,0,0,7.096601277372263,98.12153462530333,RB1;CDKN2A;PTEN;FOXM1;EGFR;VEGFA;CCNB1;CCND1;CDK4;MYC;ERBB2;E2F1;MET;TP53
GO_Biological_Process_2021,microtubule cytoskeleton organization involved in mitosis (GO:1902850),5/128,1.2440768092745254e-06,3.291471786823459e-05,0,0,32.271544715447156,438.79996351470095,CDC20;CCNB1;BIRC5;BUB1;AURKA
GO_Biological_Process_2021,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",4/56,1.4306062572969215e-06,3.679837206269304e-05,0,0,58.928994082840234,793.0317666964794,CCNB1;E2F1;TP53;AURKA
GO_Biological_Process_2021,phosphorylation (GO:0016310),7/400,1.6618811208450946e-06,4.159194372709615e-05,0,0,15.160858502046686,201.75404010842968,ALK;PIK3CA;CDK4;ERBB2;BIRC5;BRAF;AURKA
GO_Biological_Process_2021,positive regulation of transferase activity (GO:0051347),5/148,2.5452345695736795e-06,6.202334766908493e-05,0,0,27.73006993006993,357.1990099143294,ALK;MYC;ERBB2;MET;EGFR
GO_Biological_Process_2021,cytokine-mediated signaling pathway (GO:0019221),8/621,2.6402287055231068e-06,6.268850721318967e-05,0,0,11.48272282366899,147.49149846049016,PIK3CA;CCND1;MMP1;MYC;BIRC5;MMP9;TP53;VEGFA
GO_Biological_Process_2021,ERBB signaling pathway (GO:0038127),4/66,2.7781889874226016e-06,6.274641469154461e-05,0,0,49.39950372208437,632.0029882878963,PIK3CA;ERBB2;BRAF;EGFR
GO_Biological_Process_2021,positive regulation of cell cycle (GO:0045787),4/66,2.7781889874226016e-06,6.274641469154461e-05,0,0,49.39950372208437,632.0029882878963,CCNB1;CCND1;CDK4;EGFR
GO_Biological_Process_2021,mitotic spindle organization (GO:0007052),5/157,3.4005796521994466e-06,7.34832320163586e-05,0,0,26.07631578947369,328.3416162255878,CDC20;CCNB1;BIRC5;BUB1;AURKA
GO_Biological_Process_2021,positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),3/20,3.412288311774752e-06,7.34832320163586e-05,0,0,130.41176470588235,1641.6399128222724,CCNB1;CCND1;CDK4
GO_Biological_Process_2021,myeloid leukocyte differentiation (GO:0002573),4/71,3.72597760282196e-06,7.841489227757126e-05,0,0,45.701492537313435,571.2769422532601,CDK4;E2F1;MMP9;VEGFA
GO_Biological_Process_2021,regulation of ubiquitin protein ligase activity (GO:1904666),3/21,3.976980759391483e-06,8.183742629325586e-05,0,0,123.1604938271605,1531.499217211056,CDC20;UBE2C;PTEN
GO_Biological_Process_2021,regulation of chromosome organization (GO:0033044),3/22,4.600272051318671e-06,9.260547651132802e-05,0,0,116.67251461988305,1433.8346311808384,RB1;MYC;BUB1
GO_Biological_Process_2021,"positive regulation of transcription, DNA-templated (GO:0045893)",10/1183,5.100540338322769e-06,9.949081988894036e-05,0,0,8.012361466325661,97.6399514580974,COL1A1;MYC;ERBB2;E2F1;SPP1;FOXM1;MET;TP53;EGFR;VEGFA
GO_Biological_Process_2021,cellular response to UV (GO:0034644),4/77,5.15719152772045e-06,9.949081988894036e-05,0,0,41.93256059009484,510.533890176415,MMP1;MYC;MMP9;TP53
GO_Biological_Process_2021,positive regulation of cell cycle G2/M phase transition (GO:1902751),3/23,5.284966899503806e-06,9.987508875388825e-05,0,0,110.83333333333331,1346.696399028853,CCNB1;CCND1;CDK4
GO_Biological_Process_2021,"negative regulation of transcription, DNA-templated (GO:0045892)",9/948,6.753447820719468e-06,0.0001246100577727779,0,0,8.685988133272478,103.41066165617502,RB1;CCND1;CDKN2A;MYC;E2F1;BIRC5;FOXM1;TP53;VEGFA
GO_Biological_Process_2021,protein phosphorylation (GO:0006468),7/496,6.862972944289064e-06,0.0001246100577727779,0,0,12.124744376278118,144.15557006020202,ALK;CDK4;ERBB2;BIRC5;BRAF;EGFR;AURKA
GO_Biological_Process_2021,regulation of mitotic metaphase/anaphase transition (GO:0030071),3/26,7.735344501697224e-06,0.00013774863478022362,0,0,96.3623188405797,1134.1565994177497,RB1;CCNB1;UBE2C
GO_Biological_Process_2021,"regulation of transcription, DNA-templated (GO:0006355)",13/2244,8.145229835275475e-06,0.00014035552839680482,0,0,6.080285812218209,71.24926400785914,RB1;CDKN2A;TYMS;FOXM1;EGFR;VEGFA;COL1A1;MYC;ERBB2;E2F1;SPP1;BIRC5;TP53
GO_Biological_Process_2021,regulation of mitotic cell cycle phase transition (GO:1901990),5/188,8.192707705149034e-06,0.00014035552839680482,0,0,21.62513661202186,253.279354526915,CDC20;CCNB1;UBE2C;E2F1;AURKA
GO_Biological_Process_2021,positive regulation of nucleic acid-templated transcription (GO:1903508),7/511,8.336451470652554e-06,0.00014035552839680482,0,0,11.754830917874395,137.4712537250563,COL1A1;MYC;E2F1;SPP1;FOXM1;TP53;EGFR
GO_Biological_Process_2021,positive regulation of fibroblast proliferation (GO:0048146),3/28,9.726841758002346e-06,0.00016084027621268164,0,0,88.64444444444445,1023.0119639068774,CDK4;MYC;E2F1
GO_Biological_Process_2021,regulation of epithelial cell proliferation (GO:0050678),4/93,1.0943185324258111e-05,0.00017777876509233355,0,0,34.36646499567848,392.5610377906923,MYC;ERBB2;EGFR;VEGFA
GO_Biological_Process_2021,regulation of cell cycle phase transition (GO:1901987),4/95,1.1907152458916844e-05,0.0001901038478785689,0,0,33.607776838546066,381.05745207513735,CDC20;CCNB1;UBE2C;TP53
GO_Biological_Process_2021,negative regulation of cellular macromolecule biosynthetic process (GO:2000113),7/547,1.2976555697628123e-05,0.0002011604133078584,0,0,10.950885668276973,123.22337615321985,RB1;CDKN2A;E2F1;BIRC5;TYMS;FOXM1;TP53
GO_Biological_Process_2021,regulation of protein kinase B signaling (GO:0051896),5/207,1.3062406452714093e-05,0.0002011604133078584,0,0,19.572277227722772,220.1053709381813,PIK3CA;ERBB2;PTEN;MET;EGFR
GO_Biological_Process_2021,positive regulation of ubiquitin-protein transferase activity (GO:0051443),3/31,1.330577067114537e-05,0.0002011604133078584,0,0,79.13492063492063,888.4725019735519,CDC20;UBE2C;PTEN
GO_Biological_Process_2021,regulation of peptidyl-serine phosphorylation (GO:0033135),4/98,1.3468623785191383e-05,0.0002011604133078584,0,0,32.53027823240589,364.8318764531277,PTEN;BRAF;EGFR;VEGFA
GO_Biological_Process_2021,response to UV (GO:0009411),4/99,1.4021132937600505e-05,0.0002060883984161598,0,0,32.18623481781376,359.6793996924981,CCND1;MYC;TP53;EGFR
GO_Biological_Process_2021,ERBB2 signaling pathway (GO:0038128),3/32,1.466738837337456e-05,0.00020895387128838216,0,0,76.40229885057471,850.3487240482457,PIK3CA;ERBB2;EGFR
GO_Biological_Process_2021,regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),3/32,1.466738837337456e-05,0.00020895387128838216,0,0,76.40229885057471,850.3487240482457,RB1;E2F1;TYMS
GO_Biological_Process_2021,positive regulation of protein localization to membrane (GO:1905477),4/101,1.5176027371704345e-05,0.0002129242628211852,0,0,31.519429024583665,349.7330763791421,ERBB2;E2F1;TP53;EGFR
GO_Biological_Process_2021,regulation of cell growth (GO:0001558),5/217,1.6402619832629297e-05,0.00022669889500021983,0,0,18.639622641509433,205.37265753153028,RB1;CDKN2A;ERBB2;TP53;EGFR
GO_Biological_Process_2021,phosphatidylinositol 3-kinase signaling (GO:0014065),3/34,1.765973730172786e-05,0.00024048406972647057,0,0,71.46594982078852,782.1393087705632,PIK3CA;ERBB2;PTEN
GO_Biological_Process_2021,small GTPase mediated signal transduction (GO:0007264),4/106,1.83688783630966e-05,0.00024299401948896357,0,0,29.96681749622926,326.7837312439411,RB1;CDKN2A;KRAS;TP53
GO_Biological_Process_2021,positive regulation of protein serine/threonine kinase activity (GO:0071902),4/106,1.83688783630966e-05,0.00024299401948896357,0,0,29.96681749622926,326.7837312439411,CCND1;ERBB2;EGFR;VEGFA
GO_Biological_Process_2021,regulation of gene expression (GO:0010468),9/1079,1.912954842712098e-05,0.000249047169781128,0,0,7.570093457943925,82.24358755160058,RB1;CDK4;MYC;E2F1;BRAF;KRAS;TP53;VEGFA;AURKA
GO_Biological_Process_2021,positive regulation of macromolecule metabolic process (GO:0010604),6/384,1.936435877347863e-05,0.000249047169781128,0,0,12.957671957671955,140.6176455091447,MYC;E2F1;BRAF;KRAS;TP53;VEGFA
GO_Biological_Process_2021,positive regulation of cellular component organization (GO:0051130),4/114,2.4469635298620526e-05,0.00030620111198003525,0,0,27.776223776223777,294.9300990642989,CDC20;RB1;MMP1;VEGFA
GO_Biological_Process_2021,positive regulation of kinase activity (GO:0033674),4/114,2.4469635298620526e-05,0.00030620111198003525,0,0,27.776223776223777,294.9300990642989,ALK;ERBB2;MET;EGFR
GO_Biological_Process_2021,regulation of nitric oxide mediated signal transduction (GO:0010749),2/6,3.250333722969562e-05,0.00040130787032930857,0,0,356.5357142857143,3684.499894523836,EGFR;VEGFA
GO_Biological_Process_2021,positive regulation of epithelial cell proliferation (GO:0050679),4/123,3.298141714694363e-05,0.00040185252997460263,0,0,25.66386554621849,264.83996129648244,MYC;ERBB2;EGFR;VEGFA
GO_Biological_Process_2021,branching morphogenesis of an epithelial tube (GO:0048754),3/44,3.869184698386548e-05,0.00046530714684492775,0,0,54.00813008130081,548.7162098920684,MYC;MET;VEGFA
GO_Biological_Process_2021,chromosome condensation (GO:0030261),3/45,4.14136453788013e-05,0.0004916543028303847,0,0,52.71957671957672,532.0407033036188,RB1;TOP2A;CCNB1
GO_Biological_Process_2021,negative regulation of stress-activated protein kinase signaling cascade (GO:0070303),2/7,4.546235690936047e-05,0.0005328878797223772,0,0,285.2142857142857,2851.750942795132,MYC;FOXM1
GO_Biological_Process_2021,epidermal growth factor receptor signaling pathway (GO:0007173),3/47,4.722800299708779e-05,0.0005466641346912911,0,0,50.31818181818182,501.19543536852706,PIK3CA;BRAF;EGFR
GO_Biological_Process_2021,regulation of stress-activated MAPK cascade (GO:0032872),3/49,5.355353443650065e-05,0.0006104273639690427,0,0,48.1256038647343,473.30707301492265,MYC;FOXM1;EGFR
GO_Biological_Process_2021,negative regulation of transcription by RNA polymerase II (GO:0000122),7/684,5.43357571485425e-05,0.0006104273639690427,0,0,8.6732387129921,85.17404930240279,RB1;CCND1;MYC;E2F1;FOXM1;TP53;VEGFA
GO_Biological_Process_2021,enzyme linked receptor protein signaling pathway (GO:0007167),4/140,5.4714331759644216e-05,0.0006104273639690427,0,0,22.436651583710407,220.1794973259299,ALK;ERBB2;MET;EGFR
GO_Biological_Process_2021,negative regulation of nucleic acid-templated transcription (GO:1903507),6/464,5.584676011933568e-05,0.0006156440460774386,0,0,10.65065502183406,104.30078938692238,RB1;CDKN2A;E2F1;BIRC5;FOXM1;TP53
GO_Biological_Process_2021,regulation of cellular component movement (GO:0051270),3/50,5.691425903052129e-05,0.000620030633673679,0,0,47.09929078014184,460.3468031322656,ERBB2;EGFR;VEGFA
GO_Biological_Process_2021,Ras protein signal transduction (GO:0007265),4/142,5.78236474103305e-05,0.0006226127616507679,0,0,22.109253065774805,215.7445840397391,RB1;CDKN2A;KRAS;TP53
GO_Biological_Process_2021,regulation of G2/M transition of mitotic cell cycle (GO:0010389),4/149,6.972867537884472e-05,0.0007421695793196577,0,0,21.03448275862069,201.31890817721697,CCNB1;CCND1;CDK4;AURKA
GO_Biological_Process_2021,positive regulation of mitochondrion organization (GO:0010822),3/58,8.887739009987521e-05,0.000933416951589509,0,0,40.23232323232323,375.2972809322434,MMP9;TP53;AURKA
GO_Biological_Process_2021,protein autophosphorylation (GO:0046777),4/159,8.971286035795496e-05,0.000933416951589509,0,0,19.667493796526056,183.27933769617135,ALK;ERBB2;EGFR;AURKA
GO_Biological_Process_2021,positive regulation of protein kinase B signaling (GO:0051897),4/161,9.416140358294387e-05,0.0009688162190867336,0,0,19.41499265066144,179.98669303277816,PIK3CA;ERBB2;MET;EGFR
GO_Biological_Process_2021,"DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)",2/10,9.7147588503534e-05,0.00098855677971728,0,0,178.23214285714286,1646.7365311362207,FOXM1;TP53
GO_Biological_Process_2021,proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),5/321,0.00010579775635637448,0.0010648774172391,0,0,12.439240506329114,113.86857429979756,CDC20;RB1;CCNB1;UBE2C;AURKA
GO_Biological_Process_2021,cellular response to UV-A (GO:0071492),2/11,0.00011862538453320848,0.0011562853271342,0,0,158.4206349206349,1432.0496756090347,MMP1;MMP9
GO_Biological_Process_2021,"DNA damage response, signal transduction resulting in transcription (GO:0042772)",2/11,0.00011862538453320848,0.0011562853271342,0,0,158.4206349206349,1432.0496756090347,FOXM1;TP53
GO_Biological_Process_2021,positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),2/11,0.00011862538453320848,0.0011562853271342,0,0,158.4206349206349,1432.0496756090347,TP53;EGFR
GO_Biological_Process_2021,neuron differentiation (GO:0030182),4/174,0.00012709277160129578,0.0012259156927374,0,0,17.918552036199095,160.74004200179456,ALK;ERBB2;MET;VEGFA
GO_Biological_Process_2021,positive regulation of developmental process (GO:0051094),4/177,0.0001357435324457757,0.0012785803429037,0,0,17.605157847932414,156.7694103955469,CDC20;ALK;VEGFA;AURKA
GO_Biological_Process_2021,positive regulation of intracellular signal transduction (GO:1902533),6/546,0.00013681459856486894,0.0012785803429037,0,0,8.99537037037037,80.03076531727088,PIK3CA;ERBB2;MET;TP53;EGFR;VEGFA
GO_Biological_Process_2021,regulation of mitotic cell cycle (GO:0007346),4/178,0.00013871972775252736,0.0012785803429037,0,0,17.50309460654288,155.48095219143642,CDC20;RB1;CCNB1;UBE2C
GO_Biological_Process_2021,regulation of keratinocyte migration (GO:0051547),2/12,0.00014221789991262262,0.0012785803429037,0,0,142.57142857142858,1262.919124249693,PTEN;MMP9
GO_Biological_Process_2021,regulation of sister chromatid cohesion (GO:0007063),2/12,0.00014221789991262262,0.0012785803429037,0,0,142.57142857142858,1262.919124249693,RB1;BUB1
GO_Biological_Process_2021,replicative senescence (GO:0090399),2/12,0.00014221789991262262,0.0012785803429037,0,0,142.57142857142858,1262.919124249693,CDKN2A;TP53
GO_Biological_Process_2021,mitotic G1/S transition checkpoint signaling (GO:0044819),2/12,0.00014221789991262262,0.0012785803429037,0,0,142.57142857142858,1262.919124249693,CCND1;TP53
GO_Biological_Process_2021,cellular response to decreased oxygen levels (GO:0036294),3/69,0.0001492461826251745,0.0013162091915324,0,0,33.50841750841751,295.206255852885,MYC;TP53;VEGFA
GO_Biological_Process_2021,positive regulation of MAP kinase activity (GO:0043406),3/69,0.0001492461826251745,0.0013162091915324,0,0,33.50841750841751,295.206255852885,ERBB2;EGFR;VEGFA
GO_Biological_Process_2021,cellular response to DNA damage stimulus (GO:0006974),5/350,0.00015857875499494133,0.0013853200672199,0,0,11.376811594202898,99.53867363363952,TOP2A;CCND1;MYC;E2F1;TP53
GO_Biological_Process_2021,phosphatidylinositol-mediated signaling (GO:0048015),3/71,0.00016247922795874684,0.001406128645699,0,0,32.51960784313726,283.7322904048699,PIK3CA;ERBB2;PTEN
GO_Biological_Process_2021,negative regulation of cellular process (GO:0048523),6/566,0.00016643978547304622,0.0014270670495188,0,0,8.665178571428571,75.39465261038788,RB1;CDKN2A;MYC;PTEN;FOXM1;TP53
GO_Biological_Process_2021,negative regulation of cell differentiation (GO:0045596),4/191,0.00018185667570382255,0.001544947538548,0,0,16.27560674619498,140.17027252258384,RB1;PTEN;E2F1;EGFR
GO_Biological_Process_2021,vascular endothelial growth factor signaling pathway (GO:0038084),2/14,0.00019572323532665868,0.0016476337810225,0,0,118.79761904761904,1014.3901741044946,PIK3CA;VEGFA
GO_Biological_Process_2021,negative regulation of protein serine/threonine kinase activity (GO:0071901),3/78,0.0002147426973093748,0.0017914570964728,0,0,29.474074074074075,248.9400929097906,RB1;CDKN2A;PTEN
GO_Biological_Process_2021,positive regulation of endothelial cell chemotaxis (GO:2001028),2/15,0.0002256241583974691,0.0018489200944783,0,0,109.65384615384616,920.7238662710552,MET;VEGFA
GO_Biological_Process_2021,macrophage differentiation (GO:0030225),2/15,0.0002256241583974691,0.0018489200944783,0,0,109.65384615384616,920.7238662710552,MMP9;VEGFA
GO_Biological_Process_2021,negative regulation of cell population proliferation (GO:0008285),5/379,0.00022954966827580075,0.0018636589475213,0,0,10.479144385026736,87.80884953478704,CDKN2A;MYC;PTEN;E2F1;TP53
GO_Biological_Process_2021,negative regulation of cell cycle (GO:0045786),3/80,0.00023144792544811684,0.0018636589475213,0,0,28.705627705627705,240.29927766413917,RB1;CDKN2A;PTEN
GO_Biological_Process_2021,regulation of ERBB signaling pathway (GO:1901184),2/16,0.00025761600687002403,0.0020564863996693,0,0,101.81632653061224,841.4142385973647,ERBB2;EGFR
GO_Biological_Process_2021,extracellular structure organization (GO:0043062),4/216,0.00029088238061144585,0.002289047375094,0,0,14.338171262699564,116.74987235018932,COL1A1;MMP1;SPP1;MMP9
GO_Biological_Process_2021,positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),2/17,0.00029169286205301905,0.002289047375094,0,0,95.02380952380952,773.4756743774749,CCND1;EGFR
GO_Biological_Process_2021,external encapsulating structure organization (GO:0045229),4/217,0.00029603696132733307,0.0023036153461269,0,0,14.270133622246298,115.94521015883412,COL1A1;MMP1;SPP1;MMP9
GO_Biological_Process_2021,positive regulation of transcription by RNA polymerase II (GO:0045944),7/908,0.0003158879680919844,0.0024283706982097,0,0,6.4412971094918685,51.91764658650781,MYC;E2F1;FOXM1;MET;TP53;EGFR;VEGFA
GO_Biological_Process_2021,positive regulation of cell motility (GO:2000147),4/221,0.0003173140977142343,0.0024283706982097,0,0,14.004253810705425,112.81292509766702,COL1A1;MMP9;EGFR;VEGFA
GO_Biological_Process_2021,regulation of cell migration (GO:0030334),5/408,0.0003225648010460889,0.0024287040375895,0,0,9.710669975186104,78.06608126579629,COL1A1;PTEN;MMP9;EGFR;VEGFA
GO_Biological_Process_2021,negative regulation of fibroblast proliferation (GO:0048147),2/18,0.00032784881716921787,0.0024287040375895,0,0,89.08035714285714,714.6879621205851,MYC;TP53
GO_Biological_Process_2021,regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),2/18,0.00032784881716921787,0.0024287040375895,0,0,89.08035714285714,714.6879621205851,TP53;EGFR
GO_Biological_Process_2021,positive chemotaxis (GO:0050918),2/18,0.00032784881716921787,0.0024287040375895,0,0,89.08035714285714,714.6879621205851,MET;VEGFA
GO_Biological_Process_2021,regulation of peptidyl-tyrosine phosphorylation (GO:0050730),3/92,0.00034949988210486357,0.0025685467526119,0,0,24.820224719101123,197.5443505613132,TP53;EGFR;VEGFA
GO_Biological_Process_2021,positive regulation of peptidyl-serine phosphorylation (GO:0033138),3/93,0.0003607851781524913,0.0026306068895213,0,0,24.54320987654321,194.55961688941923,BRAF;EGFR;VEGFA
GO_Biological_Process_2021,negative regulation of MAPK cascade (GO:0043409),3/94,0.0003723028623192989,0.0026933785195911,0,0,24.27228327228327,191.6491643817023,MYC;PTEN;FOXM1
GO_Biological_Process_2021,negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),2/20,0.00040637445946356223,0.0028640798576606,0,0,79.17460317460318,618.2139479571657,CDKN2A;PTEN
GO_Biological_Process_2021,positive regulation of cyclin-dependent protein kinase activity (GO:1904031),2/20,0.00040637445946356223,0.0028640798576606,0,0,79.17460317460318,618.2139479571657,CCND1;EGFR
GO_Biological_Process_2021,granulocyte differentiation (GO:0030851),2/20,0.00040637445946356223,0.0028640798576606,0,0,79.17460317460318,618.2139479571657,CDK4;E2F1
GO_Biological_Process_2021,regulation of MAP kinase activity (GO:0043405),3/97,0.000408270562863074,0.0028640798576606,0,0,23.494089834515368,183.33802033627984,ERBB2;EGFR;VEGFA
GO_Biological_Process_2021,regulation of ERK1 and ERK2 cascade (GO:0070372),4/238,0.000420147775095021,0.0029252393965262,0,0,12.975673898750822,100.88461971693135,ERBB2;PTEN;BRAF;EGFR
GO_Biological_Process_2021,regulation of intracellular signal transduction (GO:1902531),5/437,0.0004418206619695047,0.0030330379236916,0,0,9.045370370370373,69.87192676124101,PTEN;TP53;EGFR;VEGFA;AURKA
GO_Biological_Process_2021,spindle assembly checkpoint signaling (GO:0071173),2/21,0.0004487323925980029,0.0030330379236916,0,0,75.00375939849624,578.2102706794014,CDC20;BUB1
GO_Biological_Process_2021,mitotic spindle assembly checkpoint signaling (GO:0007094),2/21,0.0004487323925980029,0.0030330379236916,0,0,75.00375939849624,578.2102706794014,CDC20;BUB1
GO_Biological_Process_2021,mitotic spindle checkpoint signaling (GO:0071174),2/21,0.0004487323925980029,0.0030330379236916,0,0,75.00375939849624,578.2102706794014,CDC20;BUB1
GO_Biological_Process_2021,negative regulation of cyclin-dependent protein kinase activity (GO:1904030),2/22,0.0004931459174352375,0.0032618079967502,0,0,71.25,542.5477632515199,CDKN2A;PTEN
GO_Biological_Process_2021,negative regulation of mitotic metaphase/anaphase transition (GO:0045841),2/22,0.0004931459174352375,0.0032618079967502,0,0,71.25,542.5477632515199,CDC20;BUB1
GO_Biological_Process_2021,negative regulation of phosphate metabolic process (GO:0045936),2/22,0.0004931459174352375,0.0032618079967502,0,0,71.25,542.5477632515199,CDKN2A;TP53
GO_Biological_Process_2021,positive regulation of cellular metabolic process (GO:0031325),3/105,0.0005149106542529526,0.0033816118144555,0,0,21.642701525054463,163.8680859692293,CCNB1;TP53;VEGFA
GO_Biological_Process_2021,regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),3/106,0.0005293731230241498,0.0034521092388757,0,0,21.431499460625673,161.67531078544127,PIK3CA;PTEN;EGFR
GO_Biological_Process_2021,response to gamma radiation (GO:0010332),2/24,0.0005881163648560729,0.0037819149573383,0,0,64.76623376623377,481.769182294251,MYC;TP53
GO_Biological_Process_2021,positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),2/24,0.0005881163648560729,0.0037819149573383,0,0,64.76623376623377,481.769182294251,TP53;VEGFA
GO_Biological_Process_2021,regulation of protein serine/threonine kinase activity (GO:0071900),3/111,0.0006055954099760554,0.0038674575837091,0,0,20.43415637860082,151.40276287997665,RB1;CCNB1;CCND1
GO_Biological_Process_2021,positive regulation of release of cytochrome c from mitochondria (GO:0090200),2/25,0.0006386616282018391,0.0040506895048965,0,0,61.9472049689441,455.6920507677008,MMP9;TP53
GO_Biological_Process_2021,negative regulation of signal transduction (GO:0009968),4/267,0.0006475080417156471,0.0040513003150587,0,0,11.527932143901726,84.6424508619817,RB1;ERBB2;PTEN;EGFR
GO_Biological_Process_2021,protein deubiquitination (GO:0016579),4/267,0.0006475080417156471,0.0040513003150587,0,0,11.527932143901726,84.6424508619817,CDC20;MYC;PTEN;TP53
GO_Biological_Process_2021,cellular protein modification process (GO:0006464),7/1025,0.0006556331132667947,0.0040746057911748,0,0,5.6660117878192535,41.53135195368726,CDK4;ERBB2;PTEN;SPP1;BIRC5;BRAF;AURKA
GO_Biological_Process_2021,positive regulation of cell migration (GO:0030335),4/269,0.0006658546679345158,0.0041105428167157,0,0,11.43976777939042,83.67548505567132,COL1A1;MMP9;EGFR;VEGFA
GO_Biological_Process_2021,regulation of protein-containing complex assembly (GO:0043254),3/116,0.0006885071123852637,0.0041295965605198,0,0,19.525073746312685,142.16176730547792,RB1;MMP1;VEGFA
GO_Biological_Process_2021,cellular response to drug (GO:0035690),2/26,0.0006912391650978139,0.0041295965605198,0,0,59.36309523809524,431.9867091057638,MYC;TP53
GO_Biological_Process_2021,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),2/26,0.0006912391650978139,0.0041295965605198,0,0,59.36309523809524,431.9867091057638,E2F1;TP53
GO_Biological_Process_2021,positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),2/26,0.0006912391650978139,0.0041295965605198,0,0,59.36309523809524,431.9867091057638,CCND1;EGFR
GO_Biological_Process_2021,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),2/26,0.0006912391650978139,0.0041295965605198,0,0,59.36309523809524,431.9867091057638,E2F1;TP53
GO_Biological_Process_2021,positive regulation of MAPK cascade (GO:0043410),4/274,0.0007133348589822405,0.0042342825603689,0,0,11.225071225071224,81.33192257391161,ERBB2;BRAF;EGFR;VEGFA
GO_Biological_Process_2021,positive regulation of protein-containing complex assembly (GO:0031334),3/118,0.000723596787971595,0.0042678383800108,0,0,19.183574879227052,138.72172928780785,MMP1;TP53;VEGFA
GO_Biological_Process_2021,protein modification by small protein removal (GO:0070646),4/276,0.0007329832874236017,0.0042897564000659,0,0,11.141402714932129,80.42296383443296,CDC20;MYC;PTEN;TP53
GO_Biological_Process_2021,cellular response to cadmium ion (GO:0071276),2/27,0.0007458431753894333,0.0042897564000659,0,0,56.98571428571429,410.3538550694941,MMP9;EGFR
GO_Biological_Process_2021,positive regulation of gene silencing by miRNA (GO:2000637),2/27,0.0007458431753894333,0.0042897564000659,0,0,56.98571428571429,410.3538550694941,TP53;EGFR
GO_Biological_Process_2021,mitotic chromosome condensation (GO:0007076),2/27,0.0007458431753894333,0.0042897564000659,0,0,56.98571428571429,410.3538550694941,RB1;CCNB1
GO_Biological_Process_2021,cellular response to epidermal growth factor stimulus (GO:0071364),2/28,0.0008024678708939625,0.0045869459780728,0,0,54.79120879120879,390.5418048109173,ERBB2;EGFR
GO_Biological_Process_2021,cellular response to oxidative stress (GO:0034599),3/125,0.0008553395536436244,0.0048591682618036,0,0,18.07650273224044,127.69263274463742,MMP9;TP53;EGFR
GO_Biological_Process_2021,response to cadmium ion (GO:0046686),2/29,0.0008611074752315914,0.0048621068418564,0,0,52.75925925925926,372.337457949904,MMP9;EGFR
GO_Biological_Process_2021,negative regulation of cell growth (GO:0030308),3/126,0.0008753174929478949,0.0048827951715045,0,0,17.9286359530262,126.23416116696262,RB1;CDKN2A;TP53
GO_Biological_Process_2021,negative regulation of growth (GO:0045926),3/126,0.0008753174929478949,0.0048827951715045,0,0,17.9286359530262,126.23416116696262,RB1;CDKN2A;TP53
GO_Biological_Process_2021,positive regulation of macromolecule biosynthetic process (GO:0010557),3/129,0.000937026120780873,0.0051957256757071,0,0,17.499118165784832,122.01784063082128,MYC;ERBB2;EGFR
GO_Biological_Process_2021,G2/M transition of mitotic cell cycle (GO:0000086),3/130,0.000958193010549833,0.0052814686176734,0,0,17.36045494313211,120.66317071692114,CCNB1;FOXM1;AURKA
GO_Biological_Process_2021,cell cycle G2/M phase transition (GO:0044839),3/131,0.00097966142379343,0.0053050671253375,0,0,17.223958333333332,119.33281135445452,CCNB1;FOXM1;AURKA
GO_Biological_Process_2021,cellular response to hypoxia (GO:0071456),3/131,0.00097966142379343,0.0053050671253375,0,0,17.223958333333332,119.33281135445452,MYC;TP53;VEGFA
GO_Biological_Process_2021,cellular response to metal ion (GO:0071248),3/131,0.00097966142379343,0.0053050671253375,0,0,17.223958333333332,119.33281135445452,BRAF;MMP9;EGFR
GO_Biological_Process_2021,extracellular matrix organization (GO:0030198),4/300,0.000999699759624912,0.005382104519841,0,0,10.225571725571726,70.63881765839963,COL1A1;MMP1;SPP1;MMP9
GO_Biological_Process_2021,negative regulation of cell-matrix adhesion (GO:0001953),2/32,0.0010490581524956,0.005582918673626,0,0,47.476190476190474,325.6801394016241,CDKN2A;PTEN
GO_Biological_Process_2021,liver development (GO:0001889),2/32,0.0010490581524956,0.005582918673626,0,0,47.476190476190474,325.6801394016241,MET;AURKA
GO_Biological_Process_2021,cellular response to vascular endothelial growth factor stimulus (GO:0035924),2/34,0.0011843277749014,0.0061611658402177,0,0,44.504464285714285,299.8968904507324,PIK3CA;VEGFA
GO_Biological_Process_2021,positive regulation of DNA binding (GO:0043388),2/34,0.0011843277749014,0.0061611658402177,0,0,44.504464285714285,299.8968904507324,RB1;MMP9
GO_Biological_Process_2021,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),2/34,0.0011843277749014,0.0061611658402177,0,0,44.504464285714285,299.8968904507324,E2F1;TP53
GO_Biological_Process_2021,sister chromatid segregation (GO:0000819),2/34,0.0011843277749014,0.0061611658402177,0,0,44.504464285714285,299.8968904507324,RB1;TOP2A
GO_Biological_Process_2021,positive regulation of cell cycle G1/S phase transition (GO:1902808),2/35,0.0012549361838792,0.0064920162361573,0,0,43.15367965367965,288.29551709674206,CCND1;EGFR
GO_Biological_Process_2021,negative regulation of gene expression (GO:0010629),4/322,0.0012986006909451,0.0066805791100846,0,0,9.507498790517658,63.19128633640498,RB1;TYMS;VEGFA;AURKA
GO_Biological_Process_2021,regulation of cell cycle G1/S phase transition (GO:1902806),2/36,0.00132751939454,0.0067173932204594,0,0,41.88235294117647,277.4472679372888,PTEN;E2F1
GO_Biological_Process_2021,regulation of microtubule-based process (GO:0032886),2/36,0.00132751939454,0.0067173932204594,0,0,41.88235294117647,277.4472679372888,ERBB2;AURKA
GO_Biological_Process_2021,positive regulation of mitotic nuclear division (GO:0045840),2/36,0.00132751939454,0.0067173932204594,0,0,41.88235294117647,277.4472679372888,RB1;AURKA
GO_Biological_Process_2021,positive regulation of intracellular protein transport (GO:0090316),3/148,0.0013923683734629,0.0069802065411135,0,0,15.191570881226054,99.91115036332026,ERBB2;E2F1;TP53
GO_Biological_Process_2021,negative regulation of stress-activated MAPK cascade (GO:0032873),2/37,0.0014020717242409,0.0069802065411135,0,0,40.68367346938776,267.2837742480994,MYC;FOXM1
GO_Biological_Process_2021,regulation of vascular associated smooth muscle cell proliferation (GO:1904705),2/37,0.0014020717242409,0.0069802065411135,0,0,40.68367346938776,267.2837742480994,PTEN;MMP9
GO_Biological_Process_2021,regulation of exit from mitosis (GO:0007096),2/39,0.0015570610672793,0.0076693539803227,0,0,38.48069498069498,248.77596779833652,CDC20;UBE2C
GO_Biological_Process_2021,endothelial cell migration (GO:0043542),2/39,0.0015570610672793,0.0076693539803227,0,0,38.48069498069498,248.77596779833652,PIK3CA;VEGFA
GO_Biological_Process_2021,negative regulation of ERBB signaling pathway (GO:1901185),2/40,0.0016374867723787,0.0080228187895382,0,0,37.46616541353384,240.3301899756201,ERBB2;EGFR
GO_Biological_Process_2021,cellular response to growth factor stimulus (GO:0071363),3/158,0.0016792809576817,0.0081842850884912,0,0,14.204301075268818,90.75681326113056,ERBB2;EGFR;VEGFA
GO_Biological_Process_2021,regulation of release of cytochrome c from mitochondria (GO:0090199),2/41,0.0017198589811284,0.0082947365444005,0,0,36.50366300366301,232.36454063940053,MMP9;TP53
GO_Biological_Process_2021,response to growth factor (GO:0070848),2/41,0.0017198589811284,0.0082947365444005,0,0,36.50366300366301,232.36454063940053,MYC;ERBB2
GO_Biological_Process_2021,positive regulation of chemotaxis (GO:0050921),2/45,0.0020687005204849,0.0098743127936548,0,0,33.10132890365448,204.59384020901297,MET;VEGFA
GO_Biological_Process_2021,positive regulation of RNA metabolic process (GO:0051254),2/45,0.0020687005204849,0.0098743127936548,0,0,33.10132890365448,204.59384020901297,TP53;EGFR
GO_Biological_Process_2021,regulation of telomerase activity (GO:0051972),2/46,0.0021607211003146,0.0102083047902622,0,0,32.3474025974026,198.5261432195098,MYC;TP53
GO_Biological_Process_2021,positive regulation of response to stimulus (GO:0048584),2/46,0.0021607211003146,0.0102083047902622,0,0,32.3474025974026,198.5261432195098,CDKN2A;MYC
GO_Biological_Process_2021,regulation of DNA binding (GO:0051101),2/47,0.0022546546050504,0.0105980211384603,0,0,31.626984126984127,192.75882990246353,E2F1;MMP9
GO_Biological_Process_2021,positive regulation of DNA repair (GO:0045739),2/48,0.0023504954789734,0.0109927212804517,0,0,30.937888198757765,187.27103230547277,FOXM1;EGFR
GO_Biological_Process_2021,positive regulation of cellular biosynthetic process (GO:0031328),3/180,0.0024341976842087,0.0113269701285289,0,0,12.42498430634024,74.77527107165375,MYC;ERBB2;EGFR
GO_Biological_Process_2021,negative regulation of catabolic process (GO:0009895),2/49,0.002448238177796,0.0113353427631958,0,0,30.278115501519757,182.0437366477304,ALK;EGFR
GO_Biological_Process_2021,intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),2/51,0.0026494069247459,0.0122057254344015,0,0,29.03935860058309,172.30269560126317,E2F1;TP53
GO_Biological_Process_2021,regulation of intrinsic apoptotic signaling pathway (GO:2001242),2/52,0.0027528219402575,0.0125572074713227,0,0,28.457142857142856,167.75852052625558,MMP9;TP53
GO_Biological_Process_2021,signal transduction in response to DNA damage (GO:0042770),2/52,0.0027528219402575,0.0125572074713227,0,0,28.457142857142856,167.75852052625558,E2F1;TP53
GO_Biological_Process_2021,regulation of cyclin-dependent protein kinase activity (GO:1904029),2/54,0.0029652857587718,0.0133944127445013,0,0,27.35989010989011,159.25595242218557,CCNB1;CCND1
GO_Biological_Process_2021,regulation of focal adhesion assembly (GO:0051893),2/54,0.0029652857587718,0.0133944127445013,0,0,27.35989010989011,159.25595242218557,PTEN;VEGFA
GO_Biological_Process_2021,negative regulation of macromolecule metabolic process (GO:0010605),3/194,0.0030084636852775,0.0134581515582947,0,0,11.50610820244328,66.80821215499986,RB1;VEGFA;AURKA
GO_Biological_Process_2021,regulation of programmed cell death (GO:0043067),3/194,0.0030084636852775,0.0134581515582947,0,0,11.50610820244328,66.80821215499986,ALK;BIRC5;TP53
GO_Biological_Process_2021,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),2/55,0.0030743235966317,0.0136211657917751,0,0,26.842318059299192,155.2739619530397,MMP9;VEGFA
GO_Biological_Process_2021,positive regulation of response to DNA damage stimulus (GO:2001022),2/55,0.0030743235966317,0.0136211657917751,0,0,26.842318059299192,155.2739619530397,MYC;EGFR
GO_Biological_Process_2021,peptidyl-tyrosine modification (GO:0018212),2/56,0.0031852247621403,0.0139787589087297,0,0,26.343915343915345,151.45729225683525,ERBB2;EGFR
GO_Biological_Process_2021,positive regulation of establishment of protein localization to mitochondrion (GO:1903749),2/56,0.0031852247621403,0.0139787589087297,0,0,26.343915343915345,151.45729225683525,E2F1;TP53
GO_Biological_Process_2021,regulation of mitotic nuclear division (GO:0007088),2/57,0.003297983801264,0.0143377136148851,0,0,25.863636363636363,147.79630077100325,CCNB1;AURKA
GO_Biological_Process_2021,regulation of reactive oxygen species metabolic process (GO:2000377),2/57,0.003297983801264,0.0143377136148851,0,0,25.863636363636363,147.79630077100325,FOXM1;TP53
GO_Biological_Process_2021,modification-dependent protein catabolic process (GO:0019941),3/201,0.0033243119085999,0.0143846393802033,0,0,11.095398428731762,63.315808706645385,CDC20;UBE2C;AURKA
GO_Biological_Process_2021,chordate embryonic development (GO:0043009),2/58,0.0034125952701803,0.014697968465986,0,0,25.40051020408163,144.28206600498726,COL1A1;VEGFA
GO_Biological_Process_2021,negative regulation of autophagy (GO:0010507),2/59,0.0035290537376922,0.0149903842252433,0,0,24.953634085213032,140.90632208004251,PIK3CA;MET
GO_Biological_Process_2021,response to reactive oxygen species (GO:0000302),2/59,0.0035290537376922,0.0149903842252433,0,0,24.953634085213032,140.90632208004251,MMP9;EGFR
GO_Biological_Process_2021,mitotic DNA damage checkpoint signaling (GO:0044773),2/59,0.0035290537376922,0.0149903842252433,0,0,24.953634085213032,140.90632208004251,CCND1;TP53
GO_Biological_Process_2021,phosphate-containing compound metabolic process (GO:0006796),3/212,0.0038605585243045,0.0163236401529955,0,0,10.505582137161085,58.37892543116343,ALK;PIK3CA;PTEN
GO_Biological_Process_2021,negative regulation of multicellular organismal process (GO:0051241),3/214,0.0039633952822407,0.0166822910516133,0,0,10.404949973670352,57.54618054905871,RB1;PTEN;EGFR
GO_Biological_Process_2021,cellular response to reactive oxygen species (GO:0034614),2/63,0.0040132493415981,0.0167399499563959,0,0,23.31264637002342,128.64277412661008,MMP9;EGFR
GO_Biological_Process_2021,positive regulation of DNA metabolic process (GO:0051054),2/63,0.0040132493415981,0.0167399499563959,0,0,23.31264637002342,128.64277412661008,MYC;EGFR
GO_Biological_Process_2021,cellular component disassembly (GO:0022411),2/66,0.004395525019554,0.0181707864647637,0,0,22.216517857142858,120.57278137525562,MMP1;MMP9
GO_Biological_Process_2021,extracellular matrix disassembly (GO:0022617),2/66,0.004395525019554,0.0181707864647637,0,0,22.216517857142858,120.57278137525562,MMP1;MMP9
GO_Biological_Process_2021,regulation of epidermal growth factor receptor signaling pathway (GO:0042058),2/67,0.0045265652607379,0.0185469001391297,0,0,21.873626373626372,118.06928211852814,MMP9;EGFR
GO_Biological_Process_2021,vascular endothelial growth factor receptor signaling pathway (GO:0048010),2/67,0.0045265652607379,0.0185469001391297,0,0,21.873626373626372,118.06928211852814,PIK3CA;VEGFA
GO_Biological_Process_2021,peptidyl-tyrosine phosphorylation (GO:0018108),2/69,0.0047940362554891,0.0195562888660042,0,0,21.218550106609808,113.31517536894962,ERBB2;EGFR
GO_Biological_Process_2021,apoptotic process (GO:0006915),3/231,0.0049055030960435,0.0198504461177663,0,0,9.620857699805068,51.15792586631809,PIK3CA;MYC;MCM2
GO_Biological_Process_2021,cellular response to light stimulus (GO:0071482),2/70,0.0049304563791428,0.0198504461177663,0,0,20.90546218487395,111.05658271288344,MYC;TP53
GO_Biological_Process_2021,establishment of protein localization to membrane (GO:0090150),2/70,0.0049304563791428,0.0198504461177663,0,0,20.90546218487395,111.05658271288344,BRAF;EGFR
GO_Biological_Process_2021,response to ionizing radiation (GO:0010212),2/72,0.0052086393816279,0.0208796539713742,0,0,20.306122448979593,106.75815162079977,MYC;TP53
GO_Biological_Process_2021,regulation of cell division (GO:0051302),2/76,0.0057862287304151,0.0228976401895915,0,0,19.204633204633204,98.94754273926414,MYC;AURKA
GO_Biological_Process_2021,regulation of epithelial to mesenchymal transition (GO:0010717),2/76,0.0057862287304151,0.0228976401895915,0,0,19.204633204633204,98.94754273926414,COL1A1;PTEN
GO_Biological_Process_2021,positive regulation of growth (GO:0045927),2/76,0.0057862287304151,0.0228976401895915,0,0,19.204633204633204,98.94754273926414,ERBB2;EGFR
GO_Biological_Process_2021,positive regulation of DNA-binding transcription factor activity (GO:0051091),3/246,0.0058404590478201,0.0230138939501338,0,0,9.020118884316416,46.389983263599625,ALK;PTEN;VEGFA
GO_Biological_Process_2021,negative regulation of apoptotic signaling pathway (GO:2001234),2/78,0.0060855510763654,0.023878052104722,0,0,18.69736842105263,95.3909445901031,RB1;MMP9
GO_Biological_Process_2021,positive regulation of cell adhesion (GO:0045785),2/80,0.0063918361606561,0.0248690768267544,0,0,18.216117216117215,92.04118939174062,ERBB2;VEGFA
GO_Biological_Process_2021,skin development (GO:0043588),2/80,0.0063918361606561,0.0248690768267544,0,0,18.216117216117215,92.04118939174062,COL1A1;MET
GO_Biological_Process_2021,regulation of cell cycle G2/M phase transition (GO:1902749),2/85,0.0071877384972766,0.0266338713816507,0,0,17.1144578313253,84.46633049181104,TP53;AURKA
GO_Biological_Process_2021,negative regulation of phosphorylation (GO:0042326),2/86,0.007352053041878,0.0266338713816507,0,0,16.90986394557823,83.07436833271562,CDKN2A;PTEN
GO_Biological_Process_2021,positive regulation of endothelial cell migration (GO:0010595),2/86,0.007352053041878,0.0266338713816507,0,0,16.90986394557823,83.07436833271562,MET;VEGFA
GO_Biological_Process_2021,pyrimidine deoxyribonucleotide biosynthetic process (GO:0009221),1/5,0.0074781928285412,0.0266338713816507,0,0,172.1206896551724,842.6622961465415,TYMS
GO_Biological_Process_2021,negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001268),1/5,0.0074781928285412,0.0266338713816507,0,0,172.1206896551724,842.6622961465415,MMP9
GO_Biological_Process_2021,apoptotic chromosome condensation (GO:0030263),1/5,0.0074781928285412,0.0266338713816507,0,0,172.1206896551724,842.6622961465415,TOP2A
GO_Biological_Process_2021,regulation of adherens junction organization (GO:1903391),1/5,0.0074781928285412,0.0266338713816507,0,0,172.1206896551724,842.6622961465415,VEGFA
GO_Biological_Process_2021,bone marrow development (GO:0048539),1/5,0.0074781928285412,0.0266338713816507,0,0,172.1206896551724,842.6622961465415,TP53
GO_Biological_Process_2021,negative regulation of organ growth (GO:0046621),1/5,0.0074781928285412,0.0266338713816507,0,0,172.1206896551724,842.6622961465415,PTEN
GO_Biological_Process_2021,cellular response to antibiotic (GO:0071236),1/5,0.0074781928285412,0.0266338713816507,0,0,172.1206896551724,842.6622961465415,TP53
GO_Biological_Process_2021,regulation of guanyl-nucleotide exchange factor activity (GO:1905097),1/5,0.0074781928285412,0.0266338713816507,0,0,172.1206896551724,842.6622961465415,MET
GO_Biological_Process_2021,cellular response to testosterone stimulus (GO:0071394),1/5,0.0074781928285412,0.0266338713816507,0,0,172.1206896551724,842.6622961465415,SPP1
GO_Biological_Process_2021,coronary artery morphogenesis (GO:0060982),1/5,0.0074781928285412,0.0266338713816507,0,0,172.1206896551724,842.6622961465415,VEGFA
GO_Biological_Process_2021,regulation of protein kinase C activity (GO:1900019),1/5,0.0074781928285412,0.0266338713816507,0,0,172.1206896551724,842.6622961465415,EGFR
GO_Biological_Process_2021,positive regulation of attachment of spindle microtubules to kinetochore (GO:0051987),1/5,0.0074781928285412,0.0266338713816507,0,0,172.1206896551724,842.6622961465415,CCNB1
GO_Biological_Process_2021,positive regulation of axon extension involved in axon guidance (GO:0048842),1/5,0.0074781928285412,0.0266338713816507,0,0,172.1206896551724,842.6622961465415,VEGFA
GO_Biological_Process_2021,regulation of retinal ganglion cell axon guidance (GO:0090259),1/5,0.0074781928285412,0.0266338713816507,0,0,172.1206896551724,842.6622961465415,VEGFA
GO_Biological_Process_2021,positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway (GO:0038033),1/5,0.0074781928285412,0.0266338713816507,0,0,172.1206896551724,842.6622961465415,VEGFA
GO_Biological_Process_2021,positive regulation of mast cell chemotaxis (GO:0060754),1/5,0.0074781928285412,0.0266338713816507,0,0,172.1206896551724,842.6622961465415,VEGFA
GO_Biological_Process_2021,positive regulation of protein kinase C activity (GO:1900020),1/5,0.0074781928285412,0.0266338713816507,0,0,172.1206896551724,842.6622961465415,EGFR
GO_Biological_Process_2021,positive regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061419),1/5,0.0074781928285412,0.0266338713816507,0,0,172.1206896551724,842.6622961465415,VEGFA
GO_Biological_Process_2021,vascular endothelial growth factor receptor-2 signaling pathway (GO:0036324),1/5,0.0074781928285412,0.0266338713816507,0,0,172.1206896551724,842.6622961465415,VEGFA
GO_Biological_Process_2021,regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),2/87,0.007518066960634,0.0266732950404105,0,0,16.710084033613445,81.71976741790144,TP53;VEGFA
GO_Biological_Process_2021,negative regulation of binding (GO:0051100),2/88,0.0076857751375322,0.0270609421192199,0,0,16.514950166112957,80.40111986589167,E2F1;AURKA
GO_Biological_Process_2021,sensory perception of mechanical stimulus (GO:0050954),2/88,0.0076857751375322,0.0270609421192199,0,0,16.514950166112957,80.40111986589167,COL1A1;BIRC5
GO_Biological_Process_2021,regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),2/89,0.0078551724663544,0.0275526125145614,0,0,16.324302134646963,79.11708604949641,MYC;VEGFA
GO_Biological_Process_2021,positive regulation of binding (GO:0051099),2/90,0.0080262538558438,0.0280464568698542,0,0,16.13798701298701,77.86639055063492,MMP9;MET
GO_Biological_Process_2021,DNA metabolic process (GO:0006259),3/277,0.0080936926136961,0.0281757870687316,0,0,7.9870235198702355,38.47085825718167,TOP2A;TYMS;MCM2
GO_Biological_Process_2021,sensory perception of sound (GO:0007605),2/91,0.0081990142194101,0.0282440637268212,0,0,15.95585874799358,76.64781842787546,COL1A1;BIRC5
GO_Biological_Process_2021,positive regulation of supramolecular fiber organization (GO:1902905),2/91,0.0081990142194101,0.0282440637268212,0,0,15.95585874799358,76.64781842787546,RB1;MET
GO_Biological_Process_2021,positive regulation of cellular component biogenesis (GO:0044089),2/92,0.0083734484870981,0.0282440637268212,0,0,15.77777777777778,75.46021169623046,MMP1;VEGFA
GO_Biological_Process_2021,positive regulation of epithelial cell migration (GO:0010634),2/94,0.0087273184884668,0.0282440637268212,0,0,15.433229813664596,73.17352801930804,MMP9;VEGFA
GO_Biological_Process_2021,positive regulation of programmed cell death (GO:0043068),3/286,0.0088313849578002,0.0282440637268212,0,0,7.729485669414998,36.55616521496702,TOP2A;E2F1;TP53
GO_Biological_Process_2021,protein-DNA complex subunit organization (GO:0071824),1/6,0.008967337727522,0.0282440637268212,0,0,137.68965517241378,649.0919521468393,MYC
GO_Biological_Process_2021,negative regulation of cell size (GO:0045792),1/6,0.008967337727522,0.0282440637268212,0,0,137.68965517241378,649.0919521468393,PTEN
GO_Biological_Process_2021,negative regulation of excitatory postsynaptic potential (GO:0090394),1/6,0.008967337727522,0.0282440637268212,0,0,137.68965517241378,649.0919521468393,PTEN
GO_Biological_Process_2021,negative regulation of fat cell proliferation (GO:0070345),1/6,0.008967337727522,0.0282440637268212,0,0,137.68965517241378,649.0919521468393,E2F1
GO_Biological_Process_2021,regulation of collagen fibril organization (GO:1904026),1/6,0.008967337727522,0.0282440637268212,0,0,137.68965517241378,649.0919521468393,RB1
GO_Biological_Process_2021,centromeric sister chromatid cohesion (GO:0070601),1/6,0.008967337727522,0.0282440637268212,0,0,137.68965517241378,649.0919521468393,BUB1
GO_Biological_Process_2021,nuclear cell cycle DNA replication initiation (GO:1902315),1/6,0.008967337727522,0.0282440637268212,0,0,137.68965517241378,649.0919521468393,MCM2
GO_Biological_Process_2021,regulation of macrophage apoptotic process (GO:2000109),1/6,0.008967337727522,0.0282440637268212,0,0,137.68965517241378,649.0919521468393,CDKN2A
GO_Biological_Process_2021,regulation of mast cell chemotaxis (GO:0060753),1/6,0.008967337727522,0.0282440637268212,0,0,137.68965517241378,649.0919521468393,VEGFA
GO_Biological_Process_2021,regulation of mitotic sister chromatid segregation (GO:0033047),1/6,0.008967337727522,0.0282440637268212,0,0,137.68965517241378,649.0919521468393,CCNB1
GO_Biological_Process_2021,regulation of mitotic spindle checkpoint (GO:1903504),1/6,0.008967337727522,0.0282440637268212,0,0,137.68965517241378,649.0919521468393,CCNB1
GO_Biological_Process_2021,free ubiquitin chain polymerization (GO:0010994),1/6,0.008967337727522,0.0282440637268212,0,0,137.68965517241378,649.0919521468393,UBE2C
GO_Biological_Process_2021,regulation of thymocyte apoptotic process (GO:0070243),1/6,0.008967337727522,0.0282440637268212,0,0,137.68965517241378,649.0919521468393,TP53
GO_Biological_Process_2021,positive regulation of deacetylase activity (GO:0090045),1/6,0.008967337727522,0.0282440637268212,0,0,137.68965517241378,649.0919521468393,VEGFA
GO_Biological_Process_2021,positive regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902043),1/6,0.008967337727522,0.0282440637268212,0,0,137.68965517241378,649.0919521468393,PTEN
GO_Biological_Process_2021,response to testosterone (GO:0033574),1/6,0.008967337727522,0.0282440637268212,0,0,137.68965517241378,649.0919521468393,SPP1
GO_Biological_Process_2021,positive regulation of kidney development (GO:0090184),1/6,0.008967337727522,0.0282440637268212,0,0,137.68965517241378,649.0919521468393,MYC
GO_Biological_Process_2021,positive regulation of receptor binding (GO:1900122),1/6,0.008967337727522,0.0282440637268212,0,0,137.68965517241378,649.0919521468393,MMP9
GO_Biological_Process_2021,mitotic DNA replication initiation (GO:1902975),1/6,0.008967337727522,0.0282440637268212,0,0,137.68965517241378,649.0919521468393,MCM2
GO_Biological_Process_2021,venous blood vessel morphogenesis (GO:0048845),1/6,0.008967337727522,0.0282440637268212,0,0,137.68965517241378,649.0919521468393,VEGFA
GO_Biological_Process_2021,postsynaptic density assembly (GO:0097107),1/6,0.008967337727522,0.0282440637268212,0,0,137.68965517241378,649.0919521468393,PTEN
GO_Biological_Process_2021,prepulse inhibition (GO:0060134),1/6,0.008967337727522,0.0282440637268212,0,0,137.68965517241378,649.0919521468393,PTEN
GO_Biological_Process_2021,negative regulation of actin filament depolymerization (GO:0030835),1/6,0.008967337727522,0.0282440637268212,0,0,137.68965517241378,649.0919521468393,PIK3CA
GO_Biological_Process_2021,positive regulation of cell cycle process (GO:0090068),2/101,0.0100178506582505,0.0305384971857523,0,0,14.336940836940837,65.99848293232873,CCNB1;AURKA
GO_Biological_Process_2021,positive regulation of cell growth (GO:0030307),2/102,0.0102087472469366,0.0305384971857523,0,0,14.192857142857145,65.06730050963371,ERBB2;EGFR
GO_Biological_Process_2021,intrinsic apoptotic signaling pathway (GO:0097193),2/102,0.0102087472469366,0.0305384971857523,0,0,14.192857142857145,65.06730050963371,E2F1;TP53
GO_Biological_Process_2021,mitotic sister chromatid segregation (GO:0000070),2/102,0.0102087472469366,0.0305384971857523,0,0,14.192857142857145,65.06730050963371,RB1;CCNB1
GO_Biological_Process_2021,chromatin remodeling (GO:0006338),2/103,0.0104012626265877,0.0305384971857523,0,0,14.051626591230551,64.15731117281341,RB1;MYC
GO_Biological_Process_2021,negative regulation of cardiocyte differentiation (GO:1905208),1/7,0.0104543235506301,0.0305384971857523,0,0,114.73563218390804,523.2793468811269,EGFR
GO_Biological_Process_2021,negative regulation of cell cycle phase transition (GO:1901988),1/7,0.0104543235506301,0.0305384971857523,0,0,114.73563218390804,523.2793468811269,PTEN
GO_Biological_Process_2021,negative regulation of dendritic spine development (GO:0061000),1/7,0.0104543235506301,0.0305384971857523,0,0,114.73563218390804,523.2793468811269,PTEN
GO_Biological_Process_2021,regulation of blood-brain barrier permeability (GO:1905603),1/7,0.0104543235506301,0.0305384971857523,0,0,114.73563218390804,523.2793468811269,VEGFA
GO_Biological_Process_2021,regulation of fat cell proliferation (GO:0070344),1/7,0.0104543235506301,0.0305384971857523,0,0,114.73563218390804,523.2793468811269,E2F1
GO_Biological_Process_2021,regulation of histone deacetylase activity (GO:1901725),1/7,0.0104543235506301,0.0305384971857523,0,0,114.73563218390804,523.2793468811269,VEGFA
GO_Biological_Process_2021,chemical homeostasis within a tissue (GO:0048875),1/7,0.0104543235506301,0.0305384971857523,0,0,114.73563218390804,523.2793468811269,VEGFA
GO_Biological_Process_2021,collagen-activated tyrosine kinase receptor signaling pathway (GO:0038063),1/7,0.0104543235506301,0.0305384971857523,0,0,114.73563218390804,523.2793468811269,COL1A1
GO_Biological_Process_2021,oxygen transport (GO:0015671),1/7,0.0104543235506301,0.0305384971857523,0,0,114.73563218390804,523.2793468811269,MYC
GO_Biological_Process_2021,DNA ligation (GO:0006266),1/7,0.0104543235506301,0.0305384971857523,0,0,114.73563218390804,523.2793468811269,TOP2A
GO_Biological_Process_2021,endothelial cell morphogenesis (GO:0001886),1/7,0.0104543235506301,0.0305384971857523,0,0,114.73563218390804,523.2793468811269,MET
GO_Biological_Process_2021,skin morphogenesis (GO:0043589),1/7,0.0104543235506301,0.0305384971857523,0,0,114.73563218390804,523.2793468811269,COL1A1
GO_Biological_Process_2021,surfactant homeostasis (GO:0043129),1/7,0.0104543235506301,0.0305384971857523,0,0,114.73563218390804,523.2793468811269,VEGFA
GO_Biological_Process_2021,positive regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045899),1/7,0.0104543235506301,0.0305384971857523,0,0,114.73563218390804,523.2793468811269,TP53
GO_Biological_Process_2021,positive regulation of synaptic plasticity (GO:0031915),1/7,0.0104543235506301,0.0305384971857523,0,0,114.73563218390804,523.2793468811269,CDC20
GO_Biological_Process_2021,positive regulation of trophoblast cell migration (GO:1901165),1/7,0.0104543235506301,0.0305384971857523,0,0,114.73563218390804,523.2793468811269,VEGFA
GO_Biological_Process_2021,vascular associated smooth muscle cell development (GO:0097084),1/7,0.0104543235506301,0.0305384971857523,0,0,114.73563218390804,523.2793468811269,VEGFA
GO_Biological_Process_2021,vascular wound healing (GO:0061042),1/7,0.0104543235506301,0.0305384971857523,0,0,114.73563218390804,523.2793468811269,VEGFA
GO_Biological_Process_2021,positive regulation of apoptotic process (GO:0043065),3/310,0.0109877395054109,0.0317978911262865,0,0,7.116539992761491,32.10253554681002,TOP2A;E2F1;TP53
GO_Biological_Process_2021,regulation of cell cycle process (GO:0010564),2/106,0.0109884720954769,0.0317978911262865,0,0,13.64423076923077,61.54787719458521,BUB1;AURKA
GO_Biological_Process_2021,chromosome organization (GO:0051276),2/106,0.0109884720954769,0.0317978911262865,0,0,13.64423076923077,61.54787719458521,TOP2A;MYC
GO_Biological_Process_2021,cellular macromolecule biosynthetic process (GO:0034645),3/314,0.0113742620265401,0.0325166348011874,0,0,7.023579849946409,31.44036824327332,E2F1;TYMS;MCM2
GO_Biological_Process_2021,negative regulation of chromosome organization (GO:2001251),1/8,0.0119391531667426,0.0325166348011874,0,0,98.33990147783253,435.442406227662,TOP2A
GO_Biological_Process_2021,commissural neuron axon guidance (GO:0071679),1/8,0.0119391531667426,0.0325166348011874,0,0,98.33990147783253,435.442406227662,VEGFA
GO_Biological_Process_2021,coronary vasculature morphogenesis (GO:0060977),1/8,0.0119391531667426,0.0325166348011874,0,0,98.33990147783253,435.442406227662,VEGFA
GO_Biological_Process_2021,regulation of metaphase/anaphase transition of cell cycle (GO:1902099),1/8,0.0119391531667426,0.0325166348011874,0,0,98.33990147783253,435.442406227662,UBE2C
GO_Biological_Process_2021,phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092),1/8,0.0119391531667426,0.0325166348011874,0,0,98.33990147783253,435.442406227662,PIK3CA
GO_Biological_Process_2021,regulation of positive chemotaxis (GO:0050926),1/8,0.0119391531667426,0.0325166348011874,0,0,98.33990147783253,435.442406227662,VEGFA
GO_Biological_Process_2021,regulation of protein localization to chromatin (GO:1905634),1/8,0.0119391531667426,0.0325166348011874,0,0,98.33990147783253,435.442406227662,RB1
GO_Biological_Process_2021,entry of bacterium into host cell (GO:0035635),1/8,0.0119391531667426,0.0325166348011874,0,0,98.33990147783253,435.442406227662,MET
GO_Biological_Process_2021,ER overload response (GO:0006983),1/8,0.0119391531667426,0.0325166348011874,0,0,98.33990147783253,435.442406227662,TP53
GO_Biological_Process_2021,excitatory synapse assembly (GO:1904861),1/8,0.0119391531667426,0.0325166348011874,0,0,98.33990147783253,435.442406227662,PTEN
GO_Biological_Process_2021,positive regulation of cell migration by vascular endothelial growth factor signaling pathway (GO:0038089),1/8,0.0119391531667426,0.0325166348011874,0,0,98.33990147783253,435.442406227662,VEGFA
GO_Biological_Process_2021,positive regulation of chromosome segregation (GO:0051984),1/8,0.0119391531667426,0.0325166348011874,0,0,98.33990147783253,435.442406227662,CCNB1
GO_Biological_Process_2021,"regulation of wound healing, spreading of epidermal cells (GO:1903689)",1/8,0.0119391531667426,0.0325166348011874,0,0,98.33990147783253,435.442406227662,PTEN
GO_Biological_Process_2021,positive regulation of execution phase of apoptosis (GO:1900119),1/8,0.0119391531667426,0.0325166348011874,0,0,98.33990147783253,435.442406227662,TP53
GO_Biological_Process_2021,positive regulation of myeloid cell apoptotic process (GO:0033034),1/8,0.0119391531667426,0.0325166348011874,0,0,98.33990147783253,435.442406227662,CDKN2A
GO_Biological_Process_2021,stress-induced premature senescence (GO:0090400),1/8,0.0119391531667426,0.0325166348011874,0,0,98.33990147783253,435.442406227662,TP53
GO_Biological_Process_2021,meiotic sister chromatid cohesion (GO:0051177),1/8,0.0119391531667426,0.0325166348011874,0,0,98.33990147783253,435.442406227662,BUB1
GO_Biological_Process_2021,postsynaptic density organization (GO:0097106),1/8,0.0119391531667426,0.0325166348011874,0,0,98.33990147783253,435.442406227662,PTEN
GO_Biological_Process_2021,pre-replicative complex assembly involved in nuclear cell cycle DNA replication (GO:0006267),1/8,0.0119391531667426,0.0325166348011874,0,0,98.33990147783253,435.442406227662,MCM2
GO_Biological_Process_2021,phosphatidylinositol metabolic process (GO:0046488),2/112,0.0122059337373962,0.0331457320845422,0,0,12.896103896103895,56.818081065593866,PIK3CA;PTEN
GO_Biological_Process_2021,actin-mediated cell contraction (GO:0070252),1/9,0.0134218294793273,0.0348140450920367,0,0,86.04310344827586,370.92087702683546,PIK3CA
GO_Biological_Process_2021,anoikis (GO:0043276),1/9,0.0134218294793273,0.0348140450920367,0,0,86.04310344827586,370.92087702683546,PIK3CA
GO_Biological_Process_2021,regulation of actin filament organization (GO:0110053),1/9,0.0134218294793273,0.0348140450920367,0,0,86.04310344827586,370.92087702683546,PIK3CA
GO_Biological_Process_2021,regulation of helicase activity (GO:0051095),1/9,0.0134218294793273,0.0348140450920367,0,0,86.04310344827586,370.92087702683546,TP53
GO_Biological_Process_2021,collagen-activated signaling pathway (GO:0038065),1/9,0.0134218294793273,0.0348140450920367,0,0,86.04310344827586,370.92087702683546,COL1A1
GO_Biological_Process_2021,DNA topological change (GO:0006265),1/9,0.0134218294793273,0.0348140450920367,0,0,86.04310344827586,370.92087702683546,TOP2A
GO_Biological_Process_2021,endothelial cell chemotaxis (GO:0035767),1/9,0.0134218294793273,0.0348140450920367,0,0,86.04310344827586,370.92087702683546,VEGFA
GO_Biological_Process_2021,positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903589),1/9,0.0134218294793273,0.0348140450920367,0,0,86.04310344827586,370.92087702683546,VEGFA
GO_Biological_Process_2021,regulation of smooth muscle cell apoptotic process (GO:0034391),1/9,0.0134218294793273,0.0348140450920367,0,0,86.04310344827586,370.92087702683546,CDKN2A
GO_Biological_Process_2021,response to leptin (GO:0044321),1/9,0.0134218294793273,0.0348140450920367,0,0,86.04310344827586,370.92087702683546,CCND1
GO_Biological_Process_2021,response to vitamin (GO:0033273),1/9,0.0134218294793273,0.0348140450920367,0,0,86.04310344827586,370.92087702683546,SPP1
GO_Biological_Process_2021,response to vitamin D (GO:0033280),1/9,0.0134218294793273,0.0348140450920367,0,0,86.04310344827586,370.92087702683546,SPP1
GO_Biological_Process_2021,positive regulation of protein kinase C signaling (GO:0090037),1/9,0.0134218294793273,0.0348140450920367,0,0,86.04310344827586,370.92087702683546,VEGFA
GO_Biological_Process_2021,tetrahydrofolate interconversion (GO:0035999),1/9,0.0134218294793273,0.0348140450920367,0,0,86.04310344827586,370.92087702683546,TYMS
GO_Biological_Process_2021,positive regulation of smooth muscle cell apoptotic process (GO:0034393),1/9,0.0134218294793273,0.0348140450920367,0,0,86.04310344827586,370.92087702683546,CDKN2A
GO_Biological_Process_2021,positive regulation of synapse maturation (GO:0090129),1/9,0.0134218294793273,0.0348140450920367,0,0,86.04310344827586,370.92087702683546,CDC20
GO_Biological_Process_2021,negative regulation of response to external stimulus (GO:0032102),2/118,0.0134799084994332,0.0348670258951821,0,0,12.225369458128078,52.649225494811425,RB1;PTEN
GO_Biological_Process_2021,negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048),1/10,0.0149023554252653,0.0367010136271163,0,0,76.47892720306514,321.6884165593148,VEGFA
GO_Biological_Process_2021,regulation of attachment of spindle microtubules to kinetochore (GO:0051988),1/10,0.0149023554252653,0.0367010136271163,0,0,76.47892720306514,321.6884165593148,CCNB1
GO_Biological_Process_2021,regulation of axon guidance (GO:1902667),1/10,0.0149023554252653,0.0367010136271163,0,0,76.47892720306514,321.6884165593148,VEGFA
GO_Biological_Process_2021,negative regulation of phosphatidylinositol 3-kinase signaling (GO:0014067),1/10,0.0149023554252653,0.0367010136271163,0,0,76.47892720306514,321.6884165593148,PTEN
GO_Biological_Process_2021,regulation of DNA methylation (GO:0044030),1/10,0.0149023554252653,0.0367010136271163,0,0,76.47892720306514,321.6884165593148,MYC
GO_Biological_Process_2021,negative regulation of telomerase activity (GO:0051974),1/10,0.0149023554252653,0.0367010136271163,0,0,76.47892720306514,321.6884165593148,TP53
GO_Biological_Process_2021,regulation of organ growth (GO:0046620),1/10,0.0149023554252653,0.0367010136271163,0,0,76.47892720306514,321.6884165593148,PTEN
GO_Biological_Process_2021,regulation of receptor binding (GO:1900120),1/10,0.0149023554252653,0.0367010136271163,0,0,76.47892720306514,321.6884165593148,MMP9
GO_Biological_Process_2021,regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045898),1/10,0.0149023554252653,0.0367010136271163,0,0,76.47892720306514,321.6884165593148,TP53
GO_Biological_Process_2021,regulation of tau-protein kinase activity (GO:1902947),1/10,0.0149023554252653,0.0367010136271163,0,0,76.47892720306514,321.6884165593148,RB1
GO_Biological_Process_2021,hematopoietic stem cell differentiation (GO:0060218),1/10,0.0149023554252653,0.0367010136271163,0,0,76.47892720306514,321.6884165593148,TP53
GO_Biological_Process_2021,positive regulation of keratinocyte migration (GO:0051549),1/10,0.0149023554252653,0.0367010136271163,0,0,76.47892720306514,321.6884165593148,MMP9
GO_Biological_Process_2021,positive regulation of mesenchymal cell proliferation (GO:0002053),1/10,0.0149023554252653,0.0367010136271163,0,0,76.47892720306514,321.6884165593148,MYC
GO_Biological_Process_2021,lactation (GO:0007595),1/10,0.0149023554252653,0.0367010136271163,0,0,76.47892720306514,321.6884165593148,VEGFA
GO_Biological_Process_2021,positive regulation of T cell apoptotic process (GO:0070234),1/10,0.0149023554252653,0.0367010136271163,0,0,76.47892720306514,321.6884165593148,TP53
GO_Biological_Process_2021,mitotic DNA replication (GO:1902969),1/10,0.0149023554252653,0.0367010136271163,0,0,76.47892720306514,321.6884165593148,MCM2
GO_Biological_Process_2021,presynaptic membrane assembly (GO:0097105),1/10,0.0149023554252653,0.0367010136271163,0,0,76.47892720306514,321.6884165593148,PTEN
GO_Biological_Process_2021,myelin maintenance (GO:0043217),1/10,0.0149023554252653,0.0367010136271163,0,0,76.47892720306514,321.6884165593148,PTEN
GO_Biological_Process_2021,regulation of phosphorylation (GO:0042325),2/125,0.0150362505284807,0.0369325410858704,0,0,11.525551684088269,48.37609771345922,CDKN2A;EGFR
GO_Biological_Process_2021,circulatory system development (GO:0072359),2/126,0.0152646533217662,0.037295696506479,0,0,11.432027649769584,47.811201675266936,PIK3CA;PTEN
GO_Biological_Process_2021,phosphatidylinositol biosynthetic process (GO:0006661),2/126,0.0152646533217662,0.037295696506479,0,0,11.432027649769584,47.811201675266936,PIK3CA;PTEN
GO_Biological_Process_2021,ubiquitin-dependent protein catabolic process (GO:0006511),3/354,0.0156747656315464,0.0379213990955021,0,0,6.210509654954099,25.80903450086288,CDC20;UBE2C;AURKA
GO_Biological_Process_2021,positive regulation of canonical Wnt signaling pathway (GO:0090263),2/130,0.0161932461679938,0.0379213990955021,0,0,11.072544642857142,45.653884539843645,COL1A1;EGFR
GO_Biological_Process_2021,angiogenesis involved in wound healing (GO:0060055),1/11,0.0163807339505408,0.0379213990955021,0,0,68.82758620689656,282.994903106762,VEGFA
GO_Biological_Process_2021,camera-type eye morphogenesis (GO:0048593),1/11,0.0163807339505408,0.0379213990955021,0,0,68.82758620689656,282.994903106762,VEGFA
GO_Biological_Process_2021,regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267),1/11,0.0163807339505408,0.0379213990955021,0,0,68.82758620689656,282.994903106762,MMP9
GO_Biological_Process_2021,central nervous system myelination (GO:0022010),1/11,0.0163807339505408,0.0379213990955021,0,0,68.82758620689656,282.994903106762,PTEN
GO_Biological_Process_2021,regulation of lipid kinase activity (GO:0043550),1/11,0.0163807339505408,0.0379213990955021,0,0,68.82758620689656,282.994903106762,RB1
GO_Biological_Process_2021,nuclear DNA replication (GO:0033260),1/11,0.0163807339505408,0.0379213990955021,0,0,68.82758620689656,282.994903106762,MCM2
GO_Biological_Process_2021,regulation of mesenchymal cell proliferation (GO:0010464),1/11,0.0163807339505408,0.0379213990955021,0,0,68.82758620689656,282.994903106762,MYC
GO_Biological_Process_2021,phosphorylated carbohydrate dephosphorylation (GO:0046838),1/11,0.0163807339505408,0.0379213990955021,0,0,68.82758620689656,282.994903106762,PTEN
GO_Biological_Process_2021,positive regulation of bone resorption (GO:0045780),1/11,0.0163807339505408,0.0379213990955021,0,0,68.82758620689656,282.994903106762,SPP1
GO_Biological_Process_2021,regulation of synapse maturation (GO:0090128),1/11,0.0163807339505408,0.0379213990955021,0,0,68.82758620689656,282.994903106762,CDC20
GO_Biological_Process_2021,positive regulation of dendrite development (GO:1900006),1/11,0.0163807339505408,0.0379213990955021,0,0,68.82758620689656,282.994903106762,ALK
GO_Biological_Process_2021,positive regulation of leukocyte apoptotic process (GO:2000108),1/11,0.0163807339505408,0.0379213990955021,0,0,68.82758620689656,282.994903106762,CDKN2A
GO_Biological_Process_2021,induction of positive chemotaxis (GO:0050930),1/11,0.0163807339505408,0.0379213990955021,0,0,68.82758620689656,282.994903106762,VEGFA
GO_Biological_Process_2021,inositol phosphate dephosphorylation (GO:0046855),1/11,0.0163807339505408,0.0379213990955021,0,0,68.82758620689656,282.994903106762,PTEN
GO_Biological_Process_2021,positive regulation of neuroblast proliferation (GO:0002052),1/11,0.0163807339505408,0.0379213990955021,0,0,68.82758620689656,282.994903106762,VEGFA
GO_Biological_Process_2021,tetrahydrofolate metabolic process (GO:0046653),1/11,0.0163807339505408,0.0379213990955021,0,0,68.82758620689656,282.994903106762,TYMS
GO_Biological_Process_2021,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),1/11,0.0163807339505408,0.0379213990955021,0,0,68.82758620689656,282.994903106762,TP53
GO_Biological_Process_2021,presynaptic membrane organization (GO:0097090),1/11,0.0163807339505408,0.0379213990955021,0,0,68.82758620689656,282.994903106762,PTEN
GO_Biological_Process_2021,monocyte differentiation (GO:0030224),1/11,0.0163807339505408,0.0379213990955021,0,0,68.82758620689656,282.994903106762,VEGFA
GO_Biological_Process_2021,regulation of cell adhesion (GO:0030155),2/133,0.0169052903850118,0.0389410420311466,0,0,10.81733914940022,44.136135547977105,ERBB2;VEGFA
GO_Biological_Process_2021,regulation of cell motility (GO:2000145),2/133,0.0169052903850118,0.0389410420311466,0,0,10.81733914940022,44.136135547977105,ERBB2;EGFR
GO_Biological_Process_2021,positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),2/134,0.0171455849404774,0.0391837734035003,0,0,10.734848484848484,43.64805041468954,TP53;VEGFA
GO_Biological_Process_2021,negative regulation of cell division (GO:0051782),1/12,0.0178569680089386,0.0391837734035003,0,0,62.56739811912226,251.8563944353508,MYC
GO_Biological_Process_2021,regulation of actin filament depolymerization (GO:0030834),1/12,0.0178569680089386,0.0391837734035003,0,0,62.56739811912226,251.8563944353508,PIK3CA
GO_Biological_Process_2021,brain morphogenesis (GO:0048854),1/12,0.0178569680089386,0.0391837734035003,0,0,62.56739811912226,251.8563944353508,PTEN
GO_Biological_Process_2021,cell cycle checkpoint signaling (GO:0000075),1/12,0.0178569680089386,0.0391837734035003,0,0,62.56739811912226,251.8563944353508,BUB1
GO_Biological_Process_2021,negative regulation of vascular permeability (GO:0043116),1/12,0.0178569680089386,0.0391837734035003,0,0,62.56739811912226,251.8563944353508,VEGFA
GO_Biological_Process_2021,chromatin assembly or disassembly (GO:0006333),1/12,0.0178569680089386,0.0391837734035003,0,0,62.56739811912226,251.8563944353508,TP53
GO_Biological_Process_2021,double-strand break repair via break-induced replication (GO:0000727),1/12,0.0178569680089386,0.0391837734035003,0,0,62.56739811912226,251.8563944353508,MCM2
GO_Biological_Process_2021,positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190),1/12,0.0178569680089386,0.0391837734035003,0,0,62.56739811912226,251.8563944353508,VEGFA
GO_Biological_Process_2021,exit from mitosis (GO:0010458),1/12,0.0178569680089386,0.0391837734035003,0,0,62.56739811912226,251.8563944353508,UBE2C
GO_Biological_Process_2021,eye photoreceptor cell differentiation (GO:0001754),1/12,0.0178569680089386,0.0391837734035003,0,0,62.56739811912226,251.8563944353508,VEGFA
GO_Biological_Process_2021,positive regulation of cellular senescence (GO:2000774),1/12,0.0178569680089386,0.0391837734035003,0,0,62.56739811912226,251.8563944353508,CDKN2A
GO_Biological_Process_2021,gas transport (GO:0015669),1/12,0.0178569680089386,0.0391837734035003,0,0,62.56739811912226,251.8563944353508,MYC
GO_Biological_Process_2021,inositol phosphate catabolic process (GO:0071545),1/12,0.0178569680089386,0.0391837734035003,0,0,62.56739811912226,251.8563944353508,PTEN
GO_Biological_Process_2021,positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),1/12,0.0178569680089386,0.0391837734035003,0,0,62.56739811912226,251.8563944353508,RB1
GO_Biological_Process_2021,positive regulation of mitotic metaphase/anaphase transition (GO:0045842),1/12,0.0178569680089386,0.0391837734035003,0,0,62.56739811912226,251.8563944353508,RB1
GO_Biological_Process_2021,positive regulation of mitotic sister chromatid separation (GO:1901970),1/12,0.0178569680089386,0.0391837734035003,0,0,62.56739811912226,251.8563944353508,RB1
GO_Biological_Process_2021,positive regulation of vascular permeability (GO:0043117),1/12,0.0178569680089386,0.0391837734035003,0,0,62.56739811912226,251.8563944353508,VEGFA
GO_Biological_Process_2021,mitotic nuclear membrane disassembly (GO:0007077),1/12,0.0178569680089386,0.0391837734035003,0,0,62.56739811912226,251.8563944353508,CCNB1
GO_Biological_Process_2021,mRNA transcription (GO:0009299),1/12,0.0178569680089386,0.0391837734035003,0,0,62.56739811912226,251.8563944353508,TP53
GO_Biological_Process_2021,chromatin organization (GO:0006325),2/142,0.0191203122992009,0.0412413380192704,0,0,10.11734693877551,40.03438268908486,RB1;MYC
GO_Biological_Process_2021,negative regulation of hydrogen peroxide-induced cell death (GO:1903206),1/13,0.0193310605643026,0.0412413380192704,0,0,57.35057471264368,226.30778348154325,MET
GO_Biological_Process_2021,regulation of cell aging (GO:0090342),1/13,0.0193310605643026,0.0412413380192704,0,0,57.35057471264368,226.30778348154325,FOXM1
GO_Biological_Process_2021,cardiac cell development (GO:0055006),1/13,0.0193310605643026,0.0412413380192704,0,0,57.35057471264368,226.30778348154325,VEGFA
GO_Biological_Process_2021,central nervous system neuron axonogenesis (GO:0021955),1/13,0.0193310605643026,0.0412413380192704,0,0,57.35057471264368,226.30778348154325,PTEN
GO_Biological_Process_2021,regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),1/13,0.0193310605643026,0.0412413380192704,0,0,57.35057471264368,226.30778348154325,CCNB1
GO_Biological_Process_2021,entry into host (GO:0044409),1/13,0.0193310605643026,0.0412413380192704,0,0,57.35057471264368,226.30778348154325,MET
GO_Biological_Process_2021,positive regulation of cell aging (GO:0090343),1/13,0.0193310605643026,0.0412413380192704,0,0,57.35057471264368,226.30778348154325,CDKN2A
GO_Biological_Process_2021,relaxation of cardiac muscle (GO:0055119),1/13,0.0193310605643026,0.0412413380192704,0,0,57.35057471264368,226.30778348154325,PIK3CA
GO_Biological_Process_2021,positive regulation of histone deacetylation (GO:0031065),1/13,0.0193310605643026,0.0412413380192704,0,0,57.35057471264368,226.30778348154325,VEGFA
GO_Biological_Process_2021,positive regulation of lipid transport (GO:0032370),1/13,0.0193310605643026,0.0412413380192704,0,0,57.35057471264368,226.30778348154325,SPP1
GO_Biological_Process_2021,negative regulation of DNA-binding transcription factor activity (GO:0043433),2/143,0.0193736307109963,0.0412413380192704,0,0,10.045086119554204,39.61623634122261,RB1;CDKN2A
GO_Biological_Process_2021,neuron development (GO:0048666),2/143,0.0193736307109963,0.0412413380192704,0,0,10.045086119554204,39.61623634122261,ALK;RB1
GO_Biological_Process_2021,branching involved in blood vessel morphogenesis (GO:0001569),1/14,0.02080301457834,0.0433864673413127,0,0,52.93633952254642,205.00430545239047,VEGFA
GO_Biological_Process_2021,nuclear membrane disassembly (GO:0051081),1/14,0.02080301457834,0.0433864673413127,0,0,52.93633952254642,205.00430545239047,CCNB1
GO_Biological_Process_2021,ovarian follicle development (GO:0001541),1/14,0.02080301457834,0.0433864673413127,0,0,52.93633952254642,205.00430545239047,VEGFA
GO_Biological_Process_2021,pancreas development (GO:0031016),1/14,0.02080301457834,0.0433864673413127,0,0,52.93633952254642,205.00430545239047,MET
GO_Biological_Process_2021,regulation of protein kinase C signaling (GO:0090036),1/14,0.02080301457834,0.0433864673413127,0,0,52.93633952254642,205.00430545239047,VEGFA
GO_Biological_Process_2021,regulation of trophoblast cell migration (GO:1901163),1/14,0.02080301457834,0.0433864673413127,0,0,52.93633952254642,205.00430545239047,VEGFA
GO_Biological_Process_2021,relaxation of muscle (GO:0090075),1/14,0.02080301457834,0.0433864673413127,0,0,52.93633952254642,205.00430545239047,PIK3CA
GO_Biological_Process_2021,steroid catabolic process (GO:0006706),1/14,0.02080301457834,0.0433864673413127,0,0,52.93633952254642,205.00430545239047,SPP1
GO_Biological_Process_2021,positive regulation of transmembrane transport (GO:0034764),1/14,0.02080301457834,0.0433864673413127,0,0,52.93633952254642,205.00430545239047,BRAF
GO_Biological_Process_2021,cellular response to organic cyclic compound (GO:0071407),2/150,0.0211864844342244,0.0440869316541389,0,0,9.566602316602316,36.87343378412446,SPP1;EGFR
GO_Biological_Process_2021,negative regulation of protein phosphorylation (GO:0001933),2/152,0.0217170439806354,0.0450319724468148,0,0,9.438095238095238,36.14467589357818,RB1;PTEN
GO_Biological_Process_2021,positive regulation of Wnt signaling pathway (GO:0030177),2/153,0.0219844015706981,0.0450319724468148,0,0,9.37511825922422,35.78878360110144,COL1A1;EGFR
GO_Biological_Process_2021,regulation of branching involved in ureteric bud morphogenesis (GO:0090189),1/15,0.0222728330244505,0.0450319724468148,0,0,49.152709359605915,186.9959576603662,VEGFA
GO_Biological_Process_2021,regulation of endothelial cell chemotaxis (GO:2001026),1/15,0.0222728330244505,0.0450319724468148,0,0,49.152709359605915,186.9959576603662,MET
GO_Biological_Process_2021,regulation of extracellular matrix organization (GO:1903053),1/15,0.0222728330244505,0.0450319724468148,0,0,49.152709359605915,186.9959576603662,RB1
GO_Biological_Process_2021,central nervous system neuron development (GO:0021954),1/15,0.0222728330244505,0.0450319724468148,0,0,49.152709359605915,186.9959576603662,PTEN
GO_Biological_Process_2021,peptidyl-tyrosine autophosphorylation (GO:0038083),1/15,0.0222728330244505,0.0450319724468148,0,0,49.152709359605915,186.9959576603662,EGFR
GO_Biological_Process_2021,photoreceptor cell development (GO:0042461),1/15,0.0222728330244505,0.0450319724468148,0,0,49.152709359605915,186.9959576603662,VEGFA
GO_Biological_Process_2021,eye photoreceptor cell development (GO:0042462),1/15,0.0222728330244505,0.0450319724468148,0,0,49.152709359605915,186.9959576603662,VEGFA
GO_Biological_Process_2021,response to muscle stretch (GO:0035994),1/15,0.0222728330244505,0.0450319724468148,0,0,49.152709359605915,186.9959576603662,PIK3CA
GO_Biological_Process_2021,positive regulation of protein export from nucleus (GO:0046827),1/15,0.0222728330244505,0.0450319724468148,0,0,49.152709359605915,186.9959576603662,TP53
GO_Biological_Process_2021,positive regulation of sprouting angiogenesis (GO:1903672),1/15,0.0222728330244505,0.0450319724468148,0,0,49.152709359605915,186.9959576603662,VEGFA
GO_Biological_Process_2021,myoblast differentiation (GO:0045445),1/15,0.0222728330244505,0.0450319724468148,0,0,49.152709359605915,186.9959576603662,RB1
GO_Biological_Process_2021,regulation of signal transduction by p53 class mediator (GO:1901796),2/156,0.0227947322131804,0.0459867582339979,0,0,9.191094619666048,34.7536042255875,TP53;AURKA
GO_Biological_Process_2021,negative regulation of anoikis (GO:2000811),1/16,0.0237405188646141,0.0465756789589676,0,0,45.87356321839081,171.5933676703201,PIK3CA
GO_Biological_Process_2021,negative regulation of cell-substrate junction organization (GO:0150118),1/16,0.0237405188646141,0.0465756789589676,0,0,45.87356321839081,171.5933676703201,PTEN
GO_Biological_Process_2021,negative regulation of epithelial cell differentiation (GO:0030857),1/16,0.0237405188646141,0.0465756789589676,0,0,45.87356321839081,171.5933676703201,MMP9
GO_Biological_Process_2021,negative regulation of focal adhesion assembly (GO:0051895),1/16,0.0237405188646141,0.0465756789589676,0,0,45.87356321839081,171.5933676703201,PTEN
GO_Biological_Process_2021,regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),1/16,0.0237405188646141,0.0465756789589676,0,0,45.87356321839081,171.5933676703201,VEGFA
GO_Biological_Process_2021,body fluid secretion (GO:0007589),1/16,0.0237405188646141,0.0465756789589676,0,0,45.87356321839081,171.5933676703201,VEGFA
GO_Biological_Process_2021,dendritic spine morphogenesis (GO:0060997),1/16,0.0237405188646141,0.0465756789589676,0,0,45.87356321839081,171.5933676703201,PTEN
GO_Biological_Process_2021,regulation of mitotic sister chromatid separation (GO:0010965),1/16,0.0237405188646141,0.0465756789589676,0,0,45.87356321839081,171.5933676703201,UBE2C
GO_Biological_Process_2021,regulation of monocyte differentiation (GO:0045655),1/16,0.0237405188646141,0.0465756789589676,0,0,45.87356321839081,171.5933676703201,MYC
GO_Biological_Process_2021,DNA unwinding involved in DNA replication (GO:0006268),1/16,0.0237405188646141,0.0465756789589676,0,0,45.87356321839081,171.5933676703201,MCM2
GO_Biological_Process_2021,resolution of meiotic recombination intermediates (GO:0000712),1/16,0.0237405188646141,0.0465756789589676,0,0,45.87356321839081,171.5933676703201,TOP2A
GO_Biological_Process_2021,response to organophosphorus (GO:0046683),1/16,0.0237405188646141,0.0465756789589676,0,0,45.87356321839081,171.5933676703201,TYMS
GO_Biological_Process_2021,mitotic sister chromatid cohesion (GO:0007064),1/16,0.0237405188646141,0.0465756789589676,0,0,45.87356321839081,171.5933676703201,RB1
GO_Biological_Process_2021,heart development (GO:0007507),2/164,0.0250153942087175,0.048026389942241,0,0,8.7336860670194,32.21213881896081,PTEN;VEGFA
GO_Biological_Process_2021,negative regulation of ATPase activity (GO:0032780),1/17,0.0252060750668781,0.048026389942241,0,0,43.00431034482759,158.28468525367578,TP53
GO_Biological_Process_2021,negative regulation of cell aging (GO:0090344),1/17,0.0252060750668781,0.048026389942241,0,0,43.00431034482759,158.28468525367578,FOXM1
GO_Biological_Process_2021,regulation of establishment of endothelial barrier (GO:1903140),1/17,0.0252060750668781,0.048026389942241,0,0,43.00431034482759,158.28468525367578,VEGFA
GO_Biological_Process_2021,cellular response to gamma radiation (GO:0071480),1/17,0.0252060750668781,0.048026389942241,0,0,43.00431034482759,158.28468525367578,TP53
GO_Biological_Process_2021,negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),1/17,0.0252060750668781,0.048026389942241,0,0,43.00431034482759,158.28468525367578,PTEN
GO_Biological_Process_2021,regulation of leukocyte migration (GO:0002685),1/17,0.0252060750668781,0.048026389942241,0,0,43.00431034482759,158.28468525367578,VEGFA
GO_Biological_Process_2021,regulation of neuroblast proliferation (GO:1902692),1/17,0.0252060750668781,0.048026389942241,0,0,43.00431034482759,158.28468525367578,VEGFA
GO_Biological_Process_2021,DNA biosynthetic process (GO:0071897),1/17,0.0252060750668781,0.048026389942241,0,0,43.00431034482759,158.28468525367578,TYMS
GO_Biological_Process_2021,epithelial cell morphogenesis (GO:0003382),1/17,0.0252060750668781,0.048026389942241,0,0,43.00431034482759,158.28468525367578,MET
GO_Biological_Process_2021,positive regulation of DNA replication (GO:0045740),1/17,0.0252060750668781,0.048026389942241,0,0,43.00431034482759,158.28468525367578,EGFR
GO_Biological_Process_2021,positive regulation of positive chemotaxis (GO:0050927),1/17,0.0252060750668781,0.048026389942241,0,0,43.00431034482759,158.28468525367578,VEGFA
GO_Biological_Process_2021,vasculature development (GO:0001944),1/17,0.0252060750668781,0.048026389942241,0,0,43.00431034482759,158.28468525367578,PIK3CA
GO_Biological_Process_2021,"protein localization to chromosome, centromeric region (GO:0071459)",1/17,0.0252060750668781,0.048026389942241,0,0,43.00431034482759,158.28468525367578,RB1
GO_Biological_Process_2021,regulation of MAPK cascade (GO:0043408),2/166,0.0255839561452235,0.0486462903295215,0,0,8.626306620209059,31.62222713955805,ERBB2;EGFR
GO_Biological_Process_2021,regulation of nucleic acid-templated transcription (GO:1903506),3/430,0.0260756390245396,0.0492933358486471,0,0,5.085349986989331,18.5450192430394,RB1;E2F1;TP53
GO_Biological_Process_2021,negative regulation of cation transmembrane transport (GO:1904063),1/18,0.0266695046006179,0.0492933358486471,0,0,40.47261663286004,146.68225415832842,MMP9
GO_Biological_Process_2021,negative regulation of lipid catabolic process (GO:0050995),1/18,0.0266695046006179,0.0492933358486471,0,0,40.47261663286004,146.68225415832842,ALK
GO_Biological_Process_2021,regulation of chromosome segregation (GO:0051983),1/18,0.0266695046006179,0.0492933358486471,0,0,40.47261663286004,146.68225415832842,BUB1
GO_Biological_Process_2021,cell migration involved in sprouting angiogenesis (GO:0002042),1/18,0.0266695046006179,0.0492933358486471,0,0,40.47261663286004,146.68225415832842,VEGFA
GO_Biological_Process_2021,negative regulation of Rho protein signal transduction (GO:0035024),1/18,0.0266695046006179,0.0492933358486471,0,0,40.47261663286004,146.68225415832842,MET
GO_Biological_Process_2021,DNA conformation change (GO:0071103),1/18,0.0266695046006179,0.0492933358486471,0,0,40.47261663286004,146.68225415832842,TOP2A
GO_Biological_Process_2021,regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091),1/18,0.0266695046006179,0.0492933358486471,0,0,40.47261663286004,146.68225415832842,TOP2A
GO_Biological_Process_2021,positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),1/18,0.0266695046006179,0.0492933358486471,0,0,40.47261663286004,146.68225415832842,VEGFA
GO_Biological_Process_2021,positive regulation of CREB transcription factor activity (GO:0032793),1/18,0.0266695046006179,0.0492933358486471,0,0,40.47261663286004,146.68225415832842,VEGFA
GO_Biological_Process_2021,regulation of transcription by RNA polymerase I (GO:0006356),1/18,0.0266695046006179,0.0492933358486471,0,0,40.47261663286004,146.68225415832842,ERBB2
GO_Biological_Process_2021,positive regulation of excitatory postsynaptic potential (GO:2000463),1/18,0.0266695046006179,0.0492933358486471,0,0,40.47261663286004,146.68225415832842,PTEN
GO_Biological_Process_2021,positive regulation of extracellular matrix organization (GO:1903055),1/18,0.0266695046006179,0.0492933358486471,0,0,40.47261663286004,146.68225415832842,RB1
GO_Biological_Process_2021,presynapse assembly (GO:0099054),1/18,0.0266695046006179,0.0492933358486471,0,0,40.47261663286004,146.68225415832842,PTEN
GO_Biological_Process_2021,neuron projection development (GO:0031175),2/171,0.0270284247863527,0.0498572138489295,0,0,8.368977176669484,30.219256789750094,RB1;PTEN
